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ABSTRACT 
When exposed to environmental stress, a pure culture of Salmonella enterica serovar 
Typhimurium (S. Typhimurium) differentiates into two specialized cell types with 34% 
differential gene expression: planktonic cells and multicellular aggregates, also called biofilm. 
Some conditions that support phenotype switching are known, but many intrinsic and extrinsic 
origins of signals are unknown. S. Typhimurium phenotype switching may promote transmission 
under variable conditions; planktonic cells express virulence factors and are immediately able to 
infect a new host, whereas aggregates can resist harsh environmental conditions until an 
opportunity to infect a new host arises. The objective of these research projects was to determine 
whether signals in the host gut could promote phenotype switching, and to determine the suite of 
genes controlled during phenotype switching, to understand this phenomenon and how it 
contributes to transmission.  
Differences in expression between biofilm aggregates and planktonic cells are directed by 
bistable expression of CsgD, the central biofilm regulator. CsgD is expressed at low levels in 
planktonic cells and at high levels in biofilm cells, and coordinates the global shift in expression . 
A ChIP-seq experiment was performed to identify the regulatory targets of CsgD. The technique 
was refined for improved antibody binding and sample consistency; however, no statistically 
significant regulatory regions were identified by this method.  
 Phenotype switching could initiate in the host gut, as a result of extrinsic signals 
from the host or microbiota, during infection. Gene expression of virulence- or persistence-
associated genes that were differentially expressed in RNA-seq data were measured by luciferase 
assay with promoter-luxCDABE reporter in the presence of chemostat waste effluent. The only 
major changes to gene expression levels or times in the presence of waste effluent may be due to 
additional resources for growth provided by the waste effluent and chemostat media control.  
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1.0 INTRODUCTION 
1.1 Introduction to Salmonella 
Salmonellae are gram-negative, oxidase negative, catalase positive, motile, facultative 
anaerobic bacilli that are 0.7-1.5 µm wide and 2.0-5.0 µm long19. Growth can occur between 4°C 
and 54°C; however, optimal growth is at 37°C, the human body core temperature156. They are 
infectious and are therefore classified as Risk Group 2 and Containment Level 2 organisms19. 
Salmonellae tolerate pH between 3.8 and 9.5, with optimal growth at pH 6.5-7.5156. The genus 
Salmonella was named after D. E. Salmon, who first isolated Salmonella enterica serovar 
Choleraesuis from porcine intestine in 1884108. In the laboratory, Salmonella can be isolated 
though growth on selective agar, such as XLD agar, Hektoen agar, or selenite agar with brilliant 
green76. They can be further identified though serotyping and genetic analysis76. In humans, 
Salmonella infections can cause gastroenteritis, enteric (typhoid) fever, bacteremia, or an 
asymptomatic carrier state46. This thesis is primarily concerned with Salmonella enterica serovar 
Typhimurium, which causes gastroenteritis and can be transmitted from other infected 
individuals, animals, or environmental sources via the fecal-oral route49,176.  
 
1.1.1 Classification of Salmonella 
Salmonella is a genus in the family Enterobacteriaceae, order Enterobacteriales, class 
Gammaproteobacteria, and phylum Proteobacteria174. The Salmonella genus is further 
subdivided into species, subspecies, serovars, and strains based on taxonomy and serology 
(Figure 1.1). Originally, species were assigned based on clinical origins, and antigenic and 
biochemical characteristics102. In the 1980’s, strains in the Salmonella genus were divided into 
two species by nucleic acid homology: Salmonella enterica36 and Salmonella bongori141,173. 
These species are further subdivided by the White-Kauffmann-Le Minor scheme into more than 
2 600 serotypes, based on flagellar (H1 or H2), oligosaccharide (O), and capsular polysaccharide 
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(K) surface antigens40,64. The most well known serotypes are S. enterica serovars Typhi, 
Paratyphi, Enteriditis, Typhimurium and Choleraesuis173. Diversity in surface antigens may be 
driven by immune selection44. Serovars are antigenically and genetically distinct with 
independently acquired regions which may include cytolethal distending toxins, anaerobic 
respiratory reductases, T3SS effectors, fimbriae, and iron acquisition systems39. S. enterica is 
divided into six subspecies64,178 which are reffered to by name and roman numeral: S. enterica 
subsp. enterica (I), S. enterica subsp. salamae (II), S. enterica subsp. arizonae (IIIa), S. enterica 
subsp. diarizonae (IIIb), S. enterica subsp. houtenae (IV), S. enterica subsp. indica (VI)64. 
Subspecies enterica are commonly isolated from infections in humans and domestic mammals, 
whereas the other five subspecies are commonly isolated from cold-blooded animals39.  
 
Figure 1.1. (Figure 1, MacKenzie et al. (2017) Frontiers in Veterinary Science110). 
Salmonella taxonomy and general classifications. The genus Salmonella is classified into 
species, subspecies, and serovars based on the White–Kauffman–Le Minor scheme. Serovars are 
often grouped into non-typhoidal or typhoidal categories; however, this referencing approach is 
not a part of the official Salmonella classification scheme.  
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Salmonella can also be categorized by the diseases that they cause in humans and the host 
organisms from which they are commonly isolated. Gastroenteritis, characterized by diarrhea 
and often accompanied by nausea, vomiting, and headache, is commonly caused by nontyphoidal 
Salmonella serovars S. Enteritidis and S. Typhimurium46,176. Typhoid or enteric fever, 
characterized by the invasion of extraintestinal tissue and often lacking symptoms of fever or 
inflammation, is caused by serovars S. Typhi, S. Paratyphi A, and S. Paratyphi B176. Recently, a 
third disease group, invasive nontyphoidal Salmonella (iNTS), has been identified as a group of 
NTS strains that can cause extraintestinal infections49.  
Salmonella are not limited to colonizing humans and can be described by their ability to 
colonize different hosts. Host generalist serovars are able to colonize several different organisms. 
For example, serovars S. Enteritidis and S. Typhimurium are able to colonize a broad range of 
organisms22. Serovars that are host-adapted mainly colonize one host organism and infrequently 
cause disease in other hosts. For example, S. Choleraesuis, S. Arizonae, and S. Dublin primarily 
colonize pigs, reptiles, and cattle, respectively22. Host restricted Salmonella cause disease in a 
single host. For example, host-restricted Salmonella serovars, S. Typhi and S. Paratyphi, cause 
disease in humans92,110.  
 
1.1.2 Salmonella diseases and epidemiology 
The global impact of typhoidal, nontyphoidal, and invasive nontyphoidal Salmonella 
infections is considerable. There are an estimated 175 000 000 illnesses and 265 000 deaths that 
can be attributed to all invasive and diarrheal Salmonella infections92. Salmonella infections are 
responsible for an estimated 8.76 million disability adjusted life years (DALYs) from all 
transmission sources, and 6.43 million DALYs from contaminated food92. The global economic 
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costs of Salmonella as a foodborne disease are extensive; they are estimated from DALYs, 
hospitalizations, lost wages, producer litigation, premature death, lost tourism revenue, and trade 
embargo175. The economic burden of nontyphoidal Salmonella in the US, estimated using these 
parameters, was 3.67 billion dollars75,161. Gastroenteritis caused by nontyphoidal Salmonella is 
the most common clinical manifestation in both developed and underdeveloped nations92. 
Invasive nontyphoidal Salmonella is endemic in underdeveloped countries, particularly sub-
Saharan African nations, with high incidence rates among infants and HIV-infected 
individuals46. Likewise, enteric fever is endemic in many African and Asian countries, with low 
incidence, less than 10 per 100 000 annually, in European and North American countries46.  
Salmonella is primarily transmitted through the fecal-oral route via food or water 
contaminated with feces from infected animals or humans. Poultry, swine, cattle, eggs, dairy 
products, some fresh fruits and vegetables are often sources of foodborne Salmonella infections46 
(Figure 1.2). Transmission from these sources may be expedited by long-term survival of 
persistent Salmonella183. Transmission is possible for the duration of shedding in feces, which 
could be up to 20 weeks for recently infected individuals, several years for chronic carriers, or 
intermittently or persistently for animal carriers19. By ingestion, the infectious dose is 
approximately 103 bacilli for nontyphoidal Salmonella, and 105 bacilli for enteric fever, although 
infectious dose varies with serotype for nontyphoidal Salmonella 19. Of course, the infectious 
dose is much lower for immunocompromised individuals or individuals who are taking stomach-
acid buffering medications, and onset of disease symptoms often depends on the size of the 
inoculum19. 
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Figure 1.2. (Adapted, Figure 4, MacKenzie et al. (2017) Frontiers in Veterinary Science110). 
Salmonella strains that are host-generalists can encounter several host species and 
environments in a typical life cycle. Transfer of Salmonella to humans may occur zoonotically 
or through ingestion of contaminated vegetables (i.e., tomatoes, sprouts) or processed foods.  
 
Gastroenteritis is usually characterized by acute onset non-bloody diarrhea, fever, 
abdominal cramps, nausea, vomiting, myalgia, and headache46. Nontyphoidal infections are 
localized to the ileum, but rare infections cause inflammation in the jejunum, duodenum, and 
stomach16,26. Uncommon complications of infection are hepatomegaly, splenomegaly, 
cholecystitis, appendicitis, and pancreatitis76. Nontyphoidal infections usually have a shorter 
incubation period than typhoid infections; symptoms usually occur 6-72 hours after 
ingestion26,46. Usually symptoms last 5-7 days and resolve spontaneously in self-limiting 
diarrheal disease26. Globally, gastroenteritis is predominantly caused by serovars S. Enteritidis, S. 
Typhimurium, and S. Newport46. After ingestion, virulence genes are expressed and colonization 
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initiates at the intestinal epithelium. Neutrophil recruitment and and inflammation in the host 
response leads to necrosis, edema, and fluid secretion, which manifests as diarrhea26. Typhoid or 
enteric fever is characterized by a gradually intensifying fever46, headache, rose-coloured rash, 
abdominal pain, myalgia, and may be accompanied by bradycardia, hepatomegaly, 
splenomegaly, diarrhea (children) or constipation (adults)96. Infants, elderly, or 
immunocompromised individuals may experience complications173 which may include 
hemmorhage due to gut perforations, myocarditis, encepalopathy, urinary tract infections, 
pancreatitis, hepatitis, and cholecystitis19,46. Symptom onset occurs a week or more after 
ingestion. Invasive disease is most commonly caused by serovars S. Typhi, S. Paratyphi, and S. 
Choleraesuis, although other serotypes are able to cause invasive salmonellosis173. After 
ingestion, Salmonella invade epithelial M-cells or are taken up by DCs in the intestine26. They 
translocate across the intestinal epithelium, access the host circulation, and infect other cell types 
and tissues26. Bacteremia is characterized by high fever and possibly leads to septic shock46. It is 
rare, more commonly caused by serovars S. Choleraesuis and S. Dublin, with a high mortality 
rate26,46. Comorbidity with other conditions is common in immunocompromised individuals19. 
Other extraintestinal complications of typhoid fever include urinary tract infections, pneumonia, 
endocarditis, meningitis, and cellulitis46. Asymptomatic carriers shed bacteria in feces for more 
than a year after acute symptoms of Salmonella infection46. Less than 5% of individuals who 
have experienced enteric fever, usually infants or elderly, become carriers. However, carriers of 
S. Typhi and S. Paratyphi are thought to be responsible for endemic transmission of enteric 
fever46. Carrier state development is even lower, approximately 0.1%, for nontyphoidal 
salmonellosis46.  
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1.1.3 Pathogenesis of Salmonella infections 
Pathogenesis of both nontyphoidal and typhoidal Salmonella serotypes is largely 
attributed to the function of two type three secretion systems (T3SS)119. The T3SSs mediate the 
transfer of virulence proteins, called effectors, into the host cytoplasm to stimulate uptake, 
invasion (SPI-1 T3SS), and survival in epithelial cells and macrophages (SPI-2 T3SS)68. The 
T3SS “needle” and effector proteins are encoded in large and unique chromosomal gene clusters 
called Salmonella pathogenicity islands62.  
Salmonellae initiate adherence and infection at the terminal ileum and colon through 
invasion of host intestinal epithelium68. After fimbrial contact with the apical surface of 
epithelial cells12, salmonellae induce their own uptake62.  SPI-1 injection of effectors SipA, 
SopB, SopD and SopE/E2 across the membrane activates cytoskeleton restructuring, or 
“membrane ruffling”, which engulfs the bacterium at the epithelial cell surface62. SPI-1 also 
activates innate immune responses: NF-kB signaling, IL-1b and IL-18 activation, 
proinflammatory cell death, and polymorphonuclear lymphocyte (PMN) recruitment across the 
intestinal epithelia26. These inflammatory effects, in addition to tight junction disruption and 
SopB-mediated chloride secretion, contributes to the development of diarrhea68,82.  
Salmonellae survive inside host cells through SPI-2-mediated alteration of host cell 
functions, including cytoskeletal rearrangements, vesicle trafficking, signal transduction, and 
cytokine expression68. These functions are directed from Salmonella resident in the intracellular 
salmonella containing vacuole (SCV), distinct from phagosomes or lysosomes59,68. Invasive 
disease proceeds when salmonellae access extraintestinal tissues, through uptake by microfold 
(M) cells or dendritic cells (DCs), and transported throughout the body84,144. They ultimately 
reside in macrophages, DCs, PMNs, other phagocytes, and hepatocytes123,145,193. 
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1.1.4 Susceptibility, treatment, and prevention of Salmonella infections 
Effective methods of controling or eliminating microorganisms is key to preventing 
incidence of disease through transmission. Salmonella survival depends on the inoculum size and 
environmental conditions, particularly the surfaces on which biofilm are established, but 
persistence has been observed on vegetable sources for days, animal products for weeks, and in 
soil and water for more than a year19. Biofilm-forming serovars may survive for longer periods 
of time32. Salmonellae can be physically inactivated with moist heat at 121°C for at least 15 
minutes, and dry heat at 170°C for at least 1 hour19. Incidence of infections can be decreased 
through proper food and water sanitation, pasteurization of dairy products, and elimination of 
human feces in food production46. Irradiation of food products is not practiced widespread, but 
can reduce the bacterial load and therefore the risk of foodborne illness46. Currently, there are 
vaccines to prevent enteric fever; however, vaccination does not protect against infections caused 
by S. Paratyphi and nontyphoidal serovars46. 
Established Salmonella infections are usually treated with fluid and electrolyte 
replacement, and antibiotics if necessary19. Antibiotics commonly prescribed are ampicillin, 
chloramphenicol, and trimethoprim-sulfamethoxazole46. However, antibiotic resistance is 
emerging as an issue for controlling Salmonella infections, since the first instance of Salmonella 
resistance to chloramphenicol was reported in the 1960s140. Salmonellae resistant to all three 
previously mentioned antibiotics are considered multi-drug resistant (MDR)46 and are often more 
virulent than susceptible strains51. MDR strains decrease the efficacy of primary treatment 
defenses, and increase the morbidity and mortality of Salmonella infections. High frequencies of 
MDR S. Typhi have been isolated in Africa and Asia; MDR nontyphoidal serovars are increasing 
globally with additional resistances to cephalosporins and nalidixic acid46. Currently, 
fluoroquinolones and next generation cephalosporins have been introduced to treat MDR 
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serotypes46. Prudent use of antimicrobial agents is key; however, host immunomodulatory agents 
may enhance infection control in the future, with decreased risk of resistance26.  
 
1.2 Salmonella Biofilms 
1.2.1 Salmonella biofilm characteristics 
Bacterial biofilms are structural aggregates of cells embedded in a self-produced matrix, 
usually associated with a physical surface32. Bacteria in these communities are resistant to 
environmental stress, antibiotics, disinfectants, and immune defenses171. As such, they are 
difficult to eradicate and are major issues in treating infections and in food production. 
Salmonella biofilms may not be visible in the environment; however, their physical attributes 
have been described. Salmonella biofilm is described as the rdar (red, dry, and rough) 
morphotype on semisolid agar supplemented with Congo Red dye and grown on low salt media 
at temperatures below 30°C or on iron-depleted media at 37°C29,155. Congo red dye binds to 
cellulose and curli amyloid fibres produced by Salmonella biofilms, which turns colonies red142. 
In liquid media, biofilm has two forms that can be seen in Figure 1.3: 1) a pellicle at the air-
liquid interface153, and 2) aggregates in the liquid phase111. Biofilm aggregates in the pellicle and 
the liquid phase share key properties of rdar biofilm; they produce curli fimbriae and cellulose186.  
Self-produced extracellular matrices formed by Salmonella are composed of extracellular 
polysaccharides and protein components that link cells together. Protein components of biofilm 
include curli fimbriae, formerly named thin aggregative fimbriae (Tafi, agf)150 and secreted 
BapA protein101. Curli are the major proteinaceous component of biofilm in Salmonella spp. and 
E. coli11. They are non-branching20, amyloid structures that are resistant to proteases and sodium 
dodecyl sulfate29. Curlin protein subunits composed of repeating strand-loop-strand motifs are 
folded into a parallel β-helix with extensive hydrogen bonding that may contribute to its 
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disproportionate stability30. Genes encoding the curlin protein and proteins for gene regulation, 
secretion, and assembly are encoded by the divergent operons csgBAC and csgDEFG, formerly 
agfBAC and agfDEFG 28,150. Regulation of biofilm formation, directed by CsgD, is complex and 
will be discussed later. Curli components encoded by the two operons are translocated through 
the inner membrane by Sec secretion, and assembled at the outer membrane11. CsgB encodes the 
minor nucleating subunit, onto which CsgA, the major structural subunits, are added. Curli fibers 
are involved in short-range adhesion to surfaces and other salmonellae in biofilm formation182, 
and to host cells in invasion11. Initial stages of biofilm formation are mediated by curli fimbriae 
interactions, which also allow salmonellae to adhere to Teflon and stainless steel surfaces8. Curli 
fimbriae are also hypothesized to have an important role in invasion and dissemination, due to 
their ability to bind to host cells130, fibronectin129, laminin128, plasminogen, and factor XII72. 
BapA, the other protein component of biofilm, is a very large (386 kDa) multidomain protein 
associated with the cell surface101. It is encoded by BapA in the bapABCD operon, which also 
encodes its own type I protein secretion system, BapBCD101. Experiments have demonstrated the 
important role of BapA in bacterial aggregation, pellicle formation, and host colonization101. 
BapA may mediate short range cell interactions in biofilm formation through direct protein-
protein binding, or by supporting curli fimbriae binding101. 
Polysaccharide components of biofilm include cellulose197, O-antigen capsule57, and 
small amounts of LPS. Cellulose is made of β(1→4)-D-glucose repeating linear polysaccharide 
chains arranged in a rigid matrix197. This polysaccharide lattice facilitates long-range surface or 
cell-cell interactions and, together with curli fimbriae, holds cells together197. It is essential for 
biofilm formation in lab models171, epithelial cell surfaces103, and abiotic surfaces139, and 
colonization of plant tissues10. The cellulose biosynthesis machinery, which produces and 
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assembles polysaccharides, is encoded by the divergent operons bcsABZC and bcsEFG 166,197. 
BcsA and BcsB (bacterial cellulose synthesis) encode the major functions for cellulose 
synthesis152. The BcsA-BcsB complex is activated when the secondary messenger c-di-GMP 
binds the BcsA PilZ domain120. Following activation, the enzyme polymerizes uridine-5’-
diphosphate α-D-glucose (UDP-glucose), originating from glycolytic intermediate glucose-6-
phosphate, to cellulose polymers152. Growing cellulose chains are synthesized on the cytoplasmic 
surface of the inner membrane, and exported to the cell surface152. The other subunits of 
cellulose synthesis alter yield, quality, and enzyme activity through modulating expression of 
biosynthesis genes, exporting the nascent chains to the cell surface, and organizing cellulose 
fibers once they have been exported152.  The O-antigen capsule is a highly hydrated lipid-
anchored exopolysaccharide with more than 2300 repeating oligosaccharide units, produced 
during biofilm formation57,165. It is structurally similar to LPS O-Antigen, but differs in size, 
charge, lipid attachment, side chain modifications, and immunoreactivity57,165,185. During 
assembly, a carrier lipid is flipped across the inner membrane, where O-Ag oligosaccharide units 
are polymerized, after which the polysaccharide is translocated across the outer membrane to the 
cell surface190. Capsule surface assembly and translocation functions are encoded by 
yihUTSRQPO and yihVW, which are conserved in the Salmonella genus57. The O-Ag capsule 
allows salmonellae to tolerate desiccation, and has proposed functions in environmental 
persistence and, ultimately, transmission to new hosts57,187. In addition, the O-Ag capsule is 
important for Salmonella attachment and biofilm formation on gallstones35 and alfalfa10.  
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Figure 1.3. Flask culture of S. Typhimurium containing biofilm aggregates and planktonic 
cells. Salmonella Typhimurium grown in 1% tryptone for 13 hours at 28°C form phenotypically 
heterogeneous biofilm aggregates and planktonic cells in the liquid phase of the flask culture. 
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1.2.2 Regulation of Salmonella biofilms  
The suites of genes that are expressed in biofilm are significantly different from those 
expressed by free-floating planktonic cells33. Expression and synthesis of the biofilm 
components described above, which are involved in stress response and carbon central 
metabolism189, occur in response to environmental stress signals and the interactions of a 
complex regulatory network (Refer to Steenackers et al. for an illustrated overview of 
regulation171) Salmonella form biofilm at temperatures lower than 30°C, in microaerophilic 
environments56, in response to iron limitation155, in the presence of intracellular bis-(3′–5′)-cyclic 
dimeric guanosine monophosphate, or cyclic-di-GMP162, and in response to nutrient 
limitation110. However, iron limitation can permit biofilm formation at temperatures that are 
higher than normal biofilm conditions110.  
The master biofilm regulator, CsgD, is the central modulator of gene expression in 
Salmonella biofilm formation. We now understand that biofilm cells, as differentiated from 
planktonic cells, arise due to bistable production of CsgD (i.e., biofilm cells are CsgD-ON; single 
cells are CsgD-OFF)61. Bimodal expression of CsgD is thought to be a result of positive 
autoregulation, which leads to a regulatory cascade causing broad changes in expression, and 
ultimately phenotype, in a subset of the population111. CsgD is a DNA-binding protein with a 
response regulator domain that binds promoter regions actively when unphosphorylated194. The 
full suite of genes that are controlled by CsgD remains to be identified; however, CsgD is known 
to increase expression of adrA, a diguanylate cyclase required for c-di-GMP production154,162, 
and the csg operon, which produces curli fimbriae and additional CsgD in a feed-forward loop150.  
The regulation of csgD expression and synthesis is complex. Trans regulators of csgD 
expression include OmpR, IHF, H-NS, CpxR, and MlrA171. OmpR, which is phosphorylated in 
response to high osmolarity and can bind DNA in high and low osmolarity, regulates CsgD 
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expression155. MlrA is also a positive regulator of csgD expression, which is suspected to rescue 
the biofilm phenotype in lab-domesticated Salmonella strains grown in LB 188. Histone-like 
proteins IHF (integrating host factor) and H-NS control several genetic processes, including 
CsgD regulation. IHF enhances csgD transcription when bound to the IHF1 site, which is also an 
OmpR binding site, and represses transcription when bound to the IHF3 site in the csgD coding 
sequence55. H-NS is an architectural protein that binds to AT-rich and bent regions of DNA; it 
activates or represses csgD transcription depending on binding location56. The stress response 
protein CpxR negatively regulates biofilm formation when phosphorylated43. Cis downregulation 
by posttranscriptional control may occur through small RNAs, OmrA and OmrB from the 174 bp 
5’ untranslated region of csgD mRNA77. This is in addition to cis regulation of the csg operon by 
CsgD itself.  
Auxiliary regulators RpoS, Crl, c-di-GMP, PhoPQ, RstA, and Rcs also regulate biofilm 
formation. RpoS (σS) is a sigma factor that forms a holoenzyme with RNA polymerase to direct 
transcription of a set of promoters during stress response or stationary phase71. At the beginning 
of stationary phase, RpoS positively regulates expression of csgD 155,188, mlrA17, csgBAC, and 
adrA171. The DNA-binding transcriptional regulator Crl acts with RpoS to increase expression of 
biofilm genes csgB, bcsA, csgD, and adrA147. Crl is a proposed temperature-sensing protein for 
biofilm regulation, due to its reduced activity at temperatures above 28°C146. The secondary 
messenger bis-(3’-5’)-cyclic dimeric guanosine monophosphate (c-di-GMP) promotes virulence 
and motility at low intracellular levels, and cellulose biosynthesis, curli biosynthesis, and 
sessility at high intracellular levels162,171. Levels of c-di-GMP in the cell are adjusted through c-
di-GMP synthesis and degradation. It is synthesized by diguanylate cyclase enzymes with an 
active GGDEF catalytic domain from two molecules of guanosine triphosphate (GTP), and 
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degraded by phosphodiesterase enzymes with active EAL domains into 5’-phosphoguanyl-(3’-
5’)-guanosine (pGpG), which is converted to two molecules of guanosine monophosphate 
(GMP). AdrA, which is regulated by CsgD, was the first diguanylate cyclase described in 
biofilm formation154,162. It produces c-di-GMP, which binds to the BcsA PilZ receptor, activating 
the enzyme to produce cellulose120. Two component signaling system consisting of inner 
membrane sensor kinase PhoQ and cytoplasmic response regulator PhoP87 responds to low 
concentrations of divalent magnesium53. Activated PhoP controls the expression of over 100 
genes87 that are required for LPS modification, host cell invasion, survival in macrophages21, and 
most importantly, repression of biofilm formation139. RstA, a response regulator that controls 
RpoS degradation, also downregulates expression of csgD 127 and bapA 18, the large biofilm 
protein. Repression of genes involved in flagellar synthesis and virulence with concurrent 
upregulation of genes involved in capsule synthesis can also occur when the Rcs phosphorelay 
system is activated112,171. The transcriptional regulator RcsA is activated through a system 
response to high osmolarity or cationic antimicrobial peptides23. Although the mechanism is 
unknown, quorum sensing through several density-dependent pathways are thought to regulate 
biofilm formation171.  
 
1.2.3 The role of biofilm formation in the life cycle of nontyphoidal Salmonella 
Bacterial biofilms are sessile, highly organized, often polymicrobial communities that are 
inherently resistant to antimicrobials and a common cause of persistent and chronic infections32. 
Their structural organization and programmed detachment of cells facilitates cooperation and 
survival in otherwise uninhabitable environments. Salmonella biofilms are resistant to 
antimicrobials, bile, disinfectants, desiccation, starvation, and immune responses171. Biofilm 
formation is conserved among nontyphoidal Salmonella serovars186,187, and is therefore expected 
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to have a significant evolutionary role. The life cycle of host generalists is dynamic and often 
unpredictable. Strategies of both survival and virulence are required by Salmonella serovars for 
transmission to new hosts. Phenotype switching observed in S. Typhimurium clonal populations, 
initiated by bistable expression of CsgD in response to environmental stress, produces biofilm 
aggregates and planktonic cells expressing virulence factors111. This may be a “bet-hedging” 
strategy whereby transmission could occur in the short-term by planktonic cells or long-term by 
biofilm. It was noted that strains lacking the ability to form biofilm tend to be more virulent and 
cause invasive disease 151. Loss of the biofilm phenotype was observed in host-adapted serovars 
S. Typhi, S. Paratyphi, and NTS strains that are associated with invasive disease110. It appears 
that selection pressures for maintaining the biofilm phenotype are opposing: stress vs. nutrition, 
intestinal vs. systemic replication, host-restriction vs. host-adaptation, short- vs. long-term 
transmission. 
 
1.3 ChIP-seq 
1.3.1 Development of the ChIP method 
Chromatin immunoprecipitation (ChIP) is a method of identifying DNA-protein 
interactions in vivo168. In ChIP, DNA bound by a transcription factor, nucleosome, or other 
DNA-associated protein is enriched by immunoprecipitation with an antibody against the protein 
of interest98,133. In the first description of this method in 1985, Solomon et al. leveraged the 
protein crosslinking characteristics of formaldehyde to map the distribution of nucleosomes on 
the chromosome169. Conventional ChIP was described later, in which formaldehyde-crosslinked 
interactions on fragmented genomic DNA are “pulled down” with a specific antibody80,107,143 
(Figure 1.4). Immunoprecipitated DNA was detected for analysis by radioactive labeling, 
quantitative real-time PCR (qPCR) and microarray (ChIP-chip) 80,107,143. Previous methods of 
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studying regulation included systematic evolution of ligands by exponential enrichment 
(SELEX), electrophoretic mobility shift assays (EMSA), ChIP-chip, promoter deletion, and 
reporter analysis, which have been complemented or replaced by ChIP-seq 54. Sequencing has 
replaced ChIP-chip due to decreases in cost for next-generation sequencing, accuracy and depth 
of data output133, less input material required, availability of high-quality reference genome 
sequences148, and opportunities for integration with other datasets98. Currently, there are diverse 
methods of performing ChIP against transcription factors, histone modifications, chromatin 
modifying complexes98, enzymatic or sonication-based DNA fragmentation126, UV or chemical 
crosslinking168, and even targeting CRISPR-Cas9 chromatin complexes195. Additionally, there 
are diverse methods and tools for analyzing ChIP-seq datasets98,121,135.  
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Figure 1.4. (Adapted, Hoffman & Jones. (2009) Journal of Endocrinology74). Simplified 
steps involved in Chromatin Immunoprecipitation (ChIP). In ChIP, 1) cells are harvested and 
2) treated with formaldehyde crosslinker to covalently link proteins to DNA. Cells are lysed to 
isolate genomic DNA and chromatin is sheared to a fragment size range acceptable for 
downstream sequencing. 3) An antibody binds the protein of interest and the antibody-protein-
DNA complex is selected by immunoprecipitation. 4) Crosslinks are reversed, protein and RNA 
is digested, and the resulting DNA is purified for library preparation and sequencing. 
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1.3.2 ChIP for identification of regulatory targets in bacteria 
ChIP has been primarily used for identifying regions controlled by nucleosomes, histone 
modifications, and protein-DNA interactions in eukaryotes. It has also been used as a tool for 
identifying genomic regions controlled by DNA-binding proteins in bacteria121. In particular, 
ChIP is used to discover transcription factors within bacterial regulatory networks. ChIP has 
been used to analyze Sfh and OmpR regulation in S.Typhimurium41,136, quorum-sensing AphA 
regulation in Vibrio alginolyticus65, RpoS regulation in Escherichia coli134, virulence regulator 
EspR regulation in Mycobacterium tuberculosis14, potential diguanylate cyclases through AmrZ 
regulation in Pseudomonas aeruginosa85, as well as VraSR regulation in Staphylococcus 
aureus160. Regulatory information from these experiments can be used to understand more about 
bacterial ecology, pathogenesis, and transmission.  
 
1.3.3 Guidelines for ChIP experiments  
The Encyclopedia of DNA Elements, or ENCODE, is a consortium that has developed 
guidelines, practices, and quality metrics to be applied to ChIP-seq experiments133. These 
guidelines account for the specificity and quality of immunoprecipitation, experimental design, 
sequencing depth, methods of data analysis, and reporting data98. The consortium has performed 
more than a thousand ChIP-seq experiments targeting different DNA-associated proteins in 
different organisms with different sequencing platforms and analysis pipelines31. These 
guidelines are built for experiments with eukaryotic organisms, specifically Homo sapiens, Mus 
musculus, Caenorhabditis elegans, and Drosophila spp.98; however, they can be useful to model 
experiments targeting transcription factors in bacteria. 
Recommendations for pre-ChIP quality checks, experimental design, and analysis are 
given by the ENCODE consortium. Antibody specificity must be tested by primary and 
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secondary methods to rule out poor reactivity and cross-reactivity98. Primary characterization by 
immunoblot on whole-cell extracts, nuclear extracts, chromatin preparations, or 
immunoprecipitated material, with the major band within 20% of the expected size and 
representing more than 50% of the detected bands98. Secondary characterization may be any one 
of five data: 1) an immunoblot with a knockdown or knockout of the target protein, 2) mass 
spectrometry following immunoprecipitation, 3) immunoprecipitation with multiple antibodies 
against different epitopes on the target protein, 4) immunoprecipitation with an epitope-tagged 
target protein, and 5) motif analysis98. ChIP samples should be prepared in biological duplicates 
with a control that matches the strain, growth stage, and treatment of test samples. Control DNA 
may either be pre-IP sonicated DNA (i.e. “Input”) or immunoprecipitated with antibody that 
binds irrelevant protein, type matched to the IP antibody (i.e. “Control IP”)98. Statistical power of 
peak discovery is stronger with more reads; therefore ENCODE recommends 20 million 
uniquely mapped reads per replicate for transcription factor ChIP with mammalian genomes. 
Fewer uniquely mapped reads are required for smaller reference genomes. Peak calling 
algorithms are not specified98, but statistical analysis of global enrichment83, cross-correlation, 
and IDR (irreproducible discovery rate)106 are specified by ENCODE. The IDR statistic 
compares peak pairs in replicates and is more consistent across laboratories, antibodies, and 
analysis protocols106. Analyzed data can be submitted to GEO (Gene Expression Omnibus) with 
metadata, and raw data can be submitted to the Short Read Archive (SRA) for public access.  
 
1.3.4 Sequencing ChIP DNA 
Sequencing is now more common than PCR or microarray methods  for obtaining data 
from ChIP experiments. ChIP-chip and PCR-based methods yield adequate regulatory data, but 
often require expensive probes and introduce amplification or hybridization and array bias 91. 
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ChIP-seq has a larger dynamic range with increased nucleotide resolution and coverage, 
improved signal-to-noise ratio and fewer artefacts when compared to ChIP-chip 133.  
Prior to sequencing, libraries are prepared from ChIP DNA by repairing ends and 
phosphorylating 5’ ends, A-tailing 3’ ends and ligating adapters, enriching adapter-ligated DNA 
by PCR, and adding index barcodes70. Barcode sequences allow for post-sequencing 
identification of replicates or samples from different growth conditions for differential 
analysis133. Libraries are then quantified and multiplexed together with differentiating library 
barcode sequences, before sequencing with a high-throughput next-generation sequencing 
platform121. ChIP-seq experiments with localized transcription factors should yield 10-14 million 
unique reads98 or 100x coverage at each base pair on the reference genome78.  
Presently, most ChIP experiments are sequenced on the Illumina platform, which 
generates millions of forward and reverse reads ranging from 25-300 base pairs depending on the 
chemistry and kit used. Illumina sequencing can be either single-end, from one end of the DNA 
fragment, or paired-end, from both the 3’ and 5’ ends of the DNA fragment94,133. Sequencing 
data is accessed as a series of nucleotide sequences and quality scores with identifiers such as the 
instrument identification and the run number in FastQ file format27. Depending on the 
sequencing platform and data output, formatting may be required before analysis. 
 
1.3.5 Bioinformatic methods for analyzing ChIP-seq data 
ChIP-sequencing data output volume and complexity require stringent statistical 
approaches for proper analysis179. There are many tools available to researchers for analyzing 
ChIP-seq datasets, and new tools are continuously being developed. Analysis of ChIP-seq data 
includes obtaining sequencing data, assessing read base quality, trimming reads by base quality, 
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mapping sequence reads to a reference genome, calling peaks at high coverage depths, 
annotating peaks and associating the peaks with genes, and downstream analysis121.  
Initial quality control should be performed on the data to determine coverage of each 
nucleotide position on the genome and base identity by quality score at each position121. FastQ 
file formats, which have become common sequencing outputs, bundle FASTA nucleotide 
information with per base quality score 27. Tools such as FastQC are available for determining 
data quality for other file formats6. Any remaining Illumina adaptors or bases that have 
unacceptably low quality are then removed from the reads by a trimming algorithm15. If the reads 
are from a paired-end experiment, they may be aligned at this step15. After trimming, the reads 
are then mapped to a high-quality reference genome121. Algorithmic tools BWA or Bowtie2 are 
commonly used for read mapping100,105. To identify areas of enrichment where a transcription 
factor binds or histone modification is located, peaks of high densities of reads are detected179. 
The peaks that are “called” are associated to particular genes based on proximity to the 
transcriptional start site of a gene121. Peak calling is the most important step in ChIP-seq 
analysis. Alignments can be visually scanned to identify peaks; however, algorithms remove 
subjectivity and find statistically significant peaks121. Peak calling algorithms use different 
methods of identifying peaks, but mainly do so through comparison of reads or change in read 
density to background (i.e. “Input-seq” or “Control-seq”) read mapping90,135,196. With these 
methods, the depth of sequencing is important. Inadequate sequencing depth will not fulfill 
genome site saturation criteria and peaks will be indistinguishable from background, whereas 
adequate sequencing depth will result in saturation of background genomic sites and statistically 
significant peaks.  
 23
Once peaks are known, downstream analysis is performed. The data can be visualized on 
a genome viewer, which is useful for identifying false positives and biologically interesting sites 
that are not found by algorithms121. At this point, called peaks can be annotated and associated 
with genes based on proximity to the transcriptional start site of the genes121 .The common 
binding sequence, or motif, is identified and analyzed against the rest of the data for over-
representation and confirmation121. MEME is a common tool used for motif analysis9. Peak and 
motif data should be compared among biological replicates to ensure data is consistent121. The 
peak data can also be used to assess differential binding between samples harvested from 
different conditions, or it can be integrated with transcriptomic gene expression data to 
understand regulons121,192. Usually ChIP-seq data is complemented or validated with phenotypic 
or biochemical assays, such as in vitro DNA binding assays (i.e. EMSA or DNAse I footprinting) 
or expression assays (i.e. RT-qPCR or luciferase assays)121,132.  
 
1.4 Luciferase reporters 
1.4.1 Photorhabdus luminescens bacterial luciferase 
Bioluminescence is derived from chemical reactions between two or more molecules in 
or associated with an organism63. This phenomenon is observed in marine and terrestrial 
organisms, and most commonly in single celled organisms24. Light-producing bacteria have been 
observed for centuries, and have been characterized at a molecular level since the mid 
1900s116,172. It is expected that bioluminescence, an energetically expensive pathway, has been 
retained due to its important evolutionary roles in nature63. Light production by symbiotic 
bacteria can help higher trophic host organisms attract prey, camouflage, or attract a mate, in 
return for a stable and nutrient rich habitat 124. It can also be involved in bacterial 
communication63. The majority of light-producing organisms are in three bacterial genera: 
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Vibrio, Photobacterium, and Photorhabdus 25,177. Bioluminescence originates from signals 
produced by bacterial luciferase (Lux), firefly luciferase (Luc), and green fluorescent protein25. 
In Photorhabdus luminescens, gene products from the luxCDABE operon LuxC, LuxD, and 
LuxE supply and regenerate the aldehyde substrate for the luciferase enzyme, a LuxAB α/β 
heterodimer. Blue-green light at 490 nm, and secondary emission at 590 nm is released when the 
luciferase enzyme (LuxAB) oxidizes a reduced flavin mononucleotide (FMNH2) in the presence 
of a long-chain fatty acid and oxygen25,117. This system can produce light independently, in 
response to an environmental signal, and in different host organisms24. 
 
1.4.2 Quantitative promoter activity from luciferase assays 
Bacterial bioluminescence is a popular, sensitive, and simple in vivo reporter for gene 
expression47,63. Over the years, bacterial luciferase technology has been improved and adapted 
for use in different organisms24. In 1985, Engebrecht et al. inserted the lux operon via mini-
Mulux transposon into E. coli 47. Four years later, Olsson et al. constructed a monocistronic 
luxAB gene from Vibrio harveyi, which could be used as a reporter in both prokaryotes (e.g. E. 
coli), and eukaryotes (e.g. Nicotiana tabacum) 131. The Photorhabdus luminescens luxCDABE 
genes were later cloned and expressed in Saccharomyces cerevisiae67 and the cassette was 
inserted into a human cell line via human cytomegalovirus promoter and tet operator 
sequences60. Developments to luciferase reporter systems have made them excellent tools for 
real-time, non-invasive, sensitive detection of biological functions63,73. Advantages to this 
approach include 1) independent light production when expressed with aldehyde biosynthesis 
genes24, 2) quantitation due to quantum yields of light177, and 3) non-destructive monitoring of 
gene expression131. Luciferase bioluminescence can be detected using photographic film, camera 
Charge Coupling Device (CCD), or a luminometer177. The sensitivity of detection is dependent 
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the level of luciferase expression, the detection equipment, the presence of ATP or oxygen, or 
the optical properties of the tissue or growth media157. Recently, the luciferase reporter has been 
used as a biosensor for gene expression, in vivo diagnostic imaging125, biocomputing163, gene 
arrays180, and high-throughput monitoring for environmental, agricultural, pharmacological, and 
clinical settings25,67.  
 
1.5 Origin and composition of chemostat waste effluent 
The diversity and functional capacity of resident organisms of the human gut microbiome 
may play a role in maintaining health and preventing gastrointestinal infections66. Commensal 
gut microbiota perform this function by priming dendritic cells, producing bactericidal products 
that inhibit pathogenic bacteria, competing for space and resources on the intestinal epithelial 
and mucosal surfaces, and maintaining colonization resistance in persistent polymicrobial 
biofilms33,149,170. Molecular or pure culture techniques used to study organisms in a complex 
intestinal community do not provide comprehensive ecological information3,115. Culturing 
fastidious and anaerobic bacteria from the human gut microbiome is challenging and limited by 
end-point analysis4,114; however, it is essential for understanding metabolic and physical 
community interactions and clinically relevant or low abundance microorganisms97. A chemostat 
seeded from a homogenous fecal inoculum and brought to equilibrium can imitate the original 
distal gut community in vitro4. This system facilitates culturing of both biofilm and planktonic 
communities, and maintains species evenness and richness4,114. Specifically, the reactors of a 
chemostat are packed with a fecal inoculum from healthy donors that have not been treated with 
antibiotics in the previous nine months114. The fecal inoculum is cultured with a modified growth 
media containing mucin for biofilm development and antifoam B silicone emulsion for 
continuous flow at a rate of 400 mL/day to mimic a 24 hour transit time115. The entire system is 
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incubated at 37°C for 36 hours to reach steady-state equilibrium114. Effluent from the steady-
state chemostat is collected into sterile bottles and filtered (0.2 µm) to produce a cell-free spent 
media extract 4. This “Liquid Gold”, as named by Emma Allen-Vercoe (University of Guelph) 
can be used as a media supplement for culturing fastidious organisms in vitro 4. It is thought to 
contain small molecules present in the gut that support the growth of previously unculturable 
organisms 4,7. Small molecules of mammalian origin are often hormone messengers104 and small 
molecules from microbial origin are often used for communication52. Therefore, small molecules 
in the gut from host, microbiome, and invading pathogens may control the balance between 
health and disease. For example, in the presence of small molecules extracted from feces, 
Salmonella invasion gene expression is highly repressed7. In particular, a small molecule 
secreted by Clostridia acts as a repressor of SPI-I virulence genes and prevents Salmonella 
invasion of host cells7. 
  
 27
2.0 HYPOTHESIS AND OBJECTIVES 
2.1 Rationale and hypotheses 
Salmonella enterica serovar Typhimurium (S. Typhimurium) is a major cause of 
gastroenteritis worldwide92. The mechanisms of S. Typhimurium transmission between humans, 
the environment, and animals are not well known, but an understanding of these mechanisms 
may be key for developing methods of preventing infection. Due to the dynamic environments 
that it experiences during its life cycle, S. Typhimurium requires different strategies for survival 
and transmission to new hosts. Mackenzie et al. demonstrated that a pure culture of S. 
Typhimurium exposed to environmental stress differentiates into two coexisting cell types: 
multicellular aggregates that are resistant to desiccation and antibiotics, and planktonic cells that 
express high levels of virulence factors111. RNA-seq analysis revealed 34% differential gene 
expression between the two cell types that may be directed by bi-stable expression of csgD, the 
Salmonella master biofilm regulator111. Biofilm cells express high levels of CsgD, whereas 
planktonic cells express low levels of CsgD61. We hypothesize that phenotype switching 
represents a bet-hedging strategy for Salmonella, since the infective population has limited time 
to react to new environments following expulsion from the host. Therefore, it is advantageous for 
the population to retain a portion of planktonic cells primed for immediate infection, and a 
portion of biofilm aggregates prepared for survival and persistence in harsh environments until 
an opportunity for infection arises. Accordingly, engaging phenotype switching during the S. 
Typhimurium life cycle supports several routes of infection and of course, evolutionary 
reproductive success.  
The regulatory network that induces biofilm formation is complex, involving many 
extrinsic environmental input signals and intrinsic regulatory elements171. We do not fully 
understand the genetic changes associated with Salmonella phenotype switching. Elucidating the 
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regulatory network leading to genetic and phenotypic heterogeneity during the S. Typhimurium 
life cycle may be key for blocking transmission. Currently, we do not know the full suite of 
genes controlled by the master biofilm regulator, CsgD. I hypothesize that CsgD regulates the 
expression of S. Typhimurium genes in multicellular aggregates at high abundance and 
planktonic cells at low abundance. Extrinsic signals for initiation of phenotype switching are 
complex and may originate from cell age, stochastic events, cell-to-cell interactions, or signals 
received from the host during the course of infection1. I hypothesize that the signals for 
phenotype switching originate in the intestine, including signals from both the host and the 
microbiota.  
 
2.2 Objectives 
The objectives of my research project were as follows: 
• To develop a method of preparing S. Typhimurium cell types for ChIP-seq 
 
• To identify genes regulated by CsgD in the S. Typhimurium 14028 genome using ChIP-
seq, and assess differential regulatory targets of CsgD between biofilm and planktonic 
cells 
 
• To identify differences in the expression of S. Typhimurium virulence- or persistence-
associated genes in the presence of waste effluent from a human microbiome culture 
using luciferase assays 
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3.0 CHIP-SEQ FOR IDENTIFYING THE REGULATORY REGIONS OF CsgD 
3.1 Introduction 
CsgD, the DNA-binding Salmonella master biofilm regulator, is involved in a complex 
regulatory network that leads to biofilm formation in limiting environmental conditions171. It is 
known that biofilm aggregate cell types have high intracellular levels of CsgD, and free-floating 
planktonic cells have low intracellular levels of CsgD61. CsgD is a transcriptional regulatory, 
DNA-binding protein, and the large difference in gene expression between the two specialized 
cell types111 is at least in part due to genetic regulation directed by CsgD. Many of the regulatory 
elements that control csg operon expression at the intergenic region are well characterized171, but 
few regulatory targets of CsgD are known. The goal of my research project was to use ChIP-seq 
to find the regulatory targets of CsgD, apart from known targets adrA162 and the csg operon154.  
ChIP-seq, a method of identifying DNA-protein interactions in vivo168, is an ideal 
technique for finding the full suite of CsgD regulatory targets on the Salmonella genome. In this 
technique, cells are harvested and DNA-binding proteins are crosslinked to DNA in vivo through 
formaldehyde cross-linker treatment133. Cells are lysed, releasing the cell contents, and 
chromatin is sheared into approximately 200-600 bp fragments. DNA fragments bound to the 
target protein are immunoprecipitated with antibody, and isolated by protein digestion following 
decrosslinking179. These DNA fragments represent protein binding sites matched by 
hybridization to a microarray (ChIP-chip) or by deep sequencing and mapping to the genome 
sequence107,148. ChIP coupled with next-generation sequencing produces massive and high-
resolution genome-wide datasets that could reveal all possible regulatory targets of CsgD. Few 
methods in the literature describe ChIP with bacteria, and most bacterial experiments begin with 
a simple growth culture14,41,65,85,136. ChIP sample preparation with single cells is straightforward 
and presents fewer challenges than ChIP sample preparation with biofilm aggregates. The 
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extracellular material surrounding biofilm aggregates interferes with crosslinking, accurate cell 
number estimation, and lysis. Therefore, my objectives in this research project were to optimize 
ChIP experimental conditions with the goal of identifying genes that are differentially regulated 
in biofilm and planktonic cell types. 
 
3.2 Materials 
3.2.1 Antibodies, bacterial strains, and culture conditions 
DNA samples were prepared from wild type Salmonella enterica serovar Typhimurium, 
ATCC 14028S (GenBank CP001363.1)81. Positive and negative controls were prepared as a 
comparison to wild type biofilm and planktonic cell types. A strain that overexpresses CsgD, S. 
Typhimurium ST14028 ∆csgD + pACYC csgDcompFOR3, was built as a positive control. In the 
flask culture, this strain overproduces biofilm aggregates and produces few planktonic cells.  The 
negative control, S. Typhimurium ST14028 ∆csgD, does not produce biofilm. These cell types 
were prepared from flask culture in limiting conditions, 1% tryptone media at 28°C (reviewed in 
Appendix B). Cells were harvested from flask culture after 13 hours of incubation, which 
corresponds to the highest transcription levels of csgD111. 
Fragments of DNA with DNA-CsgD crosslinked interactions were immunoprecipitated 
with a monoclonal antibody specific for CsgD. Purified His-tagged CsgD was used for Rapid 
Prime-Custom Monoclonal Antibody Development (Immunoprecise Antibodies Ltd., Victoria, 
BC, Canada). Initially, clone 10G5 tissue supernatant was harvested; however, it did not contain 
enough anti-CsgD antibody for ChIP immunoprecipitation. Larger concentrations of anti-CsgD 
were generated by ascites in BALB/c mice (Immunoprecise). Ascites from clone 10G5 were 
used for immunoprecipitation in the first ChIP experiment, and ascites from clone 6D4 were 
used for the second ChIP experiment. Raw ascites required filtering and concentrating to remove 
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cells and fatty material prior to application for immunoprecipitation (Figure 3.1a-c). After 
filtration through a 0.2 µm filter, the ascites was passed through a Protein G affinity 
chromatography cartridge. In total, 10 volumes of 5ml ascites diluted 1:1 in binding buffer were 
run through the column. A BioRad DC Protein assay with bovine IgG standards was performed 
on all column fractions. Fractions equal to or greater than 0.2 mg/mL were pooled and 
concentrated on a 50K MWCO Amicon centrifugal filter. Anti-CsgD antibody was stored at 3 
mg/mL in 50 mM Tris-HCl pH 8.0 (Table A1, Appendix A for details). CsgD-binding efficacy 
was confirmed by Western blot with purified CsgD-His.  
 
 
 
 
 
 
Figure 3.1a-c. Purification of  monoclonal antibody clone 6D4 for ChIP from ascites. 
Cellular and fatty material in anti-CsgD clone 6D4 monoclonal ascites was separated by 
centrifugation and filtration (40 µm) (a, b). Antibody was purified by affinity chromatography 
using a Protein G cartridge (c) with multiple flow-throughs and elutions. 
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3.2.2 ChIP-seq materials and equipment 
Performing ChIP-seq with S. Typhimurium required troubleshooting and optimization for 
biofilm and planktonic cell types and laboratory equipment. The different types of materials and 
equipment that was tested and used to perform ChIP-seq are mentioned in 3.3 Methods and 
Results. A detailed list of ChIP-seq materials and equipment, which can be found in Appendix C, 
was required for JoVE (Journal of Visualized Experiments) manuscript preparation. Method 
optimization in 3.3 Methods and Results and the materials and equipment in Appendix C are 
intended to be useful for researchers performing ChIP with bacterial biofilms and similar 
laboratory equipment.  
Materials listed and described in Table C1, Appendix C are required for growing and 
harvesting cell types in flask culture. After harvesting the cell types from flask culture, the 
materials in Table C2, Appendix C are required for homogenizing cells, crosslinking proteins to 
DNA, and fragmenting genomic DNA. The buffers in Table C3, Appendix C are used to lyse 
cells after crosslinking and prior to sonication. Materials and buffer recipes for antibody 
selection of crosslinked CsgD-DNA fragments are listed in Tables C4 and C5, Appendix C, 
respectively. Immunoprecipitated DNA is purified, tested, and made into libraries for 
sequencing. The materials for these steps are listed and described in Table C6, Appendix C. 
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3.3 Methods and Results 
3.3.1 An initial ChIP-seq experiment did not reveal regulatory peaks above background 
Sequencing data from an initial ChIP-seq experiment was analyzed for CsgD-controlled 
regulatory peaks. This experiment was performed similarly to the ChIP-seq experiment that will 
be described (see Appendix B for procedure), with a few alterations. DNA samples were 
prepared from flask culture biofilm aggregates and planktonic cells at 13 hours, when the 
intracellular concentration of CsgD is highest, and from biofilm aggregates at 32 hours, when the 
flask culture biofilm has matured and csgD expression has dropped111 (Figure 3.2). As a positive 
control, biofilm was harvested from the CsgD overexpresser strain, S. Typhimurium 14028S 
∆csgD + pACYC184-csgDcompFOR3 at 13 hour incubation. In this strain, it was expected that 
excess intracellular concentrations of CsgD will lead to occupation of all regulatory targets and 
maximum peak discovery sites. DNA samples were prepared from 30 mg biofilm and 
approximately 2.5 OD600 planktonic cells from flask culture. Biofilm cells were homogenized 
with a glass tissue homogenizer prior to formaldehyde crosslinking and lysis. Sonication 
proceeded with 5 sonication rounds of 30 s at 20-40% of 400 W and 2 min off on ice. A 
sonicated sample of input DNA was collected as background comparison, and the remainder was 
immunoprecipitated with anti-CsgD antibody 10G5 and Protein G magnetic beads. Input and 
immunoprecipitated DNA had the crosslinks reversed by incubation at 65°C, RNA was digested 
with RNase A, and proteins were digested with proteinase K at 45°C, prior to column-based 
DNA purification. Immunoprecipitated DNA was at a very low concentration, below detection 
by Nanodrop (<5 ng/µL), whereas Input DNA was 300-550 ng/µL. Libraries were prepared from 
these samples with a ThruPLEX Library Prep Kit for Illumina sequencing, and evaluated by 
Bioanalyzer electropherogram showing library size and a qPCR NEBNext Library Quant Kit 
showing library concentration. These values were used for calculations to combine libraries in 
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preparation for sequencing. The library pool was sequenced by MiSeq, producing 2x 75 bp 
reads.  
 
 
 
 
 
 
Figure 3.2. ChIP-seq samples and sequencing reads from an initial experiment. ChIP DNA 
was prepared in triplicate from flask culture incubated at 28°C with shaking (200 rpm) of wild 
type (WT) S. Typhimurium biofilm and planktonic cells at 13 h (left), wild type (WT) S. 
Typhimurium biofilm at 32 h (middle), and CsgD overexpressor (CsgD++) S. Typhimurium 
14028S ∆csgD + pACYC184-csgDcompFOR3 at 13 h (right) (a). Sonicated DNA (Input DNA) 
and DNA from immunoprecipitation with anti-CsgD antibody (ChIP DNA) was prepared for 
each of the four cell preparations. Libraries were prepared from ChIP DNA and sequenced on an 
Illumina MiSeq at 2x 75 bp. The number of reads and the expected outcome for each cell type 
library in (a) are listed (b). Replicates labelled (*) denote read samples with an unassigned read 
pair.  
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Sequencing reads were acquired in FastQ file format and analyzed using Geneious 9.1.5 
software. Reads from each dataset were trimmed with an error probability limit of 0.05, prior to 
alignment of forward and reverse read files. The aligned files were mapped to S. Typhimurium 
reference genome (GenBank CP001363.1)81 and visualized by genome browser (Figure 3.3). 
Peaks were distinguished from background coverage within each read sample. In two of three S. 
Typhimurium biofilm ChIP-seq replicates harvested at 32 hours, a single peak was observed by 
visual scanning of mapped reads on the Geneious genome browser. This peak was composed 
primarily of unpaired reverse reads at the tail end of the adrB coding region, upstream of psiF, 
and 756 bp upstream of adrA. If this peak was significant, it is expected that it would be in the 
promoter region, accompanied by other ChIP-selected regulatory peaks, and it would be 
composed of paired forward and reverse reads. In S. Typhimurium 14028S ∆csgD + pACYC184-
csgDcompFOR3 (i.e. CsgD overexpresser) biofilm samples harvested at 13 hours, there is a 
single peak at the csg intergenic region. This can be explained as an excess of this sequence, 
“donated” to ChIP libraries by multiple copies of the plasmid. In all, no significant peaks were 
identified by visualization on the genome browser. A collaborator in bioinformatics, Dr. Yejun 
Wang, analyzed these ChIP-seq datasets and called peaks using statistical methods. His analysis 
concluded that peaks among replicates were inconsistent and therefore, no statistically significant 
peaks indicative of CsgD-regulated regions could be identified.  
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Figure 3.3. Coverage map histogram of paired-end sequencing reads from an initial ChIP-
seq experiment mapped to S. Typhimurium reference genome and visualized by Geneious 
9.1.5 genome browser. One visualized replicate was shown per cell type, strain, and time point 
group. Each set of paired-end sequencing reads were trimmed, forward and reverse reads were 
aligned, and then mapped to S. Typhimurium reference genome CP001363.1. Reads “stacked” at 
each base pair on the genome are shown as coverage in blue up to the maximum coverage in read 
counts at each location. 
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3.3.2 Optimization of ChIP-seq methods  
 As our initial ChIP-seq experiment for CsgD did not identify any statistically significant 
peaks above background, we examined the possibility that we had performed a technical error 
during the procedure. Technical error could have originated at nearly all procedural steps: cell 
harvesting, homogenization, crosslinking, sonication, antibody immunoprecipitation, washing 
and eluting, or DNA purification159. My research goal was to understand each procedural step, 
optimize it for laboratory working equipment and S. Typhimurium unique cell types, and 
improve consistency among ChIP-seq samples.  
 
3.3.2.1 A comparison of bacterial ChIP-sequencing methods in the literature 
 Understanding experiments with successful results under similar constraints may reveal 
improvements that could be applied to a second ChIP-seq experiment. The majority of ChIP 
experiments in the literature have been performed in eukaryotes, and target abundant DNA-
binding proteins, such as histones. Initially, methods and materials from ChIP experiments in 
bacteria targeting transcription factors were compiled. Later, all published methods and 
materials for ChIP-sequencing experiments in bacteria targeting transcription factors were 
compiled and assessed against the procedure followed in 3.3.1. The results from the literature 
review and final protocol revisions are summarized in Table 3.1.  
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Table 3.1. Comparison of published ChIP methods and final methods to be used in this experiment. Published methods with 
bacterial cells and transcription factors were selected for their biological relevance to ChIP-seq selection of CsgD genomic targets in 
Salmonella Typhimurium.  
ChIP procedural step Literature comparison and procedural options Final protocol 
Harvest cells Inducible expression and epitope tags are an optiona 
Controls: pre-IP “input” control, parallel mock-ChIP with normal IgG, 
strain with gene deletion 
Strains and cell types are: wild type Salmonella Typhimurium ST14028 biofilm 
and planktonic cells at 13h, CsgD overexpresser Salmonella Typhimurium 
ST14028 ∆csgD + pACYC csgDcompFOR3 biofilm at 13h, and CsgD mutant 
Salmonella Typhimurium ST14028 ∆csgD planktonic cells at 13h 
Crosslink proteins to 
DNA and quench 
crosslinking 
Crosslinking for 5, 10, 20, or 30 min with 1% formaldehyde at room 
temperature or 37°C. Formaldehyde may be added directly to growth 
media.  
Crosslinking quenched with Glycine at final concentration of 0.1-0.5M. 
Cells pelleted and washed after or in lieu of quenching. 
Crosslinking: 1% formaldehyde for 30min at room temperature on a rotating 
wheel 
Quenching: 0.125M Glycine for 5min at room temperature on rotating wheel. 
Pellet cells and wash once with PBS 
Lyse cells  Lysis by osmotic shock, lysis buffer, 0.1µm zirconia glass beads, 
sonication, or lysis buffer with lysozyme.  
In lysis buffer (SDS-based) + protease inhibitors on ice 10min. Complete lysis in 
IP dilution buffer + protease inhibitors on ice 0.5-2h. 
Fragment DNA DNA fragmented by sonication, bead-beating, or micrococcal nuclease. Sonicate DNA on ice 20% 400 W 5x 30 seconds, cool 2 min between bursts.  
Pre-clearing and 
controls 
Input pre-IP sample as reference, pre-clearing with Protein G alone or 
Protein G and normal IgG optional. Mock IP (no antibody) or control 
(species-matched IgG) in parallel to IP as controls. 
Pre-clearing: incubate with 50µg mouse IgG 1h at 4°C, then with Protein G 
magnetic beads 3h at 4°C. The precleared solution is split into Input (no IP), 
Control (IP with mouse IgG), and Test (IP with anti-CsgD mAb) 
Add antibody Monoclonal, polyclonal, commercial, or commercial antibodies against 
epitope-tags.  
Incubation with 5 or 10 µg antibody 2h at room temperature or overnight 
at 4°C. 
Add 10 µg anti-CsgD antibody to test samples and 10µg normal mouse IgG to 
control samples. Incubate overnight at 4°C on a rotating wheel. 
Immunoprecipitate 
DNA 
Protein G or Protein A agarose, sepharose, or magnetic beads. Protein G magnetic beads incubated 3 h at 4°C. Beads are separated on a 
magnetic stand, washed with low salt buffer, LiCl wash buffer, TE, and eluted in 
Elution buffer.  
Reverse crosslinks 
and digest RNA 
Rnase A treatment and concurrent crosslinking, 65°C ≥6 h or overnight. 
SDS may be added.  
Add 2 µg Rnase A and NaCl to 0.3 M. Overnight incubation at 65°C 
Digest protein Incubation with Proteinase K or Pronase at 65°C overnight or at 45°C for 
≥2h  
Add 9 µg Proteinase K. Incubate 45°C for 4 hours or more.  
Purify DNA DNA purified with phenol chloroform extraction, purification columns, 
or gel purification.  
DNA purification with magnetic beads. 
QA/QC qPCR to assess a known genomic target in comparison to Input DNA or 
qPCR standard curve. Agilent Bioanalyzer HS dsDNA kit to assess 
fragment sizes. Qubit or qPCR library quantification kit to quantify 
DNA.   
Fluorimeter to quantify DNA. qRT-PCR to assess quantities of known targets 
bound by CsgD compared with Input DNA. Bioanalyzer High sensitivity DNA 
kit to assess library fragment size range. 
Analysis Artemis, Bowtie, or BWA for mapping to reference genome. 
Galaxy tools, BedTools, SAMTools for finding sequence read coverage. 
Peakfinder, CisGenome, Geneious, dPeak, MACS, MOSAiCS for calling 
peaks. 
YMF, BioProspector, or MEME for motif analysis. 
Analysis workflow: Assess read base quality, trim reads by base quality, align 
sequence reads to reference genome, call peaks, associate peaks with genes, motif 
analysis 
Tools available: Geneious, Galaxy Suite  
areferences for each procedural option are in text of 3.3.2.1 A comparison of bacterial ChIP-sequencing methods in the literature 
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 ChIP-seq methods and materials from the surveyed published protocols were reviewed 
item-by-item. Firstly, cells were usually harvested from a subculture at mid-log phase. There was 
a consensus among methods for crosslinking cells with a final concentration of 1% 
formaldehyde; however, incubation times varied from 10-30 minutes. To stop formaldehyde 
crosslinking, glycine was added at a final concentration of 0.125-0.5 M, often without a specified 
incubation time or temperature 14,34,37,42,50,65,85,118,122,134,136,167. After crosslinking, cells are usually 
pelleted and washed in either PBS or TBS to remove excess crosslinker and prevent 
overcrosslinking. The cells must be lysed prior to sonication to allow for DNA fragmentation 
and immunoprecipitation. The majority of surveyed protocols used a lysozyme and/or SDS-
based buffer to lyse cells, with Tris-HCl or HEPES included  to stabilize pH, and the addition of 
other components to support cell lysis, prevent protein degradation, and preserve DNA. 
Typically, cells were resuspended and incubated in lysis buffer for 30 minutes at 37°C 
37,42,50,65,181,192. In some cases, an IP dilution buffer was added to dilute SDS before sonication 
34,86,138,167. Cell lysis using glass beads, sonication, or mechanical disruption are alternate or 
parallel methods 86,118,138. In all of the methods surveyed, DNA was fragmented to less than 1000 
bp by sonication. However, sonication methods vary due to differences in sonicator equipment 
and the final fragment sizes required by different sequencing platforms and kits. Precipitated 
material and remaining whole cells were sedimented by centrifugation and separated from the 
cell lysate in the supernatant 65,85,181.  
 There are many different ways of performing immunoprecipitation (Table 3.1); different 
strategies and controls can influence downstream analysis. When intracellular concentration of 
transcription factors is low or below detection for ChIP experiments, expression may be 
enhanced by an inducer, such as IPTG, arabinose, or rhamnose 37,42,85,134,148,192. Some methods 
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use commercial antibodies that bind to epitope-tagged proteins. These are commonly FLAG- 
50,65,118,181, 3xFLAG 34,69,136, or His-tagged 14,134 proteins. After DNA-TF complexes were bound 
by TF-specific antibody, DNA-TF-Ab complexes were bound at the antibody Fc portion by 
Protein A or Protein G agarose118,134,136,181, sepharose34,65,69,132,192, or magnetic 
beads14,37,42,85,136,167. These beads may be pre-cleared to reduce nonspecific binding prior to 
immunoprecipitation14,34,85,132,136. Once DNA-TF-Ab complexes are bound by the beads, 
unbound protein, DNA, and buffer are washed away by wash buffers. When specified, wash 
buffers usually contain Tris-HCl and EDTA, and are described by their salt content: high salt 
(NaCl), low salt (NaCl), and LiCl. Elution buffers vary, but they usually contain SDS for eluting 
DNA from protein and EDTA for protecting DNA at an elevated pH. Transcription factors and 
antibody complexes were decrosslinked from DNA by heating at 65°C or higher, usually 
overnight 34,37,42,65,69,85,118,136,181,192. After decrosslinking, RNA was digested with Rnase37,42,65,167 
occasionally during decrosslinking, and protein was digested with Proteinase K for more than 2 
hours. Purification was performed by column purification34,37,42,65,118,136,137,164, phenol-chloroform 
extraction and ethanol precipitation34,65,69,85,167,192 or gel purification148. Libraries were prepared 
from this purified DNA using kits that are compatible with the intended sequencing platform. 
These libraries were checked for enrichment by qPCR with primers for housekeeping and known 
regulatory targets, by Bioanalyzer for library fragment size, by Qubit or by qPCR library 
quantification kit for library concentration. Sequencing was generally performed on the Illumina 
Genome Analyzer IIx122,136,167, Illumina HiSeq 200069,79,85, or related platforms. ChIP-seq peaks 
were compared to background in several different forms. Nearly all of the surveyed methods 
compare ChIP-seq peaks to mapped reads from sonicated input DNA 
34,37,50,65,85,122,132,134,148,164,181,192. Other experiments compare peaks in test IP to a control “mock” 
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IP with species-matched antibody14,164, background within the same read sample136, or to 
immunoprecipitation with a deletion or empty vector strain34,136,148,167,181. 
 
3.3.2.2 Harvesting Salmonella cell types 
Maintaining sample consistency is expected to improve the likelihood of a significant 
sequencing result. Planktonic and biofilm cell types are phenotypically distinct and require 
different handling before immunoprecipitation. Assays were performed to numerically 
understand flask culture biofilm and planktonic cells for the strains harvested for ChIP: wild type 
S. Typhimurium 14028, negative control S. Typhimurium 14028 ∆csgD, and CsgD 
overexpresser S. Typhimurium 14028 ∆csgD + pACYC csgDcompFOR3. Flask culture 
phenotypes of these strains, grown at 28°C for 13 hours with shaking, were distinctly different. 
The cell types were separated by slow speed centrifugation at 1000 rpm for 2 minutes, and 
assessed independently. Planktonic cells were enumerated by optical density (OD600) estimates 
and drop dilution plating. Biofilm aggregates were evaluated by wet weight (mg) and by drop 
dilution plating following homogenization. The wild type flask culture contained approximately 
1x1011 cells split into biofilm aggregates (39%) and planktonic cells (61%) (Figure 3.5). The 
CsgD overexpresser flask culture contained more biofilm aggregates than wild type, suspended 
in media that is virtually clear (Figure 3.4a-c). The CsgD deletion flask culture contains 
planktonic cells, but no biofilm aggregates. This abundance of planktonic cells over the wild type 
and CsgD overexpresser flask culture is evident by OD600 in Figure 3.6d. The relationship 
between wet weight of biofilm and CFU (Figure 3.6a) and the relationship between volume of 
flask culture and wet weight of biofilm was confirmed (Figure 3.6b).  
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Figure 3.4a-c. Flask cultures of S. Typhimurium in 1% tryptone harvested for ChIP-seq. 
Flasks were inoculated with 1 OD600 log-phase culture of S. Typhimurium 14028 (a), S. 
Typhimurium 14028 ∆csgD (b), or S. Typhimurium 14028 ∆csgD + pACYC csgDcompFOR3 (c) 
and incubated for 28°C for 13 hours with shaking at 200 rpm. 
 
 
 
Figure 3.5. The number and proportion of planktonic and biofilm cell types in the bulk 
liquid phase of S. Typhimurium 14028 flask culture. The colony forming units (CFU) present 
in aggregate or planktonic cell subpopulations was calculated using conversion factors 
determined from serial dilution plating after homogenization (1.92 x 109 CFU per 1.0 OD600 for 
planktonic cells; 1.73 x 108 CFU/mg for aggregates). The green bars and blue bars represent the 
proportion of planktonic cells and aggregates comprising the total number of cells in the 
population; points on the right side of the graph represent total CFU values for each cell type 
from nine replicate flask cultures. The percentage values represent the average proportion of 
each cell type. (Published: MacKenzie et al. (2017) Frontiers in Veterinary Science, Figure 2d110) 
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Figure 3.6a-d. Characterizing the biofilm and planktonic cell subsets in S. Typhimurium 
14028 grown in 1% tryptone incubated at 28°C for 13 hours. Parameters were assessed for 
wild type S. Typhimurium (WT) planktonic and biofilm cells, S. Typhimurium 14028 ∆csgD + 
pACYC csgDcompFOR3 (CsgD++) biofilm cells, and S. Typhimurium 14028 ∆csgD (∆csgD) 
planktonic cells. Biofilm and planktonic cells from the 13 hour flask culture were separated by 
slow speed centrifugation at 1000 rpm for 2 minutes and analyzed. The biofilm conversion factor 
1.73 x 108 CFU/mg was confirmed by homogenizing and performing drop dilution enumeration 
with different weights of biofilm (a) and the relationship between volume of flask culture and 
wet weight of biofilm was confirmed (b). Regression analysis was performed in Prism 7, and the 
dotted lines represent the 95% confidence intervals of the data. Total biofilm from wild type and 
CsgD overexpresser flask culture was harvested and weighed (c); and planktonic cells from all 
flask cultures were measured after separation by slow speed centrifugation by OD600 (d) and 
CFU/ml from drop dilutions.   
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 The recommended amount of DNA input for ChIP-seq is 10-25 µg58. The amount of 
biofilm to harvest for ChIP was calculated, using the biofilm conversion factor (BCF, 1.73 x 108 
CFU/mg) with the following equation: 
 
25 µ  	
1 
1	10 µ
	
6.022	10 
1 
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(3.1) 
Therefore, 30 mg biofilm was harvested for ChIP because it yields approximately 25 µg DNA.  
I hypothesized that the abundance of proteinaceous extracellular material associated with biofilm 
would interfere with the efficiency of crosslinking. If I were simply to normalize the different 
cell types by cell number, treatment of planktonic cells may result in an unequal amount of 
crosslinked product presented for immunoprecipitation. A protein assay was performed to 
determine the equivalent amount of planktonic cell material to match 30 mg of biofilm (Figure 
3.7). The results from this assay indicated that approximately 6.0 OD600 planktonic cells 
harvested for ChIP will have equivalent crosslinking capacity as 30 mg biofilm. Therefore, 30 
mg biofilm and 6.0 OD600 planktonic cells were harvested from flask culture for ChIP. 
 
  
 45
 
 
  
Figure 3.7. Total protein concentrations for planktonic cells and biofilm cell samples 
harvested from S. Typhimurium flask culture. BioRad DC Protein assays were performed and 
protein amounts relative to a BSA standard curve were measured at 750 nm. Protein content of 
lysed planktonic cell samples measured by OD600 were compared to lysed 30 mg biofilm 
aggregates. 
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3.3.2.3 Homogenizing cells 
Biofilm aggregates must first be broken apart to allow equal access of formaldehyde 
crosslinker to all cells. Previously, I had used a glass tissue homogenizer to break apart biofilms. 
This method produced aerosols and was inconsistent between samples. Homogenization by 
mixer mill keeps tubes sealed and is expected to break apart biofilm consistently between all 
samples. I tested homogenization by mixer mill to determine the parameters that would break 
apart biofilm adequately for crosslinking.  
Biofilm broken apart by glass tissue homogenizer, mixer mill (Retsch Mixer Mill MM 
400) with a glass bead, and mixer mill with a metal bead was observed. The glass tissue 
homogenizer accumulates biofilm, tends to decrease in homogenization quality with higher 
volumes processed, and produces cell numbers with higher variance. Biofilm flakes are apparent 
in tubes homogenized by mixer mill with a glass bead, but not with a metal bead (Figure 3.8). 
Identical wild type biofilm samples were homogenized at different times to determine the 
minimum duration of homogenization at 30 Hz that would adequately break apart biofilm. 
Homogenized biofilm tubes containing a 5 mm steel bead that were processed with the mixer 
mill 5 minutes or longer appeared homogenous; therefore, 5 minutes at 30 Hz was chosen as the 
standard for future ChIP sample preparation (Figure 3.9). Planktonic cells are treated the same 
way to reduce variables in the ChIP-seq experiment.  
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Figure 3.8. Qualitative comparison of homogenization of wild type S. Typhimurium 14028 
biofilm by glass tissue homogenizer, mixer mill with glass bead, and mixer mill with metal 
bead (L to R). Thirty milligrams of biofilm were harvested from flask culture and resuspended 
in conditioned tryptone before homogenizing by mixer mill for 5 minutes at 30 Hz. 
 
Figure 3.9. Homogenization of biofilm and planktonic cells from flask culture. Biofilm 
aggregates from flask culture resuspended in PBS (a, left) were homogenized using a mixer mill 
at 30 Hz for 5 min (a, right). Planktonic cells from flask culture resuspended in PBS (b) were 
processed by mixer mill at 30 Hz for 5 min for consistency between cell type samples.  
A
B
Before 
homogenization
After 
homogenization
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3.3.2.4 Crosslinking proteins to DNA 
Chemical crosslinking with formaldehyde is often used to fix protein-DNA interactions 
for chromatin immunoprecipitation158,169. ChIP experiments may use other chemicals or UV to 
immobilize protein-DNA interactions, or may forgo crosslinking entirely, as is the case with 
native ChIP126,168. Formaldehyde crosslinking was chosen for this ChIP experiment due to its 
availablility, ease of use, and success in published experiments. Formaldehyde is a small 
molecule that permeates cell membranes to crosslink reactive molecules that are in close 
proximity, and catalyzes the covalent linkage of amino and imino groups158. Crosslinking 
conditions are similar among published bacterial ChIP-seq methods (Table 3.1). The majority of 
ChIP-seq methods describe the addition of fresh formaldehyde to a final concentration of 1% in 
cells or growth media, incubation up to 30 minutes with gentle agitation, and the addition of 
glycine to stop crosslinking. During crosslinking, it is important to consider fixation time, 
methanol content of the formaldehyde, and how fresh the formaldehyde is; increased fixation 
time and methanol content can cause overcrosslinking, and old reagents can have decreased 
effective formaldehyde concentrations48. 
Homogenized S. Typhimurium cell samples were treated with 1% fresh formaldehyde 
and incubated with rotation for 30 minutes at room temperature to crosslink proteins to DNA. As 
previously described, biofilm and planktonic cell samples were harvested by protein 
concentration to ensure each contained equivalent crosslinking substrate. Conditioned tryptone, 
which contained amino acids, metabolic waste products, and other proteins, was replaced with 
PBSA to ensure that cellular interactions constitute a higher proportion of the total crosslinking 
substrate. Glycine was added to a final concentration of 0.125 M and incubated for 5 minutes 
with rotation at room temperature to quench crosslinking.  
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3.3.2.5 Lysing cells to release cell contents 
After crosslinking, cell contents were released by lysis. This allows for chromatin to be 
sheared and for downstream immunoprecipitation with cell protein and DNA. In this ChIP-seq 
experiment, lysis was achieved through resuspension in an SDS-based buffer (Table A4, 
Appendix C), which was incubated on ice for 30 minutes. Cell lysates were then combined with 
1.4 mL IP dilution buffer, which reduces the concentration of SDS before sonication. At this 
point, there were often visible, non-lysed particles in solution, particularly in biofilm cell 
samples. After correspondence with collaborators (Dr. Carsten Kröger, Trinity College Dublin, 
Stefani Kary, MSc.,Trinity College Dublin), the duration that samples were incubated on ice in 
IP dilution buffer was extended up to 4 hours, with intermittent and gentle vortexing.  
 
3.3.2.6 Fragmenting genomic DNA by sonication 
DNA must be fragmented for enrichment of fragments with crosslinked transcription 
factor during immunoprecipitation and for downstream library preparation and sequencing133. 
Crosslinked chromatin from lysed cells are fragmented to a size range compatible with 
sequencing: less than 1000 bp, with a majority 200-600 bp. Genomic DNA may be fragmented 
for next generation sequencing by physical, enzymatic, and chemical methods93. ChIP-seq 
experiments often use enzymatic fragmentation with micrococcal nuclease or physical 
fragmentation by sonication.  
In this ChIP-seq experiment, S. Typhimurium genomic DNA from lysed cell samples was 
fragmented by sonication.  DNA degradation by sonication occurs through cavitation, thermal, or 
mechanical effect by breaking hydrogen bonds45. Although there can be some bias, sonication 
fragments DNA nonspecifically. Energy transfer will vary for different sonicator units and cell 
samples, so a sonication assay is recommended to determine the number of sonication bursts 
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required to fragment DNA to less than 1 kb. Cell lysis samples that were prepared identically 
were fragmented for different numbers of sonication rounds at 20-40% of 400W at 30s on with a 
2-minute rest on ice. Note that sonication breaks apart material and makes the solution appear 
clearer than before sonication (Figure 3.10). To resolve DNA fragments on an agarose gel, this 
sample was decrosslinked at high heat and treated with RNase A at 65 °C for 2 hours and 
Proteinase K at 45 °C for 3 hours. The fragments were then run on a 2% agarose gel, and show a 
decrease in fragment size with increasing number of sonication bursts (Figure 3.11). This assay 
was performed on lysed cell samples with a probe sonicator (Ultrasonic Liquid Processor, Sonics 
& Materials, Inc., VC300) and 3 mm probe (Sonics & Materials, Inc., 630-0418) and a cup horn 
sonicator (Qsonica, 431C2). The cup horn sonicator energy transfer was weaker, and 
inadequately fragmented DNA at up to 30 rounds of sonication (i.e. 75 minutes) (data not 
shown). For S. Typhimurium ChIP samples, 5 sonication rounds were adequate to fragment 
DNA to less than 1000 base pairs. 
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Figure 3.10. Sonication changes the opacity of lysed cell preparations. Lysed cell 
preparations (L) were sonicated at 20% of 400 W for 5 rounds at 30 seconds on and 2 minutes 
rest on ice ( R).  
 
Figure 3.11. Sonication assay with pre-ChIP cell lysate. Cell samples were separated, 
crosslinked, and lysed. DNA-protein complexes were sonicated up to 8 times at 30 s on and 2 
min off on ice to break DNA into smaller fragments. A portion of the sonicated lysate was 
separated on a 2% agarose gel and the number of sonication bursts to be used in future ChIP cell 
preparations was chosen from this assay.  
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3.3.2.7 Immunoprecipitation of CsgD-DNA interactions 
Immunoprecipitation is the most important step in ChIP-seq. During 
immunoprecipitation, target transcription factors are bound by specific antibody in crosslinked 
DNA-TF interactions. The resulting DNA-TF-Ab complex is bound at the Fc portion of the 
antibody by Protein G beads, which are washed to remove nonspecifically binding DNA, protein, 
and other cell components. The complexes are dissociated from the Protein G beads by 
incubation with elution buffer, after which the TF-Ab interaction was decrosslinked from DNA 
at elevated heat, and contaminated RNA and protein was digested. 
Antibody specificity is a common issue with ChIP; antibodies generated against purified 
protein may not have available epitopes to bind in vivo113. Following our first unsuccessful ChIP 
experiment, a second antibody clone was purified and tested for CsgD-binding efficacy. 
ENCODE guidelines recommend a confirmation of antibody target-binding activity with an 
immunoblot98. After antibody purification, CsgD binding activity was confirmed by western blot 
against purified CsgD-His protein (data not shown) and against whole cell lysates (Figure 3.12a). 
Despite this positive result, we wanted to assess antibody binding to the native conformation of 
CsgD. Native PAGE is a non-denaturing protein separation method that maintains normal folded 
protein “topography” that would be recognized by antibodies in vivo. S. Typhimurium CsgD has 
an isoelectric point (pI) of 9.13 from amino acid sequence, and is therefore expected to migrate 
towards the positive electrode. I attempted Native PAGE, but could not detect CsgD by this 
method. Lysates prepared for ChIP are most relevant for immunoprecipitation, so a dot blot was 
performed with purified antibody against lysates that had been crosslinked and sonicated (Figure 
3.12b). The intensity of fluorescence corresponded with the amount of CsgD present, in 
descending order: CsgD overexpresser biofilm, wild type biofilm, wild type planktonic, and 
background fluorescence of ΔcsgD planktonic sonicated cell samples (Figure 3.12c). Compared 
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with the purified 10G5 antibody used in the initial ChIP-seq experiment described in 3.3.1, the 
purified 6D4 antibody at the same concentration performed much better.  
In the method we used to perform immunoprecipitation, DNA that binds nonspecifically 
to normal mouse IgG is removed from lysed and sonicated S. Typhimurium cell samples. The 
remaining DNA is immunoprecipitated with normal mouse IgG (i.e., Control IP) or the 
transcription-factor specific monoclonal antibody (i.e., Test IP). Preclearing was performed by 
incubating sonicated DNA with normal mouse IgG and protein G magnetic beads, and 
recovering the supernatant for immunoprecipitation. The supernatant was brought to 3 mL with 
IP dilution buffer and dispensed into two aliquots of 1.35 mL and one aliquot of 200 µL, stored 
at -80 °C as Input DNA. The Test IP aliquot was incubated with 10 µg of anti-CsgD monoclonal 
antibody and the Control IP aliquot was incubated with 10 µg of nonspecific normal mouse IgG 
overnight at 4°C on a rotating wheel. This admixture was then incubated with 50 µL Protein G 
magnetic beads at 4°C for 3 hours on a rotating wheel. Protein G magnetic beads and associated 
material were bound to the side of the tubes with a magnetic stand, and washed with cold salt 
buffer (IP wash buffer 1) twice, LiCl buffer (IP wash buffer 2) once, and TE twice (Table A6, 
Appendix C). Warmed Elution buffer was added to the washed beads, incubated at 65°C for 30 
minutes with occasional, gentle vortexing, eluted on the magnetic stand, and repeated.  
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Figure 3.12a-c. Target-binding activity of ChIP monoclonal antibody by immunoblot on 
cell lysates. Cell lysates were prepared from flask culture inoculated with S. Typhimurium 
strains and incubated at 28°C for 13 hours with shaking. Antibody specificity was assessed by 
Western blot with cell lysates from flask cultures of S. Typhimurium biofilm (WT B) and 
planktonic (WT P) cells and transcription factor overexpresser (CsgD+) S. Typhimurium 
ST14028 ∆csgD + pACYC csgDcompFOR3 biofilm (a). Transcription factor binding activity of 
monoclonal antibody clones 10G5 (previous ChIP-seq) and 6D4 was assessed by fluorescent dot 
blot on equal amounts of sonicated preparations from S. Typhimurium biofilm (WT B) and 
planktonic (WT P) cells, CsgD overexpresser S. Typhimurium ST14028 ∆csgD + pACYC 
csgDcompFOR3 biofilm (CsgD+ B), and CsgD deletion strain S. Typhimurium ST14028 ∆csgD 
planktonic (∆csgD P) cells from flask culture (b). Fluorescence intensity was read on the LiCor 
imager and normalized to background and to S. Typhimurium ST14028 ∆csgD (c).  
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3.3.2.8 Purification of immunoprecipitated DNA 
The small amounts of DNA from chromatin immunoprecipitation must be purified for 
library preparation and sequencing. The ideal purification method retains a high proportion of 
ChIP DNA and removes contaminants that could interfere with library preparation. I performed a 
dilution series of known starting Input DNA concentrations and measured the concentration of 
each sample before and after purification with Qiagen spin columns (QIAQuick PCR 
Purification Kit, Qiagen, 28104) or Axygen magnetic beads (Macherey-Nagel, 744970). Input 
DNA prepared for the standard curve was readily available, could be diluted to a known 
concentration, could be measured by Nanodrop, and approximates immunoprecipitated DNA 
fragment size and composition. The concentration of each standard was measured by Nanodrop. 
Each standard was dispensed into three replicate tubes per purification method. These three 
replicates were purified by column or magnetic beads according to the recommended protocol, 
with elution in nuclease-free water at 65°C. Figure 3.13 shows that at low concentrations of 
DNA, magnetic bead purification measures closer to the expected concentration from the 
standard curve than column purification. Some loss of DNA is apparent for both purification 
methods, as expected. Magnetic bead purification was chosen over column-based purification 
because it retained low concentrations of input ChIP DNA, removed contaminants, and measured 
true to standard concentrations (Figure 3.13). ChIP control and test DNA prepared from S. 
Typhimurium cells was purified using magnetic beads and DNA concentration was measured 
using the Qubit (Thermofisher Scientific, #Q33216) and a high sensitivity double-stranded DNA 
kit (Thermofisher Scientific, #Q32850). 
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Figure 3.13. Comparison of purification strategies for small amounts of DNA resulting 
from ChIP-seq experiments. DNA purification of low concentrations of sonicated Input DNA 
measures closest to the standard curve (“Expected concentration”) than column purification.  
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3.3.3 Confirmatory tests 
Tests were performed on prepared ChIP DNA prior to library preparation to determine 
DNA concentration, fragment size profile, and enrichment of known regulatory targets of CsgD. 
Input DNA was high enough for detection by Nanodrop; however, ChIP sample DNA was below 
accurate detection (<5 ng/µL). Therefore, DNA concentration was measured with a Qubit 
double-stranded DNA High Sensitivity Assay Kit (Thermo Fisher Scientific, #Q32851) 
measured on the Qubit 3.0 Fluorometer (Thermo Fisher Scientific, #Q33216). Input 
concentrations were 15 to 35 ng/µL and test and control ChIP DNA concentrations ranged from 
about 10 to 270 pg/µL. After library preparation, DNA concentration was measured on the Qubit 
3.0 Fluorometer with the Qubit double-stranded DNA Broad Range Assay Kit (Thermo Fisher 
Scientific, #Q32850) 
The fragment size range of ChIP DNA, used to estimate library preparation size 
selection, was confirmed by Bioanalyzer (Agilent, #G2939BA) of Input DNA (Figure 3.14a). 
Immunoprecipitated DNA fragment sizes were below detection of the Bioanalyzer (Figure 
3.14b), but amplified adapter-ligated DNA after library preparation could be detected (Figure 
3.14c). The Bioanalyzer electropherogram can also reveal excess adapter dimers at 
approximately 120 bp that require additional clean-up (Figure 3.14d).  
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Figure 3.14a-d. ChIP DNA preparations and libraries visualized chronologically by 
Bioanalyzer electropherogram. Fragment sizes of genomic DNA after cell lysis and sonication 
were below 1000 bp, with a majority of fragments at 200-500 bp (a). Starting material for library 
preparation was below detection (b); however, adapter ligation and PCR enrichment allowed for 
visualization of libraries (c). A library preparation unacceptable for sequencing has low DNA 
peaks, oddly shaped or high molecular weight peaks, or adapter peaks at approximately 100 bp 
(d). 
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 Enrichment of known regulatory binding regions can be assessed by qPCR, by comparing 
Cts between known target and reference gene sequence abundance in immunoprecipitated test 
and control DNA samples. These were compared to a standard curve of sonicated Input DNA. 
The abundance of an intergenic portion of csgB, a known regulatory target of CsgD, was 
compared to fabG and groEL, genes which are constitutively expressed and whose products are 
not expected to be involved in biofilm formation. We expect enrichment of csgB over groEL in 
the CsgD overexpresser and wild type biofilm ChIP samples and negative enrichment in the 
csgD deletion planktonic samples. Fold enrichment, calculated from these qPCR experiments, is 
inconsistent among replicates and does not align with expected results. Target and reference gene 
abundance was inconsistent in multiple replicate experiments.  
 
Table 3.2. Fold Change (2-∆∆Ct) from a qPCR experiment assessing enrichment of a known 
CsgD regulatory target, csgB, over a control gene, groEL. The average abundance of these 
two targets were compared between libraries prepared from ChIP DNA and a standard curve of 
Input DNA. Cts were recorded in duplicate and compared using the method described by Livak 
et al.109  
ChIP Sample Library ∆Ct 
Libraries 
∆Ct Standard 
curve 
∆∆Ct Fold enrichment 
(2-∆∆Ct) 
Standard 
deviation 
S. Typhimurium  
Planktonic 
1 -0.53 0.04 -0.57 1.4820 0.1152 
2 2.90 0.04 2.86 0.1378 0.2636 
3 -0.40 0.04 -0.44 1.3574 0.1826 
S. Typhimurium  
Biofilm 
4 -1.22 0.04 -1.26 2.3867 0.1280 
5 -0.71 0.04 -0.74 1.6732 0.2635 
6 -0.36 0.04 -0.40 1.3174 0.1537 
S. Typhimurium 
CsgD++ 
Biofilm 
7 0.08 0.04 0.04 0.9724 0.1050 
8 -0.35 0.04 -0.38 1.3043 0.2020 
9 -1.43 0.04 -1.46 2.7572 0.2429 
S. Typhimurium 
∆csgD 
Planktonic 
10 -0.44 0.04 -0.48 1.3934 0.0979 
11 -0.37 0.04 -0.40 1.3217 0.1146 
12 -0.60 0.04 -0.64 1.5559 0.1371 
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3.3.4 Library preparation 
ChIP test and ChIP control DNA samples were converted into high quality libraries for 
Illumina sequencing. In this library preparation scheme, DNA fragments undergo end repair, 5’ 
phosphorylation, and dA-tailing in preparation for adapter ligation and adapter loop excision 
(Figure 3.15). Library fragment sizes were selected by magnetic beads, after which adapter-
ligated library fragments were amplified with added universal and unique index sequences 
during PCR enrichment. Libraries were prepared with the NEBNext Ultra II DNA Library Prep 
Kit for Illumina (#E7645S), with adjustments for ChIP DNA. This kit was ideal because it was 
designed to accommodate low DNA concentrations in its broad range of starting material, from 
500 pg to 1 µg. Low concentrations of ChIP DNA starting material were not visible by 
Bioanalyzer electropherogram until PCR enrichment of adapter-ligated fragments (Figure 3.14) 
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Figure 3.15. (Adapted, Figure 1 NEBNext Ultra II DNA Library Prep Kit for Illumina 
manual) Illustrated steps of NEBNext library preparation, with modifications for low 
concentration ChIP DNA starting material. Library preparation involves end repair of 
fragmented DNA starting material, phosphorylation and dA-Tailing, adapter ligation and U-
Excision with USER enzyme, and finally, PCR enrichment and indexing with universal and 
unique barcode primers. 
 
 
  
PCR Enrichment and Indexing
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Adapter Clean up and Size 
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 A size selection test was performed to determine magnetic bead ratios appropriate for a 
library size majority of 500 bp before library preparation with ChIP samples. In this assay, 
libraries were prepared from sonicated input DNA. These libraries were prepared in parallel and 
under identical conditions, apart from the ratios of magnetic beads during size selection. 
Magnetic bead-based size selection leverages magnetic bead affinity for high molecular weight 
DNA fragments. The largest DNA fragments are bound by the higher initial ratio of beads and 
discarded. The second ratio of beads binds to the remaining majority of higher molecular weight 
fragments, which are purified from the lowest molecular weight fragments. Input libraries were 
selected with two different ratios of magnetic beads to DNA in solution to determine the ratios to 
use for size selection of ChIP DNA. These libraries were compared by Bioanalyzer 
electropherogram (Figure 3.16). The ratios of beads to DNA that produced library fragment sizes 
closest to 500 bp, 0.30 and 0.15, was chosen for subsequent library preparations. This ratio 
produced a tight peak with a fragment size range of 300-600 bp and a median of about 450 bp.  
ChIP DNA library preparation requires a couple of method-specific considerations. Low 
DNA concentrations after immunoprecipitation may not be visible by Bioanalyzer 
electropherogram, but can be visualized after library preparation due to amplification of adapter-
ligated fragments (Figure 3.14b and c). Library preparation with ChIP DNA requires accurate 
and sensitive DNA quantification so that the right amount of starting material can be used to 
create a diverse library. DNA concentration is measured prior to library preparation by Qubit 
with a high sensitivity double stranded DNA kit, and by Qubit with a broad range double 
stranded DNA kit. In addition, the lowest recommended dilution of adapters was added for 
adapter ligation, to prevent an excess of adapters (Figure 3.14d), which interferes with cluster 
formation on the MiSeq flow cell. In addition, library enrichment of low yield ChIP DNA 
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requires the maximum number of recommended amplification cycles (i.e., 15). PCR enrichment 
may introduce bias; however, amplification prepares libraries for quantification, characterization, 
dilution, and sequencing. 
 
 
 
 
 
Figure 3.16. Bioanalyzer electropherogram of library magnetic bead size selection assay 
with input DNA. Libraries were prepared with sonicated and purified input DNA, with ratios of 
magnetic beads to DNA 0.40 and 0.20 (0.40/0.20) compared with 0.30 and 0.15 (0.30/0.15) in 
the size selection step. Magnetic bead ratios 0.30/0.15 produce libraries of fragment sizes 300-
550 bp with a median of approximately 450 bp and were chosen for ChIP library preparation. 
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3.3.5 Sequencing ChIP-seq DNA 
ChIP DNA libraries prepared from S. Typhimurium samples were sequenced on the 
Illumina MiSeq with the MiSeq Reagent Kit v3 (150-cycle, 2x75 bp, MS-102-3001). The 
Illumina MiSeq was chosen for its sequencing capacity, flexibility, availability, run cost per data 
output, ease of data acquisition, and established success in ChIP-seq and related experiments. 
The indexed libraries that were prepared from ChIP DNA (see 3.3.5 Library Preparation) were 
multiplexed and sequenced together on the flow cell in a single lane191. Each unique library was 
tagged with a index sequence as part of the initial primers, that is detected and used to sort 
sequence reads by library for data acquisition and downstream analysis. In order to improve 
genome coverage and expected number of reads per library, two replicates were chosen from 
each sample type. Libraries with a single, strong Bioanalyzer peak consistent across two samples 
with no adapter peak were chosen. Illumina recommends around 100x coverage for ChIP-seq 
experiments; 8 indexed libraries are expected to yield approximately 5.6 million reads per 
library, which is expected for bacterial ChIP-seq experiments in the literature. Coverage was 
calculated using the following equation: 
 
$%& =
%&' (ℎ ()	 *% # %&' 
  ()
 
(3.2) 
i.e., 
2	75  	 5.6 	 10 %&'
4.79	 10 
= 175.4	 
 
This is more than enough coverage. Indexed libraries were pooled to produce reads of equal 
proportion and adequate coverage for downstream ChIP-seq analysis. Firstly, library 
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concentration was converted from ng/µl to nM, and adjusted based on average fragment sizes 
from Bioanalyzer electropherogram (Figure 3.14c).  
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This concentration was used to find the volume required for 20 nM pooled library final 
concentration, or 1.67 nM per library.  
5* (µ0) =
6(&  ... (/)
# # %&%
	 8 $* (µ0)	
1
0%&%9 ... (/)
 
 (3.4) 
i.e., 
20 /
8 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
	 100µ0 	
1
130.6 / (#% 3.4)
= 1.91 µ 
 
The calculated volumes of each library were combined and the pool was brought to 1 mM Tris-
HCl with 10 mM stock and nuclease free water on-site. The 20 nM pool was diluted to a final 
concentration of 16 pM and denatured as per kit instructions. After preparatory washes, the 
library pool was loaded onto the flow cell and sequenced.  
 
  
 66
3.3.6 Bioinformatic methods for analyzing ChIP-sequencing data 
There are many bioinformatic tools available for processing and analyzing large amounts 
of heterogenous ChIP-seq data. The general steps for processing and analyzing ChIP-seq data are 
shown in Figure 3.17. After data is acquired from the sequencing platform, reads are scored for 
base quality, trimmed, aligned if paired-end, and mapped to a high quality reference genome. 
Trimmomatic is a common tool used for trimming reads, and BWA, Bowtie, or Bowtie2 are 
common tools used for aligning reads to a reference genome100,105. Once mapped to a reference 
genome, peaks are called and associated with particular genes based on proximity to the 
transcriptional start site of a gene121. At this point, peaks are visualized on a genome browser, 
annotated, and evaluated for consistency across biological replicates. Multiple peak sequences 
can be evaluated by tools such as MEME (Multiple Em for Motif Elicitation)9 for consistency 
and a common binding motif. Peak data can also be compared across samples in differential 
analysis, or can be integrated with expression data for a deeper understanding of regulatory 
networks.  
Geneious 9.1.5 software88 was used primarily for analyzing this dataset because most 
functions required for ChIP-seq data analysis are integrated on a single platform. Quality control 
by base quality score at each nucleotide is automatically assigned in FastQ file format from 
Illumina sequencing. The remaining Illumina adapters or bases that have unacceptably low 
quality were trimmed with an error probability limit of 0.05. This sequencing dataset was not 
paired-end and as such, forward and reverse reads did not need to be aligned. Instead, trimmed 
reads were immediately mapped to S. Typhimurium 14028 reference genome (GenBank 
CP001363.1)81 using the Bowtie2 plugin for Geneious. Some analysis methods recommend 
visualization of mapped reads on a genome browser following peak calling with a statistical tool; 
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however, the mapped reads were visualized first. Due to the nature of the data, it was not 
necessary to call peaks and perform downstream analysis after visualization.  
 Peaks were called with bioinformatics tools to confirm the peaks observed visually. All 
raw FastQ files were uploaded to the Galaxy Tools suite2 for complete bioinformatic processing. 
Reads in each file were trimmed with Trimmomatic, which used a sliding window of four bases 
and an average threshhold quality of 2015. Trimmed sequence files were then mapped to the S. 
Typhimurium 14028S reference genome (GenBank CP001363.1)81 with Bowtie2 sensitive end-
to-end alignment99. CsgD deletion ChIP samples were expected to return no peaks, and wild type 
S. Typhimurium planktonic ChIP samples were expected to return few peaks, if any. Therefore, 
peak analysis was assessed based on these two ChIP sample types as background. Peak calling 
was performed in Galaxy with the MACS2 (Model-based Analysis of ChIP-seq) tool. Peaks were 
called on a trimmed and aligned “test” file, with the background set as the “control” file input. 
Peak calling with MACS2 proceeded with the following parameters: effective genome size, 
5x106 bp; band width, 450 bp; lower mfold, 2; upper mfold, 100; q-value, 0.05; with no shifting 
model.  
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Figure 3.17a and b. Analysis of ChIP-seq data using bioinformatic methods. ChIP-seq reads 
are trimmed by base quality and mapped to a reference genome, where peaks can be resolved at 
specific genomic locations and associated with genes for biologically relevant information that 
can be further analyzed (a). Geneious 9.1.5 was used to perform most of the functions required 
for analysis. Figure b shows Geneious windows for (top to bottom) base quality in sequence 
reads, trimmed reads, mapped reads, visualized peaks, and peaks associated with genes.  
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3.3.7 ChIP-sequencing results 
The sequencing run ended more than 4 hours earlier than expected with one read set 
sequenced, due to an error on the sample sheet that directs the MiSeq. Even so, there were 
approximately 2 million reads per sample (Figure 3.18), which is still adequate for a bacterial 
ChIP-seq experiment. The cluster density was low compared to saturated sequencing flow cells. 
DNA concentration by Qubit may have been overestimated, which would lead to 
underclustering. This may be partially why the read data was high quality (Phred quality score of 
Q>30), albeit half the volume than expected. Control ChIP libraries were not sequenced, after a 
quick check for peaks in the test ChIP sequencing reads. 
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Table 3.3. Metadata and summary statistics from test ChIP sequencing run. MiSeq data 
output for sequencing with S. Typhimurium test ChIP libraries.  
Sequencing platform MiSeq 
Sequencing kit MiSeq Reagent Kit v3 
2x75 bp 
Data output Cluster density 1047 K/mm2 
Clusters passing filter 91.4% 
Estimated yield 1820.6 Mb 
Total sequences 18 025 265 
 
 
 
 
Figure 3.18. ChIP-seq samples and sequencing reads. ChIP DNA was prepared in duplicate 
from flask culture incubated at 28°C for 13 hours with shaking (200 rpm) of wild type (WT) S. 
Typhimurium biofilm and planktonic cells (left), CsgD overexpressor (CsgD++) S. 
Typhimurium 14028S ∆csgD + pACYC184-csgDcompFOR3 biofilm (middle), and CsgD 
deletion S. Typhimurium 14028S ∆csgD planktonic cells (right) (a). Sonicated DNA (Input 
DNA), DNA from immunoprecipitation with anti-CsgD antibody (ChIP DNA), and DNA from 
immunoprecipitation with normal mouse IgG (ChIP Control) was prepared for each of the cell 
preparations. Libraries were prepared from DNA and sequenced on an Illumina MiSeq at 2x 75 
bp. The number of reads and the expected outcome for each cell type library in (a) are listed (b).  
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ChIP data was acquired from the MiSeq in FastQ file format, and processed as described 
in 3.3.6 Bioinformatic methods for analyzing ChIP-sequencing data. Sequencing reads that were 
mapped to the S. Typhimurium 14028 (GenBank: CP001363.1)81 genome can be seen in Figure 
3.19. In a successful ChIP dataset, multiple, strong peaks two-fold or more above background at 
known and previously unknown regulatory regions should be obvious by visual scanning of 
mapped reads, and apparent by statistical isolation. Initially, the mapped reads were visually 
inspected for peaks two-fold above background reads. There were no peaks that met this criteria 
in ChIP samples from wild type S. Typhimurium biofilm and planktonic cells. As expected, there 
was a strong peak in both of the CsgD overexpresser biofilm replicates that spanned the csgD 
coding region and the csg operon intergenic region (1 188 331 to 1 189 680 bp on the genomic 
map), contributed by the CsgD expression plasmid. In S. Typhimurium csgD deletion replicates, 
there was a peak (at about 1 911 000bp on the genomic map) in the ycgO coding region. A 
statistically nonsignificant peak at ycgO was also seen in one wild type S. Typhimurium 14028 
planktonic, one wild type S. Typhimurium 14028 biofilm, and one S. Typhimurium 14028 CsgD 
overexpresser biofilm replicate by visual scanning. Another common but statistically 
nonsignificant peak was seen by visual scanning (at about 1 502 500 bp on the genomic map) in 
a putative inner membrarne protein coding region behind uvrA in both replicates for wild type S. 
Typhimurium 14028 biofilm and planktonic ChIP samples. Peak calling was performed with 
Galaxy MACS2 callpeak to confirm the results observed visually (Table 3.3). The same peaks 
were called at csgD and the csg intergenic region in S. Typhimurium CsgD overexpresser 
libraries 7 (3.6-fold enrichment) and 8 (6.5-fold enrichment). New peaks at several different 
genomic locations were called in S. Typhimurium planktonic library 2 at approximately 2-fold 
enrichment.  
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Figure 3.19. Coverage map histogram of ChIP-sequencing reads mapped to S. 
Typhimurium reference genome and visualized by Geneious 9.1.5 genome browser. Each 
set of reads were trimmed, forward and reverse reads were aligned, and then reads were mapped 
to S. Typhimurium reference genome CP001363.1. Coverage maps from the duplicate libraries 
are shown. The scale to the right of the maps indicates read count coverage at each location of 
the genome. 
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Table 3.4. Called peaks from Galaxy MACS2 analysis of ChIP-seq data. Sequence reads that were trimmed (Trimmomatic) and 
mapped to the S. Typhimurium reference genome (Bowtie2) were assessed by MACS2 analysis for peaks against S. Typhimurium 
wild type planktonic or ∆csgD planktonic background control. MACS2 returned peaks that were less than 100-fold and greater than 2-
fold above background. Peaks that were two-fold above background were recorded.  
ChIP sample Library  Background 
(Strain, cell 
type, library)   
Peak 
start 
(bp) 
Peak 
end 
(bp) 
Length 
(bp) 
Fold 
enrichment 
Associated gene 
S. Typhimurium 
14028S  
Planktonic  
2 WT P 3 No peak 
∆csgD P 10 4434666 4435462 797 2.12 putative phage tail fiber protein H 
CDS, putative cytoplasmic protein 
CDS 
∆csgD P 11 2616907 2617662 756 2.20 ethanolamine utilization protein 
EutK, EutR  
3647225 3647678 454 2.10 putative surface-exposed virulence 
protein BigA 
2903965 2905614 1650 2.10 Putative permease protein, NupG 
3 No peaks for all background comparisons 
S. Typhimurium 
14028S  
Biofilm 
4 No peaks for all background comparisons 
5 No peaks for all background comparisons 
S. Typhimurium 
14028S ∆csgD + 
pACYC184-
csgDcompFOR3 
Biofilm 
7 WT P 2 1187828 1189268 1441 3.62 CsgD, csg intergenic region 
WT P 3 1187832 1189267 1436 3.62 
∆csgD P 10 1187815 1189273 1459 3.63 
∆csgD P 11 1187825 1189271 1447 3.63 
8 WT P 2 1187765 1189295 1531 6.49 
WT P 3 1187770 1189292 1523 6.49 
∆csgD P 10 1187769 1189294 1526 6.49 
∆csgD P 11 1187770 1189292 1523 6.49 
S. Typhimurium 
14028S ∆csgD 
Planktonic 
10 No peaks for all background comparisons 
11 No peaks for all background comparisons 
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3.4 Discussion 
A second ChIP-seq experiment did not return any meaningful statistically significant 
peaks at genomic regions regulated by CsgD. There is an inherent risk for introducing error in 
the many procedural steps involved in ChIP-seq. However, risk of error was minimized by the 
use of a verified monoclonal anti-CsgD antibody and by step-wise alterations to ChIP methods 
based on successful published protocols and experimental optimization159.  
 In my initial ChIP-seq experiment, DNA samples were harvested from wild type S. 
Typhimurium biofilm and planktonic cells at 13 hours and from biofilm at 32 hours of flask 
growth. In the flask culture at 13 hours, intracellular CsgD is highest and is expected to bind to 
its regulatory regions, whereas intracellular CsgD concentration lessens and biofilm matures at 
32 hours. The S. Typhimurium CsgD overexpresser strain has high levels of intracellular CsgD 
and is expected to saturate all available binding locations to return strong, positive regulatory 
peaks from immunoprecipitation. ChIP DNA strains, cell types, and time points were refined for 
the second experiment. CsgD binding and regulatory control is expected to occur earlier in S. 
Typhimurium growth; therefore, we did not include a biofilm sample from 32 hour flask culture. 
Instead, S. Typhimurium 14028S ∆csgD was harvested as negative control, since it should not 
return any regulatory peaks from immunoprecipitation with anti-CsgD antibody. Furthermore, 
immunoprecipitation was designed to facilitate a different type of analysis. In the first ChIP 
experiment, sonicated input DNA was harvested in parallel with immunoprecipitation with the 
monoclonal anti-CsgD antibody. Peaks were distinguished as regions of coverage above 
background coverage in a single set of reads, but background also could have been referenced as 
Input DNA. Immunoprecipitation in the second experiment was much more stringent: sonicated 
input DNA and DNA from immunoprecipitation with normal mouse IgG could be used as 
background for immunoprecipitation with anti-CsgD antibody. This method accounts for error 
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that could arise from immunoprecipitation, whereas sonicated input DNA simply covers the 
genome and can introduce error through local differences in coverage.  
 The second ChIP sample preparation was improved from the last. The new monoclonal 
antibody (6D4) bound better to CsgD than the antibody clone used in the initial ChIP-seq 
experiment. Methods were also changed based on analysis of successful ChIP-seq with bacterial 
transcription factors. For example, a washing step was added after crosslinking to remove excess 
crosslinker, a preclearing step was added before adding Protein G magnetic beads to the 
sonicated cell lysate with antibody, and a portion of the precleared chromatin was 
immunoprecipitated with normal mouse IgG (i.e. “control IP”) For the most part, buffer recipes 
varied little between published protocols and functioned as they were intended. I also changed a 
few methods after experimental optimization for S. Typhimurium cell types and the lab 
equipment available for preparing ChIP DNA. The goal of method optimization was to improve 
sample consistency and thereby reduce opportunities for introducing error. I determined the 
amount of planktonic cells to harvest so both cell types have an equal amount of substrate for 
protein crosslinking. Mechanical homogenization of cell samples in a mixer mill at 30 Hz for 5 
min broke apart biofilm consistently. After consulting with collaborators collaborators (Dr. 
Carsten Kröger, Trinity College Dublin, Stefani Kary, MSc.,Trinity College Dublin), cell 
samples were incubated in lysis buffer on ice longer, which reduced the amount of visible 
material in the tube before sonication. Planktonic cells were processed by mixer mill at the same 
time to reduce variables. DNA fragmentation by sonication with a cup horn sonicator was tested, 
but was not as consistent and effective as probe sonication. Most protocols that were surveyed 
used column-based or phenol-chloroform extraction. Magnetic beads were chosen for future 
ChIP DNA purification after I performed an assay comparing column kits to magnetic beads.  
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 Libraries were made from ChIP DNA, which were tested for concentration, fragment size 
range by Bioanalyzer, and enrichment by qPCR. After size selection during library preparation, 
library fragment sizes were confirmed with a range of about 300-700bp and a median of 450 bp. 
Tests for the enrichment of one known regulatory target of CsgD, csgB, against control target 
groEL returned inconsistent results. There were a couple of issues that could have been 
responsible for these results: 1) bias could have been introduced due to sonication, 2) tests with 
ChIP DNA could have been at the limits of detection, and 3) the csgB target could have been 
outside of a regulatory peak, which are often narrow for transcription factors. We concluded that 
the any issues of detection that were encountered with qPCR would be resolved by sequencing, 
since it is much more sensitive.   
 Despite these improvements to ChIP methods, no significant peaks at CsgD regulatory 
regions were identified. By visual inspecition and MACS2 peak calling, a strong peak 3.6-6.5 
fold above background was identified in S. Typhimurium ST14028 ∆csgD + pACYC 
csgDcompFOR3 biofilm ChIP reads. This peak is not significant because the plasmid contributed 
extra copies of csgD with the intergenic region to background reads. Peaks at other known 
regulatory regions (i.e., adrA), or at unknown regions should accompany this peak, if it was truly 
the result of successful immunoprecipitation. In addition, the intergenic peak was abnormally 
broad for normal transcription factor binding sites. MACS2 analysis also identified peaks in S. 
Typhimurium ST14028 planktonic ChIP reads (Library 2) that were about 2-fold above 
background. Since these peaks are not called in the other planktonic ChIP reads (Library 3), are 
fairly low fold enrichment, and are in unrelated genes, they are likely nonsignificant. Localized 
low coverage in background alignments compared with Library 2 coverage at these genomic 
locations may have caused MACS2 to call peaks. By visual inspection, peaks were observed at 
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ycgO in S. Typhimurium ST14028 ∆csgD planktonic ChIP reads. They were also observed to a 
lesser extent in S. Typhimurium ST14028 wild type biofilm and planktonic ChIP reads. If this 
peak were significant, it would be accompanied by known binding regions (i.e. adrA, csg) or 
other biologically relevant genomic sites, and would be distinguishable by differential binding 
analysis between strain and cell types. This peak may be an artifact from sonication or 
immunoprecipitation. Common artifacts in ChIP experiments with human cell lines are 
“blacklisted” on databases such the Duke Excluded Regions (DER)74,89,95. However, it appears 
that no such database exists for bacterial reference genomes. 
 The low yield of DNA that I’ve achieved after immunoprecipitation may still be 
attributed to ChIP selection of a small population of fragments. Enrichment tests by qPCR were 
inconsistent, but in hindsight may have indicated low enrichment. However, no change in 
enrichment was observed for S. Typhimurium ST14028 ∆csgD + pACYC csgDcompFOR3 
biofilm ChIP DNA, which contained additional csg fragments from the plasmid and should show 
artificial enrichment. A common ChIP issue, antibody specificity, is likely the cause of 
immunoprecipitation failure in this experiment. Even though the second antibody appeared to 
bind CsgD in immunoblots with sonicated cell lysates prepared for ChIP, binding epitopes may 
not be available for immunoprecipitation of DNA-CsgD crosslinked fragments. Epitopes for 
efficient ChIP binding may differ from those predominant in the CsgD-His protein used to 
generate the monoclonal antibodies or they may be shielded by CsgD dimerization184, 
interactions with DNA or other proteins, or protein folding in vivo113. Commercial antibodies 
against epitope tags may provide more consistent read peaks from immunoprecipitation. ChIP-
sequencing remains a powerful tool for identifying the regulatory targets of transcription factors, 
and generates massive amounts of data for analysis and integration with other components of 
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regulatory networks. The modifications made to these ChIP-seq methods for the identification of 
CsgD regulatory targets in the two S. Typhimurium cell types may be useful if the right antibody 
or anti-TF construct is chosen. 
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TRANSITION 
Origins of signals for regulation of biofilm formation 
Overall, my hypotheses address the changes that S. Typhimurium initiates in response to 
environmental stress. My two main research projects concern phenotypic heterogeneity from 
different perspectives. The project previously described, identifying the regulatory targets of 
CsgD using ChIP-seq, focuses narrowly on one transcription factor and the handful of genes it 
controls under laboratory conditions. The research project I will describe in the next chapter 
considers the broader relationship between the host and S. Typhimurium during infection, with 
the goal of identifying genes that exhibit altered expression levels when exposed to factors 
present in the gut. These changes in gene expression may be involved in S. Typhimurium 
phenotype switching and strategies of infection and transmission. Together, these findings could 
identify the intrinsic and extrinsic factors that lead to population heterogeneity.  
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4.0 EXPRESSION OF VIRULENCE AND PERSISTENCE GENES IN THE PRESENCE 
OF WASTE EFFLUENT 
4.1 Introduction 
MacKenzie et al. discovered that many genes were differentially expressed in biofilm and 
planktonic cell types that are formed in response to environmental stress111. The signals for 
initiation of phenotype switching are complex and may originate from stochastic events, cell age, 
cell-to-cell interactions, or signals received from the host during the course of infection1. 
Currently, we do not know when S. Typhimurium experiences signals leading to bistability of 
CsgD, or if differential gene expression leading to population heterogeneity arises within the host 
due to small molecules encountered in the gut from the host or the microbiota. The goal of this 
research project was to determine if small molecules from the human gut microbiota change 
expression of genes involved in S. Typhimurium phenotype switching. A precedent for this 
experiment was set by Antunes et al., who demonstrated that a small molecule secreted by 
microbiota member Clostridia represses expression of S. Typhimurium SPI-1 and genes involved 
in host cell invasion7. Therefore, the expression of genes known to be involved in virulence or 
persistence were measured in the presence of effluent from the steady-state culture of a human 
intestinal microbiota. Promoters for genes involved in biofilm formation or virulence were 
inserted behind the luxCDABE operon on a plasmid introduced to S. Typhimurium. When the 
promoter is activated, luxCDABE gene products are made, which oxidizes a reduced flavin 
mononucleotide (FMNH2) and produces light at 490 nm, with a secondary emission at 590 
nm25,117. Light production due to promoter activation can be measured quantitatively as gene 
expression levels throughout the organism’s growth177. The growth media for these reporter 
strains was supplemented with liquid gold, waste effluent from a steady-state chemostat seeded 
with donor feces. Liquid gold is thought to contain small molecules present in the gut that 
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originate from the host or microbiota4,7, and could contain the signals for bistable expression of 
virulence and persistence genes. I noted whether there was any difference in promoter activity 
when S. Typhimurium was grown in the presence of waste effluent at biofilm-inducing and host-
mimicking growth conditions.  
 
4.2 Materials and Methods 
4.2.1 Strains for luciferase assays 
Promoters for genes that are important in virulence or persistence functions were chosen 
for ligation with pCS26 plasmid vector containing luxCDABE genes and kanamycin antibiotic 
resistance selection genes (Table 4.1). These ligated plasmids were electroporated into S. 
Typhimurium.  
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Figure 4.1. Promoters for genes primarily expressed in biofilm or planktonic cell types 
were cloned behind luxCDABE reporters in pCS26 plasmid and electroporated into S. 
Typhimurium 14028. This was maintained through kanamycin resistance (aph) carried on the 
plasmid. When the promoter is activated, luciferase genes are expressed and light measured as 
fluorescence counts per second (CPS) is detected proportional to the strength of promoter 
activation13.  
  
  
83
 
Table 4.1. S. Typhimurium ST14028 strains containing pCS26 vectors with luciferase genes 
(luxCDABE) controlled by a S. Typhimurium promoter involved in virulence or biofilm 
formation. Promoter-reporters labeled (*) were constructed and tested by White et al.189 and 
promoter-reporters labeled (+) were constructed for luciferase assays with waste effluent. 
 
Plasmid 
pCS26 
Gene function Gene 
association 
PadrA::lux* diguanylate cyclase, produces c-di-GMP, catalyzes 
conversion of 2GTP into c-di-GMP, induces cellulose 
biosynthesis, cell adherence, swimming/swarming, activates 
cellulose biosynthesis (bcsABZC) 
Persistence 
PcsgB::lux* Curli fimbriae subunit for adhesion, biofilm formation, and 
aggregation 
PcsgD::lux* DNA-binding transcriptional regulator CsgD, activates 
csgBA and csgDEFG operons 
Psig38H4::lu
x* 
RpoS, global regulator of gene expression during stress and 
starvation 
PSTM1987::
lux 
Diguanylate cyclase, produces c-di-GMP, involved in 
cellulose synthesis and biofilm formation 
PhilA::lux+ Transcriptional regulator, activates expression of invasion 
genes an and pathogenicity island type III secretion system 
Virulence 
PhilD::lux Transcriptional regulator, helix-turn-helix, activator for 
invasion genes, derepresses hilA expression 
PinvF::lux Transcriptional regulator for SPI-I Type III Secretion system 
effector proteins 
PmisL::lux+ Binds fibronectin, allows for colonization of the intestine 
PprgH::lux+ Secretion system protein, needle complex inner membrane 
protein, invasion type III secretion apparatus 
PshdA::lux+ Involved in intestinal persistence and prolonged shedding 
PsicA::lux SPI-1 chaperone, regulates expression of virulence genes 
PssrAB::lux+ Secretion system sensor kinase, type III secretion system 
regulator, regulated by OmpR-EnvZ 
PyhjH::lux c-di-GMP phosphodiesterase degrades c-di-GMP to 
counteract biofilm formation, enhances motility 
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4.2.2 Preparation of waste effluent 
Initial luciferase assays were performed with liquid gold in growth media; however, 
results were inconsistent between replicates. This may have been due to unequally distributed 
silt-like material in the liquid gold. After consulting Dr. Emma Allen-Vercoe, we performed 
separation and filtration steps on waste effluent and chemostat medium to remove this material.  
Thawed waste effluent and chemostat media was spun to pellet precipitates (47 800 xg at 
4°C for 45 minutes, Figure 4.2a). These tubes were placed on ice and the supernatant was filtered 
with a 0.45 µm syringe filter, followed by a 0.2 µm syringe filter. Filtrate of waste effluent and 
chemostat media was dispensed into single-use aliquots and stored in the freezer to prevent 
freeze-thaw degradation. Filtered waste effluent and chemostat media, shown in Figure 4.2b, was 
light yellow and free of debris.  
 
 
 
Figure 4.2a and b. Waste effluent, or “liquid gold” before (a) and after (b) separation and 
filtration to remove precipitate material. Precipitated material was pelleted by centrifugation, 
and the supernatant was filtered down to 0.2 µm.   
A B
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4.2.3 Luciferase assays measuring promoter activity in the presence of waste effluent 
Gene expression in the presence of waste effluent was assessed at 37°C and 28°C, human 
core temperature and environmental biofilm temperature, respectively. The environmental 
temperature is expected to promote biofilm-associated gene expression, and the human core 
temperature is expected to more closely match host infection. Gene expression was also assessed 
in the presence of waste effluent and iron chelator 2,2-dipyridyl at 37°C and 28°C by luciferase 
assay. Overnight cultures of bacterial reporter strains (Table 4.1) were grown at 37°C with 
shaking in LB supplemented with 50 µg/mL kanamycin. These overnight cultures were diluted 1 
in 600 in 1% tryptone supplemented with 50 µg/mL kanamycin to a final volume of 150 µl in a 
96-well clear-bottom black plate (Corning, #3631). When specified, supplements such as diluted 
waste effluent, chemostat media, or 2,2-dipyridyl (Sigma-Aldrich, #D7505) were added to wells 
containing media. Waste effluent was diluted in chemostat media to 1 in 10 and added at one-
tenth of the final well volume for a final dilution of 1 in 100. Growth media with kanamycin 
alone, or the latter with supplemented chemostat media was used as a control for waste effluent. 
Each well contained the same final volume, and media was adjusted such that each well was 
nutritionally consistent. Mineral oil was added on top of the media with cells to prevent 
evaporation. Absorbance was measured at 590 nm and luminescence was measured as counts per 
second (CPS) on the VICTOR X3 or VICTOR3V 1420 (Perkin Elmer, cat. 2030-0050, 1420-
040) every 30 minutes with agitation (1 min, 10 min intervals) for 48 hours at 28°C or 37°C. The 
run was restarted at 48 hours. After the data were exported from the Victor, any data for which 
growth by OD590 was slow or abnormal was excluded. Data for OD590 and luminescence over 
time showed expression levels during S. Typhimurium growth.  
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Figure 4.3. An overview of the method used to perform luciferase assays with waste effluent 
or chemostat media. Growth media (1% Tryptone) with 50 µg/mL Kanamycin is added to each 
well in a 96-well, clear bottom plate. Strains containing a pCS26 plasmid with luxCDABE genes 
behind a promoter of interest are grown overnight at 37°C with shaking and added to the 
appropriate wells. Liquid gold (waste effluent) or chemostat media are added to the appropriate 
wells at 1:100 final dilution, and mineral oil was layered on top. Cell growth was measured at 
590 nm and light production was measured as counts per second (CPS) by a plate reader. 
 
  
1% Tryptone + 
50 µg/mL Kanamycin
OR
Light (CPS)
OD (590 nm)
1:600 overnight 
culture
Liquid gold Chemostat media
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4.3 Results 
The expression of  promoters (listed in Table 4.1) in S. Typhimurium was assessed by 
luciferase assay in the presence of waste effluent at 28°C and 37°C and supplemented with iron 
chelator 2,2-dipyridyl. Expression of persistence- and virulence-associated genes was assessed in 
the presence of waste effluent at 28°C, introducing environmental stress, and at 37°C, 
reproducing conditions in the host gut. To test conditions that more closely mimicked the human 
gut, an additional parameter, iron limitation, was altered. The human body and microbiome has 
several mechanisms of sequestering iron, and as such, it is a growth-limiting nutrient5,38.  
Representative results were shown for each set of growth conditions (Figure 4.5a-e, 
Figure 4.6a-f). Figure 4.4 shows a normal growth plot for the strains that were tested in each set 
of conditions. The strains grew to about 0.6 OD590 in media supplemented with waste effluent, 
slightly less in media supplemented with chemostat media, and to 0.4 OD590 in unsupplemented 
media. There were five main trends in expression that were observed in these assays: 1) 
expression peaking at about 25 hours of growth, 2) time-shifted expression peaking at about 50 
hours of growth, 3) no expression, 4) an early drop-off in expression, and 5) low, random, or 
multimodal expression. Expression peaking at about 25 hours of growth was observed for 
virulence-associated genes at 28°C, which is shown in representative plots of hilD and yhjH  
(Figure 4.5a, Figure 4.6b). Most biofilm-associated gene expression at 28°C was time-shifted 
and peaked at about 50 hours of growth. This is shown in representative plots of csgD with or 
without 2,2-dipyridyl (Figure 4.5b, Figure 4.6a). No expression was observed for most 
persistence-associated genes at 37°C, which is shown in representative plots of csgB and adrA 
(Figure 4.5c, Figure 4.6d). An early drop-off in expression was observed for most persistence-
associated genes at 37°C, which is shown in representative plots of misL and sicA (Figure 4.5d, 
Figure 4.6e). Random or multimodal expression was observed for only a few genes. Multimodal 
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expression was observed for csgD at 37°C, sig38H4 at 37°C with 2,2-dipyridyl, and for ssrA at 
37°C without 2,2-dipyridyl and at 28°C with 2,2-dipyridyl demonstrated in Figure 4.5e and 4.6f. 
In general, higher expression levels by fluorescence counts were observed in the presence of 
waste effluent, followed by the chemostat control and finally, media without supplements. 
A third luciferase assay in the presence of waste effluent, at 37°C with 0.2 mM iron 
chelator 2,2-dipyridyl was performed, which mimicked gut conditions with a higher amount of 
iron chelator. This amount was chosen because it was used by Romling et al. to observe agf (csg) 
expression and aggregative fimbriae production in environmental conditions of iron depletion155. 
Expression results were similar to the previous experiment with more random error, which could 
have originated from the iron chelator (data not shown). The data were largely inconsistent; 
however, it appears that the additional 2,2-dipyridyl did not increase expression of any genes in 
the presence of waste effluent.  
 
Figure 4.4. Representative growth plot for S. Typhimurium strains grown in 1% tryptone 
with waste effluent at 28 °C and 37 °C. The growth of S. Typhimurium strains in the presence 
of waste effluent, chemostat media, and a media control was measured at 590 nm over the course 
of the luciferase assay. The OD590 for the treatment groups in this growth plot of the S. 
Typhimurium 14028 PcsgD::lux promoter-reporter strain at 28°C is typical for other promoter-
reporters.  
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Figure 4.5a-e. Representative expression plots for S. Typhimurium promoter-reporter 
strains grown in 1% tryptone with waste effluent at 28 °C and 37 °C. Gene expression in S. 
Typhimurium promoter-luxCDABE reporter strains grown at 28°C (a and b) or 37°C (c-e) in 1% 
tryptone with 1:10 waste effluent measured as luciferase reporter signal over time on a Victor 
plate reader. Expression plots for hilD (b), csgD (c), csgB (d), misL (e), and ssrA (f) are 
representative of trends observed for other genes. Red labels indicate virulence-associated genes 
and orange labels indicate persistence-associated genes. 
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Figure 4.6a-f. Representative expression plots for S. Typhimurium promoter-reporter 
strains grown in 1% tryptone with waste effluent and 40 µM iron chelator 2,2-dipyridyl at 
28 °C and 37 °C. Gene expression in S. Typhimurium promoter-luxCDABE reporter strains 
grown at 28°C (a-c) or 37°C (d-f) in 1% tryptone with 1:10 waste effluent and 40 µM 2,2-
dipyridyl measured as luciferase reporter signal over time on a Victor plate reader. Expression 
plots for csgD (a), yhjH (b), ssrA (c), adrA (d), sicA (e), and sig38H4 (f) are representative of 
trends observed for other genes. Red labels indicate virulence-associated genes and orange labels 
indicate persistence-associated genes. 
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4.4 Discussion 
Luciferase assays were performed by measuring light production of strains with a 
plasmid-based promoter-luxCDABE reporter when gene expression is induced. The reporter 
strains harboured promoter-reporter constructs for persistence- or virulence-associated genes of 
interest (Table 4.1). When strains were grown in tryptone media supplemented with waste 
effluent at 28°C, most genes were expressed at some point during growth. Virulence-associated 
genes were expressed earlier during exponential growth at or before 25 hours. Conversely, 
persistence-associated genes were expressed at the beginning of stationary phase. These results 
were expected, due to the functions required by Salmonella to survive long-term in conditions 
low in nutrients. Overall, higher expression was observed in the presence of waste effluent at 
28°C, but it was not significantly (i.e., 2-fold) above expression levels observed in chemostat 
control and tryptone. The strains also grew to different optical densities measured at 590 nm in 
waste effluent, chemostat control and media control, in descending order. Therefore, expression 
levels above media control and differences in the timing of biofilm-associated peak expression 
may be attributed at least partially to growth resources added by chemostat media or waste 
effluent. Shifts in the timing of in biofilm-associated peak expression may represent a delay in 
expression of genes involved in stress response until S. Typhimurium has run out of resources, 
which could occur later in the presence of resource-rich chemostat media and waste effluent. In 
general, growth of the S. Typhimurium strains in tryptone is less than in tryptone supplemented 
with chemostat media or Waste effluent. Waste effluent and chemostat media are hypothesized 
to bolster bacterial growth, with a higher concentration of resources usable by S. Typhimurium 
compared to the same volume of tryptone media. 
Gene expression patterns were different when strains were grown in tryptone media 
supplemented with waste effluent at 37°C than expression patterns at 28°C. The majority of 
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virulence-associated genes shut off expression before 10 hours of growth (refer to Figure 4.5d). 
Virulence-associated genes are normally expressed in elevated temperatures and rich media 
during exponential growth; this drop off in expression could be indicative of a shift in expression 
from rich media in the overnight inoculum to limiting media during luciferase assays. 
Persistence-associated promoters adrA, csgB, and STM1987 were inactive at 37°C (refer to 
Figure 4.5c). These genes are generally expressed when S. Typhimurium is exposed to 
environmental stress and temperatures below 28°C. Low, random, or multimodal expression was 
observed for ssrA and csgD (refer to Figure 4.5e). The reason for this is unknown; however, it 
may be due to additional resources for growth in chemostat media and waste effluent that were 
described previously. Ultimately, the presence of waste effluent at 37°C did not significantly 
increase expression of any of the genes surveyed.  
Mammalian cells have strategies of sequestering iron, and as such, iron availability is a 
common limiting factor for growth of microorganisms internally. Previous luciferase assays did 
not indicate a major role of waste effluent in altering gene expression; however, conditions that 
mimic the gut in temperature, small molecule content, and iron limitation were hypothesized to 
alter gene expression. Promoter activity of persistence- or virulence-associated genes listed in 
Table 4.1 were measured by luciferase assay in the presence of waste effluent and 40 µM iron 
chelator 2,2-dipyridyl at 28°C, to assess the stress response, and 37°C, to assess human distal gut 
conditions. Expression patterns were largely the same at 28°C in the presence or absence of 40 
µM 2,2-dipyridyl; however, the expression of biofilm-associated genes was slightly enhanced in 
the presence of waste effluent and 2,2-dipyridyl above that of media with waste effluent or media 
with chemostat control and 2,2-dipyridyl (refer to Figure 4.6a). This may be a response to limited 
resources. Expression patterns for virulence-associated genes was similar to those observed in 
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the absence of 2,2-dipyridyl, with a drop in expression before 25 hours of growth. However, no 
effect of waste effluent and iron limitation was observed. The expression of ssrA was 
inconsistent, bimodal, and showed no effect of waste effluent or iron limitation which was 
similar to the pattern of expression observed for ssrA in the absence of the iron chelator at 37°C. 
Iron chelation may mimic the distal gut in a similar way that temperature does for ssrA 
expression. Expression patterns were similar at 37°C in the presence or absence of 40 µM 2,2-
dipyridyl. The biofilm-associated genes that were shut off in media with waste effluent at 37°C 
were also shut off in the presence of 2,2-dipyridyl. Likewise, virulence-associated genes were 
expressed initially and dropped off in media with waste effluent at 37°C also did so in the 
presence of 2,2-dipyridyl. Expression of csgD, ssrA, and sig38H4 was static and multimodal at 
37°C whether the iron chelator was present or absent, with no effect of waste effluent observed. 
Taken together, these findings did not indicate an obvious role of waste effluent and iron 
limitation in altering expression of persistence- and virulence-associated genes at 37°C.  
I increased the amount of 2,2-dipyridyl in luciferase assays with waste effluent at 37°C 
from 40 µM to 200 µM (0.2 mM) to see if these conditions would mimic the distal gut more 
closely and alter gene expression. The increase in 2,2-dipyridyl did not change gene expression 
from the patterns observed in media with waste effluent and 40 µM 2,2-dipyridyl at 37°C. 
Expression was often shifted in time or inconsistent between replicates. This may be due to the 
excessive amount of iron chelator added, which did not promote normal growth. Overall, waste 
effluent and iron chelation at environmental and internal temperatures did not significantly alter 
expression of persistence- and virulence- associated genes by luciferase assay. Waste effluent 
may signals from the human microbiota for phenotype switching; however, they were not 
immediately apparent in this context and with the promoters that were assessed. These luciferase 
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assays should be regarded as preliminary; more research is required to understand the subtler 
increases in expression in the presence of waste effluent, and the trends in expression observed 
for S. Typhimurium virulence- and persistence-associated genes. 
. 
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5.0 CONSIDERATIONS AND CONCLUSIONS 
5.1 Discussion 
Three key findings led to my research project to identify the regulatory targets of CsgD 
using ChIP-seq. Firstly, the identification of a phenotypically heterogenous population of S. 
Typhimurium biofilm and planktonic cells when exposed to environmental stress 61,186. 
Secondly, that 34% of the genes in the genome were differentially expressed between the two 
cell types111. And thirdly, that the master biofilm regulator, CsgD, is at high intracellular levels 
in biofilm and at low intracellular levels in planktonic cells61. We hypothesized that bistable 
expression CsgD, the master biofilm regulator, was responsible for coordinating phenotype 
switching through its functions as a transcription factor. I intended to identify the genes regulated 
by CsgD and evaluate those targets by differential analysis in the two cell types. However, the S. 
Typhimurium cell types are physically very different and present a unique challenge to 
manipulate and evaluate as equivalents.  
I performed an initial ChIP-seq experiment with a published protocol for a successful 
ChIP experiment in S. Typhimurium by Dillon et al.41 We designed an experiment using the 
same organism and protocol, differing only by anti-CsgD monoclonal antibody, strain controls, 
background controls, and cell harvesting. This experiment did not return any peaks for regulatory 
targets of CsgD. Given the success of many ChIP experiments and the few differences between 
published procedures and our procedure, these results were unexpected. Nonetheless, ChIP-seq is 
a powerful and effective method, and produces massive amounts of high-quality data for 
identifying regions of DNA that are controlled by DNA-binding protein. For this reason, I 
diagnosed issues with this ChIP experiment and proceeded with a second, improved ChIP 
experiment to find the regulatory targets of CsgD. 
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Two main items were identified for improvement over the initial ChIP-seq experiment: 1) 
antibody specificity, and 2) enhanced sample consistency. Bortz and Wamhoff judiciously 
warned that “the assay can be cumbersome and fraught with ample opportunity to introduce 
technical error159.” It is true that there are many steps involved in ChIP with their own ways to 
introduce error. However, the published statement has been countered with an increase in 
number and quality of published ChIP-seq findings over the past seven years. We proceeded 
with due care. I evaluated each step in our procedure evaluated against the literature to introduce 
improvements. I checked each testable step in our procedure for the expected result. I optimized 
each step in our procedure for S. Typhimurium cell types and the lab equipment used to sonicate, 
immunoprecipitate, and purify DNA. Additionally, I purified and tested a new monoclonal 
antibody for its ability to bind to CsgD alone and CsgD in lysates prepared for ChIP-seq, with 
success. I tested and optimized so many parameters—cell harvesting, biofilm homogenization, 
sonication, and DNA purification, that we drafted a manuscript for performing ChIP from 
bacterial biofilms.  
Unfortunately, the second ChIP-seq experiment did not yield significant and biologically-
relevant regulatory targets of CsgD. Antibody specificity was a likely cause of failure, since I 
had optimized all testable methods and checked non-testable items against successful 
experiments in the literature. Antibody specificity is the most important part of a successful 
ChIP-seq experiment, because it determines both the DNA fragment selection and downstream 
peak resolution during analysis. I had tested many steps, but immunoprecipitation is one of the 
only steps that is not directly observable or testable until sequencing. Looking back at methods in 
the literature, very few, if any, use a monoclonal antibody. As I discussed earlier, antibody 
specificity is a common issue in ChIP due to epitopes that may be hidden in vivo by protein 
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interactions, DNA interactions, or protein folding113. Monoclonal antibodies often have a single 
binding site that is unknown unless it has been characterized. Most ChIP experiments are 
performed with polyclonal serum or an antibody specific for an epitope-tag on the target 
transcription factor. With polyclonal antibodies, any background that may be introduced due to 
non-specific binding is countered by the diversity of binding locations on a target protein. 
Although an epitope tag may interfere with protein function, commercial antibodies against 
epitope tags are often stringently tested and their use in successful experiments is reported in the 
literature.  
Antibody binding could have been affected by CsgD itself. CsgD is a 25 kDa response 
regulator protein with an N-terminal receiver domain for phosphorylation and a C-terminal 
LuxR-like helix-turn-helix motif for DNA binding194. Many binding sites for regulation of CsgD 
expression are known and characterized, but little is known about the regulatory targets of CsgD,  
and any interactions with other intracellular proteins. I have attempted ChIP-seq to address the 
dearth of information on the regulatory targets of CsgD; however, CsgD-protein interactions are 
still uncharacterized, may help coordinate phenotype switching, and may have even interfered 
with ChIP by obscuring epitopes. Unphosphorylated CsgD binds promoters of csgBA and adrA 
and controls transcription during biofilm-forming conditions. During transcriptional control, 
CsgD dimerizes at two main interfaces before binding regulatory sequences184. The anti-CsgD 
monoclonal antibodies used for both immunoprecipitations was raised against purified, His-
tagged CsgD monomers. Therefore, the epitopes of CsgD recognized by antibodies in vivo could 
be 1) hidden by dimerization, 2) absent due to His-tag interference, 3) on CsgD in an unknown 
phosphorylation state, 4) hidden by unknown protein interactions, or 5) hidden by protein folding 
or DNA binding. A polyclonal antibody could have provided a more robust selection of CsgD-
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bound DNA fragments. Even better, as long as biofilm phenotype was not impeded, a terminal 
epitope tag could enhance immunoprecipitation efficiently. 
Our results highlighted the importance of confirming antibody binding as well as 
enrichment of known regulatory targets by qPCR, if known targets are available. This step is 
recommended to confirm target enrichment prior to sequencing if known targets are available; 
however, our results were inconsistent and inconclusive. Enrichment tests by qPCR may be 
limited by low concentrations of DNA, sonication bias, or targets which are not directly at peak 
sites. ChIP peaks for transcription factors tend to be narrow or split distributed into forward and 
reverse peaks; therefore, a target site that is not directly at a peak could be misinterpreted as 
nonenriched background. We proceeded with sequencing because it provides much richer 
information and is far more sensitive than qPCR. 
Chromatin immunoprecipitation is a complex method that requires knowledge and skills 
in many different areas of expertise. It involves strain building, cell growth, immunochemistry, 
protein detection, library preparation, sequencing, and bioinformatic analysis of large amounts of 
data. It presents an excellent opportunity to learn and apply different techniques or to leverage 
the strengths of a research team. ChIP-seq methods may vary lab-to-lab with the same core 
requirements: protein-DNA interactions, lysis, DNA fragmentation, selection by 
immunoprecipitation, DNA purification, data acquisition, and analysis. Each step should be 
tested to control variables and avoid introducing error. Variation matters less for a few 
procedural items that are fairly consistent among published methods, such as the composition of 
lysis buffers. Compared to other methods of obtaining regulatory data, ChIP-seq is costly in time 
and expense. However, the cost of sequencing is lowering, and the amount and richness of ChIP-
seq data is incomparable.  
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These ChIP experiments may not have yielded biologically significant regulatory targets 
of CsgD. Even so, I hope that this method of processing biofilm cells will be useful for other 
researchers studying S. Typhimurium or other biofilm-forming microbes. In particular, the 
techniques I have tested and described for harvesting biofilm, normalizing cell types, comparing 
against planktonic cells, can be used as a starting point for processing other biofilm-forming 
species, with adaptations. Adaptations could include using equation 3.1 to find the wet weight of 
biofilm to harvest, cell type separation or normalization to a control cell type if required, and 
mechanical separation of biofilm. 
As previously discussed, my research project investigated the origins of signals for 
population heterogeneity: 1) molecularly and intrinsically by CsgD regulation, and 2) 
extrinsically with unknown signals from the human gut microbiota. Understanding more about 
when and why S. Typhimurium forms two cell types could reveal opportunities to block 
transmission or reduce the severity of infections.  
Currently, we do not fully understand when and where signals for phenotype switching 
come from. We do know that the conditions that S. Typhimurium experiences once expelled by 
the host are unpredictable; it could encounter harsh conditions in the environment or a new host 
to infect. Therefore, S. Typhimurium requires strategies to survive in the face of an uncertain 
future. Phenotype switching produces two distinct cell types: persistent biofilm cells that are 
resistant to desiccation and antibiotics, and planktonic cells that express virulence factors and are 
prepared to infect a new host. This way, a population of S. Typhimurium can conserve energy 
and ensure survival by expressing two different suites of genes to perform two vastly different 
functions. It would be advantageous for phenotype switching to occur in the host gut in 
anticipation of unknown future conditions. I hypothesized that S. Typhimurium experiences 
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extrinsic signals for state-switching during infection in the human body. Waste effluent from 
steady state chemostat culture seeded from feces was thought to contain small molecules that 
could initiate phenotype switching, so this was used observe phenotype switching through 
expression of virulence- or biofilm-associated genes.  
As it turns out, any increase in gene expression was likely due to addition of resources for 
bacterial growth in chemostat media or waste effluent. We expected that if waste effluent truly 
had an effect on switching cell types, a large at least 2-fold difference in expression would be 
observed. We did not observe an increase or decrease in expression to that scale. The differences 
in expression are subtler than expected, and more research is required to understand whether any 
increase in expression is biologically significant. Gene expression in the presence of waste 
effluent did shift gene expression earlier or later, most likely due to additional resources in waste 
effluent and chemostat media that support bacterial growth. To increase our chances of finding a 
difference in expression, we added an iron chelator. This would simulate iron limitation S. 
Typhimurium would experience in the human distal gut due to sequestering by the host and the 
microbiome. Gene expression from these assays did not differ significantly from assays without 
iron limitation. Instead, it introduced more noise, which Ackermann et al. suggested could lead 
to bistability1. Stress and iron sequestering could initiate bistability, but those effects were not 
observed in these tests.  
These luciferase assays measured gene expression of a whole population of cells. We 
know that a flask culture in similar conditions is comprised of about 61% planktonic cells and 
39% biofilm aggregates. Population proportions are not observable in the small wells of a 
luciferase assay. Therefore, during bistability, these assays would not be able to detect a gene 
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expression effect wherein one portion of the population drops expression and another portion of 
the population increases expression.  
These luciferase assays with waste effluent approximated conditions that S. Typhimurium 
would encounter in the mammalian gut. There are many other complex interactions that could 
initiate population heterogeneity. For example, physical interactions between host or microbiota 
cells and S. Typhimurium could initiate population heterogeneity. Signals could also originate 
from local differences in nutrition, physical interactions with microbiota and material in the host 
gut, or interactions with the products and cells involved in host defense.  
These assays did provide information about which genes involved in virulence or 
persistence were expressed in tryptone media at 37°C or 28°C. The waste effluent likely has too 
many unknown components to identify individual small molecules with a large influence. Waste 
effluent already has a function in culturing fastidious organisms from the human gut 
microbiome4; we  could use waste effluent in other assays to understand more about S. 
Typhimurium infections.  
 
5.2 Future directions 
In the future, ChIP-seq could be performed with epitope-tagged CsgD and a commercial 
antibody to overcome limitations to antibody specificity using a monoclonal antibody. In fact, 
we have built a S. Typhimurium strain with a 3xFLAG tag on the C-terminus of CsgD for 
immunoprecipitation with a commercial anti-FLAG antibody. This csgD::3xFLAG construct was 
inserted chromosomally in S. Typhimurium ∆csgD to encourage physiological concentrations of 
CsgD. It retains the biofilm phenotype in flask culture, and has the rdar phenotype on agar 
supplemented with Congo Red dye, indicating that the 3xFLAG tag does not interfere with 
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biofilm formation (data not shown). We assume that the function of CsgD as a transcription 
factor is not altered by the tag; however, the 3xFLAG tag could inhibit interactions with other 
proteins. ChIP-seq with this strain and the methods I have checked and optimized is expected to 
produce strong peaks at genomic regions regulated by CsgD.  
Another approach could identify the genomic locations regulated by CsgD. A full suite of 
CsgD binding motifs have been characterized in E. coli127 by ChIP-chip, and a few binding sites 
have been identified in S. Typhimurium194.  These known binding motifs could be used to find 
putative regulatory sites in silico. These sites could then be assessed for DNA binding by CsgD 
through DNA footprinting or luciferase assays measuring promoter activity in a wild type and 
CsgD deletion strain. A similar approach, combined with expression data, was used by 
Zakikhany et al.194.  
 As discussed, the methods I have described and developed could be used by other 
researchers searching for regulatory targets in biofilm-forming bacteria. ChIP-seq, a technique 
for finding sequences controlled by proteins, is continually being developed for new purposes. In 
the future, it could be used in conjunction with biofilm methods for discovering more about the 
regulatory networks in biofilm-forming species of bacteria. 
 Waste effluent has a described application as a media supplement for culturing fastidious 
organisms in the gut microbiome4. I used waste effluent in luciferase assays, but it could also be 
added to flask culture or to semisolid media to observe any phenotype changes that could occur 
in the presence of small molecules from the gut. As a media supplement, it’s suggested 
concentration was 3%4. Luciferase assays could be performed with supplemented waste effluent 
at this concentration; however, the increase or time-shift of expression due to additional 
resources for bacterial growth is likely to change even more. This would obscure more subtle 
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changes to gene expression. One could characterize the small molecules in the waste effluent by 
fractionating and testing for an effect on gene expression and overall phenotype.  
 
5.3 Conclusions 
The methods described in this thesis for troubleshooting and optimizing parameters for 
ChIP-seq are useful for other researchers using ChIP-seq to find regulatory targets in other 
biofilm-forming bacterial species. I did not discover any significant peaks at CsgD-regulated 
regions; however, this could be due to epitopes that were not available for our monoclonal 
antibodies to bind in vivo. We identified antibody specificity as a key for successful ChIP 
experiments, and qPCR enrichment as an important confirmation prior to sequencing.  
 In the presence of chemostat media and waste effluent, I observed 5 main trends in 
expression of virulence- and persistence-associated genes. I observed that persistence-associated 
genes were not expressed at 37°C, virulence-associated gene expression dropped off early at 
37°C, virulence-associated genes were expressed early at 28°C, persistence-associated genes at 
28°C were expressed later and were time-shifted in the presence of waste effluent, and csgD, 
sig38H4, and ssrA exhibited multimodal expression at 37°C. Some differences in expression 
could be attributed to a nutritional increase provided by waste effluent and chemostat media. 
There may be other factors that lead to higher expression of some genes in the presence of waste 
effluent, but more research is needed to understand these differences.  
 We focused on the intrinsic changes to gene expression mediated by the S. Typhimurium 
master biofilm regulator, CsgD, using ChIP-seq, and on the extrinsic factors in the gut that could 
lead to differences in expression, using waste effluent containing products of the human gut 
microbiota. The signals for phenotype switching are complex and involve many different players 
in a coordinated effort to produce two cell types with different functions.  
  
104
REFERENCES 
 
1. Ackermann, M. A functional perspective on phenotypic heterogeneity in 
microorganisms. Nature Reviews Microbiology 13, 497-508, doi:10.1038/nrmicro3491 
(2015). 
 
2. Afgan, E., Baker, D., van den Beek, M., Blankenberg, D., Bouvier, D., Čech, M., 
Chilton, J., Clements, D., Coraor, N., Eberhard, C., Grüning, B., Guerler, A., 
Hillman-Jackson, J., Von Kuster, G., Rasche, E., Soranzo, N., Turaga, N., Taylor, 
J., Nekrutenko, A. & Goecks, J. The Galaxy platform for accessible, reproducible and 
collaborative biomedical analyses: 2016 update. Nucleic Acids Research 44, W3-W10, 
doi:10.1093/nar/gkw343 (2016).  
 
3. Allen-Vercoe, E. Bringing the gut microbiota into focus through microbial culture: 
recent progress and future perspective. Current Opinion in Microbiology 16, 625-629, 
doi:10.1016/j.mib.2013.09.008 (2013).  
 
4. Allen-Vercoe, E., McDonald, Julie. Media Supplements and Methods to Culture Human 
Gastrointestinal Anaerobic Microorganisms. United States patent (2014).  
 
5. Andrews, N. C. & Schmidt, P. J. Iron Homeostasis. Annual Review of Physiology 69, 
69-85, doi:10.1146 (2007).  
 
6. Andrews, S. FastQC: A Quality Control tool for High Throughput Sequence Data.  
(2010).  
 
7. Antunes, L. C., McDonald, J. A., Schroeter, K., Carlucci, C., Ferreira, R. B., Wang, 
M., Yurist-Doutsch, S., Hira, G., Jacobson, K., Davies, J., Allen-Vercoe, E. & Finlay, 
B. B. Antivirulence activity of the human gut metabolome. MBio 5, e01183-01114, 
doi:10.1128/mBio.01183-14 (2014).  
 
8. Austin, J. W., Sanders, G., Kay, W. W. & Collinson, S. K. Thin aggregative fimbriae 
enhance Salmonella enteritidis biofilm formation. FEMS Microbiology Letters 162, 295-
301 (1998).  
 
9. Bailey, T. L., Boden, M., Buske, F. A., Frith, M., Grant, C. E., Clementi, L., Ren, J., 
Li, W. W. & Noble, W. S. MEME SUITE: tools for motif discovery and searching. 
Nucleic Acids Research 37, W202-208, doi:10.1093/nar/gkp335 (2009).  
 
10. Barak, J. D., Jahn, C. E., Gibson, D. L. & Charkowski, A. O. The Role of Cellulose 
and O-Antigen Capsule in the Colonization of Plants by Salmonella enterica. Molecular 
Plant-Microbe Interactions 20, 1083-1091 (2007).  
 
11. Barnhart, M. M. & Chapman, M. R. Curli biogenesis and function. Annual Review of 
Microbiology 60, 131-147, doi:10.1146/annurev.micro.60.080805.142106 (2006).  
  
105
 
12. Bäumler, A. J., Tsolis, R. M., Heffron, F. Contribution of fimbrial operons to 
attachment to and invasion of epithelial cell lines by Salmonella typhimurium. Infection 
and Immunity 64, 1862-1865 (1996).  
 
13. Bjarnason, J., Southward, C. M. & Surette, M. G. Genomic Profiling of Iron-
Responsive Genes in Salmonella enterica Serovar Typhimurium by High-Throughput 
Screening of a Random Promoter Library. Journal of Bacteriology 185, 4973-4982, 
doi:10.1128/jb.185.16.4973-4982.2003 (2003).  
 
14. Blasco, B., Chen, J. M., Hartkoorn, R., Sala, C., Uplekar, S., Rougemont, J., Pojer, 
F. & Cole, S. T. Virulence regulator EspR of Mycobacterium tuberculosis is a nucleoid-
associated protein. PLoS Pathogens 8, e1002621, doi:10.1371/journal.ppat.1002621 
(2012).  
 
15. Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina 
sequence data. Bioinformatics 30, 2114-2120, doi:10.1093/bioinformatics/btu170 (2014).  
 
16. Boyd, J. F. Pathology of the alimentary tract in Salmonella typhimurium food poisoning. 
Gut 26, 935-944 (1985).  
 
17. Brown, P. K., Dozois, C. M., Nickerson, C. A., Zuppardo, A., Terlonge, J. & Curtiss, 
R. MlrA, a novel regulator of curli (AgF) and extracellular matrix synthesis by 
Escherichia coli and Salmonella enterica serovar Typhimurium. Molecular Microbiology 
41, 349-363 (2001).  
 
18. Cabeza, M. L., Aguirre, A., Soncini, F. C. & Vescovi, E. G. Induction of RpoS 
degradation by the two-component system regulator RstA in Salmonella enterica. 
Journal of Bacteriology 189, 7335-7342, doi:10.1128/JB.00801-07 (2007).  
 
19. Government of Canada. Pathogen Safety Data Sheets: Infectious Substances – 
Salmonella enterica spp. (2018).  
 
20. Chapman, M. R., Robinson, L. S., Pinkner, J. S., Roth, R., Heuser, J., Hammar, M., 
Normark, S. & Hultgren, S. J. Role of Escherichia coli Curli Operons in Directing 
Amyloid Fiber Formation. Science 295, 851-855 (2002).  
 
21. Charles, R. C., Harris, J. B., Chase, M. R., Lebrun, L. M., Sheikh, A., LaRocque, R. 
C., Logvinenko, T., Rollins, S. M., Tarique, A., Hohmann, E. L., Rosenberg, I., 
Krastins, B., Sarracino, D. A., Qadri, F., Calderwood, S. B. & Ryan, E. T. 
Comparative proteomic analysis of the PhoP regulon in Salmonella enterica serovar 
Typhi versus Typhimurium. PLoS One 4, e6994, doi:10.1371/journal.pone.0006994 
(2009).  
 
  
106
22. Chiu, C. H., Su, L. H. & Chu, C. Salmonella enterica Serotype Choleraesuis: 
Epidemiology, Pathogenesis, Clinical Disease, and Treatment. Clinical Microbiology 
Reviews 17, 311-322, doi:10.1128/cmr.17.2.311-322.2004 (2004).  
 
23. Clarke, D. J. The Rcs phosphorelay: More than just a two-component pathway. Future 
Microbiology 5, 1173-1184 (2010).  
 
24. Close, D., Xu, T., Smartt, A., Rogers, A., Crossley, R., Price, S., Ripp, S. & Sayler, 
G. The evolution of the bacterial luciferase gene cassette (lux) as a real-time bioreporter. 
Sensors (Basel) 12, 732-752, doi:10.3390/s120100732 (2012).  
 
25. Close, D. M., Ripp, S. & Sayler, G. S. Reporter proteins in whole-cell optical 
bioreporter detection systems, biosensor integrations, and biosensing applications. 
Sensors (Basel) 9, 9147-9174, doi:10.3390/s91109147 (2009).  
 
26. Coburn, B., Grassl, G. A. & Finlay, B. B. Salmonella, the host and disease: a brief 
review. Immunology & Cell Biology 85, 112-118, doi:10.1038/sj.icb.7100007 (2007).  
 
27. Cock, P. J., Fields, C. J., Goto, N., Heuer, M. L. & Rice, P. M. The Sanger FASTQ 
file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants. 
Nucleic Acids Research 38, 1767-1771, doi:10.1093/nar/gkp1137 (2010).  
 
28. Collinson, S. K., Clouthier, S. C., Doran, J. L., Kay, W. W. Salmonella enteritidis 
agfBAC operon encoding thin, aggregative fimbriae. Journal of Bacteriology 178, 662-
667 (1996).  
 
29. Collinson, S. K., Emödy, L., Müller, K. H., Trust, T. J., Kay, W. W. Purification and 
characterization of thin, aggregative fimbriae from Salmonella enteritidis. Journal of 
Bacteriology 173, 4773–4781 (1991).  
 
30. Collinson, S. P., J. M. R, Hodges, R. S. & Kay, W. W. Structural predictions of AgfA, 
the insoluble fimbrial subunit of Salmonella thin aggregative fimbriae. Journal of 
Molecular Biology 290, 741-756 (1999).  
 
31. The ENCODE Project Consortium. The ENCODE (ENCyclopedia of DNA Elements) 
Project. Science 306, 636-640, doi:10.1126/science.1105136 (2004).  
 
32. Costerton, J. W., Stewart, Philip S., Greenberg, E.P. Bacterial Biofilms: A Common 
Cause of Persistent Infections. Science 284, 1318-1322 (1999).  
 
33. Costerton, W. J., Lewandowski, Zbigniew, Caldwell, Douglas E., Korber, Darren R. 
Lappin-Scott, Hilary M. Microbial Biofilms. Annual Review of Microbiology 49, 711-
745, doi:10.1146/annurev.mi.49.100195.003431 (1995).  
 
34. Crack, J. C., Munnoch, J., Dodd, E. L., Knowles, F., Al Bassam, M. M., Kamali, S., 
Holland, A. A., Cramer, S. P., Hamilton, C. J., Johnson, M. K., Thomson, A. J., 
  
107
Hutchings, M. I. & Le Brun, N. E. NsrR from Streptomyces coelicolor is a nitric oxide-
sensing [4Fe-4S] cluster protein with a specialized regulatory function. J Biol Chem 290, 
12689-12704, doi:10.1074/jbc.M115.643072 (2015).  
 
35. Crawford, R. W., Gibson, D. L., Kay, W. W. & Gunn, J. S. Identification of a bile-
induced exopolysaccharide required for Salmonella biofilm formation on gallstone 
surfaces. Infection and Immunity 76, 5341-5349, doi:10.1128/IAI.00786-08 (2008).  
 
36. Crosa, J. H. B., D.J., Ewing, W. H., Falkow, S. Molecular Relationships Among the 
Salmonelleae. Journal of Bacteriology 115, 307-315 (1973).  
 
37. Davies, B. W., Bogard, Ryan W., Mekalanos, John J. Mapping the regulon of Vibrio 
cholerae ferric uptake regulator expands its known network of gene regulation. PNAS 
108, 12467-12472 (2011).  
 
38. Deriu, E., Liu, J. Z., Pezeshki, M., Edwards, R. A., Ochoa, R. J., Contreras, H., 
Libby, S. J., Fang, F. C. & Raffatellu, M. Probiotic bacteria reduce salmonella 
typhimurium intestinal colonization by competing for iron. Cell Host & Microbe 14, 26-
37, doi:10.1016/j.chom.2013.06.007 (2013).  
 
39. Desai, P. T., Porwollik, S., Long, F., Cheng, P., Wollam, A., Bhonagiri-Palsikar, V., 
Hallsworth-Pepin, K., Clifton, S. W., Weinstock, G. M. & McClelland, M. 
Evolutionary Genomics of Salmonella enterica Subspecies. MBio 4, 
doi:10.1128/mBio.00579-12 (2013).  
 
40. Dieckmann, R. & Malorny, B. Rapid screening of epidemiologically important 
Salmonella enterica subsp. enterica serovars by whole-cell matrix-assisted laser 
desorption ionization-time of flight mass spectrometry. Applied and Environmental 
Microbiology 77, 4136-4146, doi:10.1128/AEM.02418-10 (2011).  
 
41. Dillon, S. C., Cameron, A. D., Hokamp, K., Lucchini, S., Hinton, J. C. & Dorman, 
C. J. Genome-wide analysis of the H-NS and Sfh regulatory networks in Salmonella 
Typhimurium identifies a plasmid-encoded transcription silencing mechanism. Molecular 
Microbiology 76, 1250-1265, doi:10.1111/j.1365-2958.2010.07173.x (2010).  
 
42. Dong, T. G. & Mekalanos, J. J. Characterization of the RpoN regulon reveals 
differential regulation of T6SS and new flagellar operons in Vibrio cholerae O37 strain 
V52. Nucleic Acids Research 40, 7766-7775, doi:10.1093/nar/gks567 (2012).  
 
43. Dorel, C., Lejeune, P. & Rodrigue, A. The Cpx system of Escherichia coli, a strategic 
signaling pathway for confronting adverse conditions and for settling biofilm 
communities? Research in Microbiology 157, 306-314, doi:10.1016/j.resmic.2005.12.003 
(2006).  
 
44. Dougan, G., John, Victoria, Palmer, Sophie, Mastroeni, Pietro. Immunity to 
salmonellosis. Immunological Reviews 240, 196-210 (2011).  
  
108
 
45. Elsner, H. I. & Lindblad, E. B. Ultrasonic Degradation of DNA. DNA 8, 
doi:10.1089/dna.1989.8.697 (1989).  
 
46. Eng, S.-K., Pusparajah, P., Ab Mutalib, N.-S., Ser, H.-L., Chan, K.-G. & Lee, L.-H. 
Salmonella: A review on pathogenesis, epidemiology and antibiotic resistance. Frontiers 
in Life Science 8, 284-293, doi:10.1080/21553769.2015.1051243 (2015).  
 
47. Engebrecht, J., Simon, M., Silverman, M. Measuring gene expression with light. 
Science 227 (1985).  
 
48. Epigenie. Getting your Fix: Optimizing Chromatin Fixation for ChIP Analysis. (2012). 
http://epigenie.com/getting-your-fix-optimizing-chromatin-fixation-for-chip-analysis/ 
 
49. Feasey, N. A., Dougan, G., Kingsley, R. A., Heyderman, R. S. & Gordon, M. A. 
Invasive non-typhoidal Salmonella disease: an emerging and neglected tropical disease in 
Africa. The Lancet 379, 2489-2499, doi:10.1016/s0140-6736(11)61752-2 (2012).  
 
50. Fitzgerald, D. M., Bonocora, R. P. & Wade, J. T. Comprehensive mapping of the 
Escherichia coli flagellar regulatory network. PLoS Genetics 10, e1004649, 
doi:10.1371/journal.pgen.1004649 (2014).  
 
51. Fluit, A. C. Towards more virulent and antibiotic-resistant Salmonella? FEMS 
Immunology and Medical Microbiology 43, 1-11, doi:10.1016/j.femsim.2004.10.007 
(2005).  
 
52. Fuqua, W. C., Winans, S. C., & Greenberg, E. P. Quorum sensing in bacteria: the 
LuxR-LuxI family of cell density-responsive transcriptional regulators. Journal of 
Bacteriology 176, 269-275 (1994).  
 
53. Garcia Vescovi, E., Soncini, F. C., Groisman, E. A. Mg2+ as an extracellular signal: 
Environmental regulation of Salmonella virulence. Cell 84, 165-174 (1996).  
 
54. Geertz, M. & Maerkl, S. J. Experimental strategies for studying transcription factor-
DNA binding specificities. Briefings in Functional Genomics 9, 362-373, 
doi:10.1093/bfgp/elq023 (2010).  
 
55. Gerstel, U., Kolb, A. & Romling, U. Regulatory components at the csgD promoter--
additional roles for OmpR and integration host factor and role of the 5' untranslated 
region. FEMS Microbiology Letters 261, 109-117, doi:10.1111/j.1574-
6968.2006.00332.x (2006).  
 
56. Gerstel, U., Park, C. & Römling, U. Complex regulation of csgD promoter activity by 
global regulatory proteins. Molecular Microbiology 49, 639-654, doi:10.1046/j.1365-
2958.2003.03594.x (2003).  
 
  
109
57. Gibson, D. L., White, A. P., Snyder, S. D., Martin, S., Heiss, C., Azadi, P., Surette, 
M. & Kay, W. W. Salmonella produces an O-antigen capsule regulated by AgfD and 
important for environmental persistence. Journal of Bacteriology 188, 7722-7730, 
doi:10.1128/JB.00809-06 (2006).  
 
58. Gill, A. Cross-linking chromatin immunoprecipitation (X-ChIP) protocol. (2017). 
http://docs.abcam.com/pdf/protocols/X-ChIP_protocol.pdf 
 
59. Gorvel J. P., M. S. Maturation steps of the Salmonella-containing vacuole. Microbes and 
Infection 3 (2001).  
 
60. Gossen, M., Bujard, H. Tight control of gene expression in mammalian cells by 
tetracycline-responsive promoters. Proceedings of the National Academy of Sciences 89, 
5547-4451 (1992).  
 
61. Grantcharova, N., Peters, V., Monteiro, C., Zakikhany, K. & Romling, U. Bistable 
expression of CsgD in biofilm development of Salmonella enterica serovar typhimurium. 
Journal of Bacteriology 192, 456-466, doi:10.1128/JB.01826-08 (2010).  
 
62. Grassl, G. A. & Finlay, B. B. Pathogenesis of enteric Salmonella infections. Current 
Opinion in Gastroenterology 24, 22-26 (2008).  
 
63. Greer, L. F., 3rd & Szalay, A. A. Imaging of light emission from the expression of 
luciferases in living cells and organisms: a review. Luminescence 17, 43-74, 
doi:10.1002/bio.676 (2002).  
 
64. Grimont, P. A., Weill, Francois-Xavier. (ed WHO Collaborating Center for Reference 
and Research on Salmonella) (World Health Organization, 2007).  
 
65. Gu, D., Liu, H., Yang, Z., Zhang, Y. & Wang, Q. Chromatin Immunoprecipitation 
Sequencing Technology Reveals Global Regulatory Roles of Low-Cell-Density Quorum-
Sensing Regulator AphA in the Pathogen Vibrio alginolyticus. Journal of Bacteriology 
198, 2985-2999, doi:10.1128/JB.00520-16 (2016).  
 
66. Guinane, C. M., Cotter, Paul D. Role of the gut microbiota in health and chronic 
gastrointestinal disease: understanding a hidden metabolic organ. Therapeutic advances 
in Gastroenterology 6, 295–308, doi:10.1177/ 1756283X13482996 (2013).  
 
67. Gupta, R., Patterson, S., Ripp, S., Simpson, M. & Sayler, G. Expression of the 
Photorhabdus luminescens lux genes (luxA, B, C, D, and E) in Saccharomyces cerevisiae. 
FEMS Yeast Research 4, 305-313, doi:10.1016/s1567-1356(03)00174-0 (2003).  
 
68. Haraga, A., Ohlson, M. B. & Miller, S. I. Salmonellae interplay with host cells. Nature 
Reviews Microbiology 6, 53-66, doi:10.1038/nrmicro1788 (2008).  
 
  
110
69. Haycocks, J. R., Sharma, P., Stringer, A. M., Wade, J. T. & Grainger, D. C. The 
molecular basis for control of ETEC enterotoxin expression in response to environment 
and host. PLoS Pathogens 11, e1004605, doi:10.1371/journal.ppat.1004605 (2015).  
 
70. Head, S. R., Komori, H. K., LaMere, S. A., Whisenant, T., Van Nieuwerburgh, F., 
Salomon, D. R. & Ordoukhanian, P. Library construction for next-generation 
sequencing: overviews and challenges. Biotechniques 56, 6168, doi:10.2144/000114133 
(2014).  
 
71. Hengge-Aronis, R. Signal Transduction and Regulatory Mechanisms Involved in 
Control of the  S (RpoS) Subunit of RNA Polymerase. Microbiology and Molecular 
Biology Reviews 66, 373-395, doi:10.1128/mmbr.66.3.373-395.2002 (2002).  
 
72. Herwald H, M. M., Olsen A, Rhen M, Dahlback B, Muller-Esterl, W, Bjorck, L. 
Activation of the contact-phase system on bacterial surfaces—a clue to serious 
complications in infectious diseases. Nature Methods 4, 298-302 (1998).  
 
73. Hill P. J., S. G. S. Use of lux genes in applied biochemistry. Journal of Bioluminescence 
and Chemiluminescence 9, 211-215, doi:10.1002/bio.1170090315 (1994).  
 
74. Hoffman M, E. J., Wilder S, Kundaje A, Harris R, Libbrecht M et al. Integrative 
annotation of chromatin elements from ENCODE data. Nucleic Acids Research 41, 827-
841 (2012).  
 
74. Hoffman, Brad G. & Jones, Steven J. M. Genome-wide identification of DNA-protein 
interactions using chromatin immunoprecipitation coupled with flow cell sequencing. 
Journal of Endocrinology 201, 1-13 (2009).  
 
75. Hoffmann, S., Batz, M. B. & Morris, J. G., Jr. Annual cost of illness and quality-
adjusted life year losses in the United States due to 14 foodborne pathogens. Journal of 
Food Protection 75, 1292-1302, doi:10.4315/0362-028X.JFP-11-417 (2012).  
 
76. Hohmann, E. L. Nontyphoidal salmonellosis. Clinical Infectious Disease 15, 263-269 
(2001).  
 
77. Holmqvist, E., Reimegard, J., Sterk, M., Grantcharova, N., Romling, U. & Wagner, 
E. G. Two antisense RNAs target the transcriptional regulator CsgD to inhibit curli 
synthesis. EMBO Journal 29, 1840-1850, doi:10.1038/emboj.2010.73 (2010).  
 
78. Illumina. Estimating Sequencing Coverage. (2014).  
 
79. Imam, S., Noguera, Daniel R., Donohue, Timothy J. Global Analysis of 
Photosynthesis Transcriptional Regulatory Networks. PLoS Genetics 10 (2014).  
 
  
111
80. Iyer, V. R., Horak, Christine E., Scafe, Charles S., Botstein, David, Snyder, Michael, 
Brown, Patrick O. Genomic binding sites of the yeast cell-cycle transcription factors 
SBF and MBF. Nature 409, doi:10.1038/35054095.  
 
81. Jarvik, T., Smillie, C., Groisman, E. A. & Ochman, H. Short-term signatures of 
evolutionary change in the Salmonella enterica serovar typhimurium 14028 genome. 
Journal of Bacteriology 192, 560-567, doi:10.1128/JB.01233-09 (2010).  
 
82. Jepson, M. A., Collares-Buzato, C. B., Clark, M. A., Hirst, B. H., Simmons, N. L.  
Rapid disruption of epithelial barrier function by Salmonella typhimurium is associated 
with structural modification of intercellular junctions. Infection and Immunity 63, 356-
359 (1995).  
 
83. Ji, H., Jiang, H., Ma, W., Johnson, D. S., Myers, R. M. & Wong, W. H. An integrated 
software system for analyzing ChIP-chip and ChIP-seq data. Nature Biotechnology 26, 
1293-1300, doi:10.1038/nbt.1505 (2008).  
 
84. Jones B. D., G. N., Falkow S. Salmonella typhimurium initiates murine infection by 
penetrating and destroying the specialized epithelial M cells of the Peyer’s patches. 
Journal of Experimental Medicine 180, 15-23 (1994).  
 
85. Jones, C. J., Newsom, D., Kelly, B., Irie, Y., Jennings, L. K., Xu, B., Limoli, D. H., 
Harrison, J. J., Parsek, M. R., White, P. & Wozniak, D. J. ChIP-Seq and RNA-Seq 
reveal an AmrZ-mediated mechanism for cyclic di-GMP synthesis and biofilm 
development by Pseudomonas aeruginosa. PLoS Pathogens 10, e1003984, 
doi:10.1371/journal.ppat.1003984 (2014).  
 
86. Kahramanoglou, C., Seshasayee, A. S., Prieto, A. I., Ibberson, D., Schmidt, S., 
Zimmermann, J., Benes, V., Fraser, G. M. & Luscombe, N. M. Direct and indirect 
effects of H-NS and Fis on global gene expression control in Escherichia coli. Nucleic 
Acids Research 39, 2073-2091, doi:10.1093/nar/gkq934 (2011).  
 
87. Kato, A. & Groisman, E. A. The PhoQ/PhoP regulatory network of Salmonella 
enterica. Advances in Experimental Medicine and Biology 631, 7-21 (2008).  
 
88. Kearse, M., Moir, R., Wilson, A., Stones-Havas, S., Cheung, M., Sturrock, S., 
Buxton, S., Cooper, A., Markowitz, S., Duran, C., Thierer, T., Ashton, B., Mentjies, 
P., & Drummond, A. Geneious Basic: an integrated and extendable desktop software 
platform for the organization and analysis of sequence data. Bioinformatics 28, 1647-
1649 (2012).  
 
89. Kharchenko P, T. M., Park, P. Design and analysis of ChIP-seq experiments for DNA-
binding proteins. Nature Biotechnology 26, 1351-1359 (2008).  
 
  
112
90. Kim, N.-K., Jayatillake, R. V., & Spouge, J. L. NEXT-peak: a normal-exponential two-
peak model for peak-calling in ChIP-seq data. BMC Genomics 14, doi:10.1186/1471-
2164-14-349 (2013).  
 
91. Kim, T. H., Barrera, L. O., Zheng, M., Qu, C., Singer, M. A., Richmond, T. A., Wu, 
Y., Green, R. D. & Ren, B. A high-resolution map of active promoters in the human 
genome. Nature 436, 876-880, doi:10.1038/nature03877 (2005).  
 
92. Kirk, M. D., Pires, S. M., Black, R. E., Caipo, M., Crump, J. A., Devleesschauwer, 
B., Dopfer, D., Fazil, A., Fischer-Walker, C. L., Hald, T., Hall, A. J., Keddy, K. H., 
Lake, R. J., Lanata, C. F., Torgerson, P. R., Havelaar, A. H. & Angulo, F. J. World 
Health Organization Estimates of the Global and Regional Disease Burden of 22 
Foodborne Bacterial, Protozoal, and Viral Diseases, 2010: A Data Synthesis. PLoS 
Medicine 12, e1001921, doi:10.1371/journal.pmed.1001921 (2015).  
 
93. Knierim, E., Lucke, B., Schwarz, J. M., Schuelke, M. & Seelow, D. Systematic 
comparison of three methods for fragmentation of long-range PCR products for next 
generation sequencing. PLoS One 6, e28240, doi:10.1371/journal.pone.0028240 (2011).  
 
94. Korbel, J. O., Urban, A. E., Affourtit, J. P., Godwin, B., Grubert, F., Simons, J. F., 
Kim, P. M., Palejev, D., Carriero, N. J., Du, L., Taillon, B. E., Chen, Z., Tanzer, A., 
Saunders, A. C., Chi, J., Yang, F., Carter, N. P., Hurles, M. E., Weissman, S. M., 
Harkins, T. T., Gerstein, M. B., Egholm, M. & Snyder, M. Paired-end mapping 
reveals extensive structural variation in the human genome. Science 318, 420-426, 
doi:10.1126/science.1149504 (2007).  
 
95. Kundaje, A. A comprehensive collection of signal artifact blacklist regions in the human 
genome. ENCODE (2013).  
 
96. Kuvandik C., K. I., Namiduru M., Baydar I. Predictive value of clinical and laboratory 
findings in the diagnosis of the enteric fever. New Microbiologica 32, 25-30 (2009).  
 
97. Lagier, J. C., Armougom, F., Million, M., Hugon, P., Pagnier, I., Robert, C., Bittar, 
F., Fournous, G., Gimenez, G., Maraninchi, M., Trape, J. F., Koonin, E. V., La 
Scola, B. & Raoult, D. Microbial culturomics: paradigm shift in the human gut 
microbiome study. Clinical Microbiology and Infection 18, 1185-1193, 
doi:10.1111/1469-0691.12023 (2012).  
 
98. Landt, S. G. et al. ChIP-seq guidelines and practices of the ENCODE and modENCODE 
consortia. Genome Research 22, 1813-1831, doi:10.1101/gr.136184.111 (2012).  
 
99. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nature 
Methods 9, 357-359, doi:10.1038/nmeth.1923 (2012).  
 
  
113
100. Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. Ultrafast and memory-efficient 
alignment of short DNA sequences to the human genome. Genome Biology 10, 
doi:10.1186/gb-2009-10-3-r25 (2009).  
 
101. Latasa, C., Roux, A., Toledo-Arana, A., Ghigo, J. M., Gamazo, C., Penades, J. R. & 
Lasa, I. BapA, a large secreted protein required for biofilm formation and host 
colonization of Salmonella enterica serovar Enteritidis. Molecular Microbiology 58, 
1322-1339, doi:10.1111/j.1365-2958.2005.04907.x (2005).  
 
102. Le Minor, L., Popoff, Michel Y. Designation of Salmonella enterica sp. nov., norn. rev., 
as the Type and Only Species of the Genus Salmonella. International Journal of 
Systematic Bacteriology, 465-468 (1987).  
 
103. Ledeboer, N. A. & Jones, B. D. Exopolysaccharide sugars contribute to biofilm 
formation by Salmonella enterica serovar typhimurium on HEp-2 cells and chicken 
intestinal epithelium. Journal of Bacteriology 187, 3214-3226, 
doi:10.1128/JB.187.9.3214-3226.2005 (2005).  
 
104. Levine, M. Normal mineral homeostasis. Interplay of parathyroid hormone and vitamin 
D. Endocrine Development 6, 14-33 (2003).  
 
105. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler 
transform. Bioinformatics 25, 1754-1760, doi:10.1093/bioinformatics/btp324 (2009).  
 
106. Li, Q., Brown, J. B., Huang, H. & Bickel, P. J. Measuring reproducibility of high-
throughput experiments. The Annals of Applied Statistics 5, 1752-1779, doi:10.1214/11-
aoas466 (2011).  
 
107. Lieb, J. D. in Functional Genomics Vol. 224 Methods in Molecular Biology (ed 
Khodursky A.B.  Brownstein M.J.) 99-109 (Humana Press, 2003).  
 
108. Lin-Hui Su, M. C.-H. C. Salmonella: Clinical importance and Evolution of 
Nomenclature. Chang Gung Medical Journal 30 (2007).  
 
109. Livak, K. J. & Schmittgen, T. D. Analysis of Relative Gene Expression Data Using 
Real-Time Quantitative PCR and the 2−ΔΔCT Method. Methods 25, 402-408, 
doi:10.1006/meth.2001.1262 (2001).  
 
110. MacKenzie, K. D., Palmer, M. B., Koster, W. L. & White, A. P. Examining the Link 
between Biofilm Formation and the Ability of Pathogenic Salmonella Strains to Colonize 
Multiple Host Species. Frontiers in Veterinary Science 4, 138, 
doi:10.3389/fvets.2017.00138 (2017).  
 
111. MacKenzie, K. D., Wang, Y., Shivak, D. J., Wong, C. S., Hoffman, L. J., Lam, S., 
Kroger, C., Cameron, A. D., Townsend, H. G., Koster, W. & White, A. P. Bistable 
  
114
expression of CsgD in Salmonella enterica serovar Typhimurium connects virulence to 
persistence. Infection and Immunity 83, 2312-2326, doi:10.1128/IAI.00137-15 (2015).  
 
112. Majdalani, N. & Gottesman, S. The Rcs phosphorelay: A complex signal transduction 
system. Annual Review of Microbiology, 59, 379−405. Annual Review of Microbiology 
59, 379-405, doi:10.1146/ (2005).  
 
113. Marx, V. Finding the right antibody for the job. Nature Methods 10, 703-707, 
doi:10.1038/nmeth.2570 (2013).  
 
114. McDonald, J. A., Fuentes, S., Schroeter, K., Heikamp-deJong, I., Khursigara, C. M., 
de Vos, W. M. & Allen-Vercoe, E. Simulating distal gut mucosal and luminal 
communities using packed-column biofilm reactors and an in vitro chemostat model. 
Journal of Microbiological Methods 108, 36-44, doi:10.1016/j.mimet.2014.11.007 
(2015).  
 
115. McDonald, J. A., Schroeter, K., Fuentes, S., Heikamp-Dejong, I., Khursigara, C. M., 
de Vos, W. M. & Allen-Vercoe, E. Evaluation of microbial community reproducibility, 
stability and composition in a human distal gut chemostat model. Journal of 
Microbiological Methods 95, 167-174, doi:10.1016/j.mimet.2013.08.008 (2013).  
 
116. McElroy, W. D., Hastings, J. W. The Requirement of Riboflavin Phosphate for 
Bacterial Luminescence. Science 118, 385-386, doi:10.1126/science.118.3066.385 
(1953).  
 
117. Meighen, E. A. Bacterial bioluminescence: organization, regulation, and application of 
the lux genes. Federation of American Societies for Experimental Biology 7 1016-1022 
(1993).  
 
118. Minch, K. J., Rustad, T. R., Peterson, E. J., Winkler, J., Reiss, D. J., Ma, S., Hickey, 
M., Brabant, W., Morrison, B., Turkarslan, S., Mawhinney, C., Galagan, J. E., 
Price, N. D., Baliga, N. S. & Sherman, D. R. The DNA-binding network of 
Mycobacterium tuberculosis. Nature Communications 6, 5829, doi:10.1038/ncomms6829 
(2015).  
 
119. Moest, T. P. & Meresse, S. Salmonella T3SSs: successful mission of the secret(ion) 
agents. Current Opinion in Microbiology 16, 38-44, doi:10.1016/j.mib.2012.11.006 
(2013).  
 
120. Morgan, J. L., McNamara, J. T. & Zimmer, J. Mechanism of activation of bacterial 
cellulose synthase by cyclic di-GMP. Nature Structural and Molecular Biology 21, 489-
496, doi:10.1038/nsmb.2803 (2014).  
 
121. Myers, K. S., Park, D. M., Beauchene, N. A. & Kiley, P. J. Defining bacterial regulons 
using ChIP-seq. Methods 86, 80-88, doi:10.1016/j.ymeth.2015.05.022 (2015).  
 
  
115
122. Myers, K. S., Yan, H., Ong, I. M., Chung, D., Liang, K., Tran, F., Keles, S., Landick, 
R. & Kiley, P. J. Genome-scale analysis of escherichia coli FNR reveals complex 
features of transcription factor binding. PLoS Genet 9, e1003565, 
doi:10.1371/journal.pgen.1003565 (2013).  
 
123. Nakoneczna I., H. H. S. The comparative histopathology of primary and secondary 
lesions in murine salmonellosis. British Journal of Experimental Pathology 61, 76-84 
(1980).  
 
124. Nealson, K. H., & Hastings, J. W. Bacterial bioluminescence: its control and ecological 
significance. Microbiological Reviews 43, 496-518 (1979).  
 
125. O'Connell-Rodwell, C. E., Burns, Stacy M., Bachmann, Michael H., Contag, 
Christopher H. Bioluminescent indicators for in vivo measurements of gene expression. 
Trends in Biotechnology 20, pS19-S23, doi:10.1016/S0167-7799(02)02001-2 (2002).  
 
126. O'Neill, L. Immunoprecipitation of native chromatin: NChIP. Methods 31, 76-82, 
doi:10.1016/s1046-2023(03)00090-2 (2003).  
 
127. Ogasawara, H., Hasegawa, A., Kanda, E., Miki, T., Yamamoto, K. & Ishihama, A. 
Genomic SELEX search for target promoters under the control of the PhoQP-RstBA 
signal relay cascade. Journal of Bacteriology 189, 4791-4799, doi:10.1128/JB.00319-07 
(2007).  
 
128. Olsen A, A. A., Hammar M, Sukupolvi S, Normark S. The RpoS sigma factor relieves 
H-NS-mediated transcriptional repression of csgA, the subunit gene of fibronectin-
binding curli in Escherichia coli. Molecular Microbiology 7, 523-536 (1993).  
 
129. Olsen A, J. A., Normark S. Fibronectin binding mediated by a novel class of surface 
organelles on Escherichia coli. Nature 338, 652-655 (1989).  
 
130. Olsen A, W. M., Morgelin M, Bjorck L. 1998. Infect. & 66:944–49, I. Curli, fibrous 
surface proteins of Escherichia coli, interact with major histocompatibility complex class 
I molecules. Infection and Immunity 66, 944-949 (1998).  
 
131. Olsson, O., Escher, Alan, Sandberg, Göran, Schell, Jeff, Koncz, Csaba, Szalay, 
Aladar A. Engineering of monomeric bacterial luciferases by fusion of luxA and luxB 
genes in Vibrio harveyi. Gene 81, 335-347, doi:10.1016/0378-1119(89)90194-7 (1989).  
 
132. Park, D. M., Akhtar, M. S., Ansari, A. Z., Landick, R. & Kiley, P. J. The bacterial 
response regulator ArcA uses a diverse binding site architecture to regulate carbon 
oxidation globally. PLoS Genetics 9, e1003839, doi:10.1371/journal.pgen.1003839 
(2013).  
 
133. Park, P. J. ChIP-seq: advantages and challenges of a maturing technology. Nature 
Reviews Genetics 10, 669-680, doi:10.1038/nrg2641 (2009).  
  
116
 
134. Peano, C., Wolf, J., Demol, J., Rossi, E., Petiti, L., De Bellis, G., Geiselmann, J., Egli, 
T., Lacour, S. & Landini, P. Characterization of the Escherichia coli sigma(S) core 
regulon by Chromatin Immunoprecipitation-sequencing (ChIP-seq) analysis. Scientific 
Reports 5, 10469, doi:10.1038/srep10469 (2015).  
 
135. Pepke, S., Wold, B. & Mortazavi, A. Computation for ChIP-seq and RNA-seq studies. 
Nature Methods 6, S22-32, doi:10.1038/nmeth.1371 (2009).  
 
136. Perkins, T. T., Davies, M. R., Klemm, E. J., Rowley, G., Wileman, T., James, K., 
Keane, T., Maskell, D., Hinton, J. C., Dougan, G. & Kingsley, R. A. ChIP-seq and 
transcriptome analysis of the OmpR regulon of Salmonella enterica serovars Typhi and 
Typhimurium reveals accessory genes implicated in host colonization. Molecular 
Microbiology 87, 526-538, doi:10.1111/mmi.12111 (2013).  
 
137. Petrone, B. L., Stringer, Anne M., Wadea, Joseph T. Identification of HilD-Regulated 
Genes in Salmonella enterica Serovar Typhimurium. Journal of Bacteriology 196, 1094-
1101 (2014).  
 
138. Prieto, A. I., Kahramanoglou, C., Ali, R. M., Fraser, G. M., Seshasayee, A. S. & 
Luscombe, N. M. Genomic analysis of DNA binding and gene regulation by 
homologous nucleoid-associated proteins IHF and HU in Escherichia coli K12. Nucleic 
Acids Research 40, 3524-3537, doi:10.1093/nar/gkr1236 (2012).  
 
139. Prouty, A. M. & Gunn, J. S. Comparative Analysis of Salmonella enterica Serovar 
Typhimurium Biofilm Formation on Gallstones and on Glass. Infection and Immunity 71, 
7154-7158, doi:10.1128/iai.71.12.7154-7158.2003 (2003).  
 
140. Ramsey, C. H., Edwards, P. R. Resistance of Salmonellae Isolated in 1959 and 1960 to 
Tetracyclines and Chloramphenicol. Applied and Environmental Microbiology 9, 389-
391 (1961).  
 
141. Reeves, M. W., Evins, G. M., Heiba, A. A., Plikaytis, B. D. & Farmer, J. J. I. Clonal 
nature of Salmonella typhi and its genetic relatedness to other salmonellae as shown by 
multilocus enzyme electrophoresis and proposal of Salmonella bongori comb. nov. 
Journal of Clinical Microbiology 27, 313-320 (1989).  
 
142. Reichhardt, C., McCrate, O. A., Zhou, X., Lee, J., Thongsomboon, W. & Cegelski, 
L. Influence of the amyloid dye Congo red on curli, cellulose, and the extracellular 
matrix in E. coli during growth and matrix purification. Analytical and Bioanalytical 
Chemistry 408, 7709-7717, doi:10.1007/s00216-016-9868-2 (2016).  
 
143. Ren, R., Wyrick, Aparicio, Jennings, Simon, Young. Genome-wide location and 
function of DNA binding proteins. Science 290, 2306-2309 (2000).  
 
  
117
144. Rescigno M., U. M., Valzasina B., Francolini M., Rotta G., Bonasio R. et al. 
Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to 
sample bacteria. Nature Immunology 2, 361-367 (2001).  
 
145. Richter-Dahlfors A., B. A. M., Finlay B. B. Murine salmonellosis studied by confocal 
microscopy: Salmonella typhimurium resides intracellularly inside macrophages and 
exerts a cytotoxic effect on phagocytes in vivo. Journal of Experimental Medicine 186, 
569-580 (1997).  
 
146. Robbe-Saule, V., Carreira, I., Kolb, A. & Norel, F. Effect of growth temperature on 
Crl-dependent regulation of sigmaS activity in Salmonella enterica serovar 
Typhimurium. Journal of Bacteriology 190, 4453-4459, doi:10.1128/JB.00154-08 
(2008).  
 
147. Robbe-Saule, V., Jaumouille, V., Prevost, M. C., Guadagnini, S., Talhouarne, C., 
Mathout, H., Kolb, A. & Norel, F. Crl activates transcription initiation of RpoS-
regulated genes involved in the multicellular behavior of Salmonella enterica serovar 
Typhimurium. Journal of Bacteriology 188, 3983-3994, doi:10.1128/JB.00033-06 
(2006).  
 
148. Robertson, G., Hirst, M., Bainbridge, M., Bilenky, M., Zhao, Y., Zeng, T., 
Euskirchen, G., Bernier, B., Varhol, R., Delaney, A., Thiessen, N., Griffith, O. L., 
He, A., Marra, M., Snyder, M. & Jones, S. Genome-wide profiles of STAT1 DNA 
association using chromatin immunoprecipitation and massively parallel sequencing. 
Nature Methods 4, 651-657, doi:10.1038/nmeth1068 (2007).  
 
149. Rolfe, R. D. Role of Volatile Fatty Acids in Colonization Resistance to Clostridium 
dificile. Infection and Immunity 45, 185-191 (1984).  
 
150. Romling, U., Bian, Z., Hammar, M., Sierralta, W. D. & Normark, S. Curli Fibers Are 
Highly Conserved between Salmonella typhimurium and Escherichia coli with Respect 
to Operon Structure and Regulation. Journal of Bacteriology (1998). 
 
151. Romling, U., Bokranz, W., Rabsch, W., Zogaj, X., Nimtz, M. & Tschape, H. 
Occurrence and regulation of the multicellular morphotype in Salmonella serovars 
important in human disease. International Journal of Food Microbiology 293, 273-285, 
doi:10.1078/1438-4221-00268 (2003). 
 
152. Romling, U. & Galperin, M. Y. Bacterial cellulose biosynthesis: diversity of operons, 
subunits, products, and functions. Trends in Microbiology 23, 545-557, 
doi:10.1016/j.tim.2015.05.005 (2015). 
 
153. Römling, U. & Rohde, M. Flagella modulate the multicellular behavior of Salmonella 
typhimurium on the community level. FEMS Microbiology Letters 180, 91-102 (1999). 
 
  
118
154. Romling, U., Rohde, M., Olsen, A., Normark, S. & Reinkoster, J. AgfD, the 
checkpoint of multicellular and aggregative behaviour in Salmonella typhimurium 
regulates at least two independent pathways. Molecular Microbiology 36, 10-23 (2000). 
 
155. Romling, U., Sierralta, W. D., Eriksson, K. & Normark, S. Multicellular and 
aggregative behaviour of Salmonella typhimurium strains is controlled by mutations in 
the agfD promoter. Molecular Microbiology 28, 249-264 (1998). 
 
156. Ryan, M. P., O'Dwyer, J. & Adley, C. C. Evaluation of the Complex Nomenclature of 
the Clinically and Veterinary Significant Pathogen Salmonella. BioMed Research 
International 2017, doi:10.1155/2017/3782182 (2017). 
 
157. Sadikot, R. T. & Blackwell, T. S. Bioluminescence imaging. Proceedings of the 
American Thoracic Society 2, 537-540, 511-532, doi:10.1513/pats.200507-067DS 
(2005). 
 
158. Schmiedeberg, L., Skene, P., Deaton, A. & Bird, A. A temporal threshold for 
formaldehyde crosslinking and fixation. PLoS One 4, e4636, 
doi:10.1371/journal.pone.0004636 (2009). 
 
159. Schoppee Bortz, P. D. & Wamhoff, B. R. Chromatin immunoprecipitation (ChIP): 
revisiting the efficacy of sample preparation, sonication, quantification of sheared DNA, 
and analysis via PCR. PLoS One 6, e26015, doi:10.1371/journal.pone.0026015 (2011). 
 
160. Sengupta, M., Jain, V., Wilkinson, B. J. & Jayaswal, R. K. Chromatin 
immunoprecipitation identifies genes under direct VraSR regulation in Staphylococcus 
aureus. Canadian Journal of Microbiology 58, 703-708, doi:10.1139/w2012-043 (2012). 
 
161. USDA Economic Research Service. Cost Estimates of Foodborne Illnesses (2014). 
http://ers.usda.gov/data-products/cost-estimates-of-foodborne-illnesses.aspx. 
 
162. Simm, R., Morr, M., Kader, A., Nimtz, M. & Romling, U. GGDEF and EAL domains 
inversely regulate cyclic di-GMP levels and transition from sessility to motility. 
Molecular Microbiology 53, 1123-1134, doi:10.1111/j.1365-2958.2004.04206.x (2004). 
 
163. Simpson, M. L., Sayler, Gary S., Fleming, James T., Applegate, Bruce. Whole-cell 
biocomputing 19 (2001). 
 
164. Singh, S. S., Singh, N., Bonocora, R. P., Fitzgerald, D. M., Wade, J. T. & Grainger, 
D. C. Widespread suppression of intragenic transcription initiation by H-NS. Genes & 
Development 28, 214-219, doi:10.1101/gad.234336.113 (2014). 
 
165. Snyder, D. S., Gibson, D., Heiss, C., Kay, W. & Azadi, P. Structure of a capsular 
polysaccharide isolated from Salmonella enteritidis. Carbohydrate Research 341, 2388-
2397, doi:10.1016/j.carres.2006.06.010 (2006). 
 
  
119
166. Solano, C., García, Begoña, Valle, Jaione, Berasain, Carmen, Ghigo, Jean-Marc, 
Gamazo, Carlos, Lasa, Iñigo. Genetic analysis of Salmonella enteritidis biofilm 
formation: critical role of cellulose. Molecular Microbiology 43, doi:10.1046/j.1365-
2958.2002.02802.x (2002). 
 
167. Solans, L., Gonzalo-Asensio, J., Sala, C., Benjak, A., Uplekar, S., Rougemont, J., 
Guilhot, C., Malaga, W., Martin, C. & Cole, S. T. The PhoP-dependent ncRNA Mcr7 
modulates the TAT secretion system in Mycobacterium tuberculosis. PLoS Pathogens 10, 
e1004183, doi:10.1371/journal.ppat.1004183 (2014). 
 
168. Solomon, L. & Varshavsky, A. Mapping protein-DNA interactions in vivo with 
formaldehyde: Evidence that histone H4 is retained on a highly transcribed gene. Cell 53, 
937-947 (1988). 
 
169. Solomon, M. J. & Varshavsky, A. Formaldehyde-mediated DNA-protein cross-linking: 
a probe for in vivo chromatin structures. Proceedings of the National Academy of 
Sciences 82, 6470-6474 (1985). 
 
170. Stecher, B. & Hardt, W. D. Mechanisms controlling pathogen colonization of the gut. 
Current Opinion in Microbiology 14, 82-91, doi:10.1016/j.mib.2010.10.003 (2011). 
 
171. Steenackers, H., Hermans, K., Vanderleyden, J. & De Keersmaecker, Sigrid C. J. 
Salmonella biofilms: An overview on occurrence, structure, regulation and eradication. 
Food Research International 45, 502-531, doi:10.1016/j.foodres.2011.01.038 (2012). 
 
172. Strehler, B. L., Harvey, E. N., Chang, J. J., Cormier, M. J. The luminescent oxidation 
of reduced riboflavin or reduced riboflavin phosphate in the bacterial luciferin-luciferase 
reaction. Proceedings of the National Academy of Sciences USA 40, 10-12 (1954). 
 
173. Su, L. H., Chiu, C.H. Salmonella: clinical importance and evolution of nomenclature. 
Chang Gung Medical Journal 30, 210-219 (2007). 
 
174. Integrated Taxonomic Information System (ITIS). Salmonella Lignieres, 1900. 
(National Museum of Natural History, USA, 2012). 
 
175. Tauxe, R. V., Doyle, M. P., Kuchenmuller, T., Schlundt, J. & Stein, C. E. Evolving 
public health approaches to the global challenge of foodborne infections. International 
Journal of Food Microbiology 139, S16-28, doi:10.1016/j.ijfoodmicro.2009.10.014 
(2010). 
 
176. Tennant, S. M., MacLennan, C. A., Simon, R., Martin, L. B. & Khan, M. I. 
Nontyphoidal Salmonella disease: Current status of vaccine research and development. 
Vaccine 34, 2907-2910, doi:10.1016/j.vaccine.2016.03.072 (2016). 
 
177. Thouand, G., Daniel, P., Horry, H., Picart, P., Durand, M. J., Killham, K., Knox, O. 
G., DuBow, M. S. & Rousseau, M. Comparison of the spectral emission of lux 
  
120
recombinant and bioluminescent marine bacteria. Luminescence 18, 145-155, 
doi:10.1002/bio.716 (2003). 
 
178. Tindall, B. J., Grimont, P. A., Garrity, G. M. & Euzeby, J. P. Nomenclature and 
taxonomy of the genus Salmonella. International Journal of Systematic and Evolutionary 
Microbiology 55, 521-524, doi:10.1099/ijs.0.63580-0 (2005). 
 
179. Valouev, A., Johnson, D. S., Sundquist, A., Medina, C., Anton, E., Batzoglou, S., 
Myers, R. M. & Sidow, A. Genome-wide analysis of transcription factor binding sites 
based on ChIP-Seq data. Nature Methods 5, 829-834, doi:10.1038/nmeth.1246 (2008). 
 
180. Van Dyk, T. K., Wei, Yan, Hanafey, Michael K.,  Dolan, Maureen, Reeve, Mary 
Jane G., Rafalski, J. Antoni, Rothman-Denes, Lucia B., LaRossa, Robert A. A 
genomic approach to gene fusion technology. PNAS 98, 2555-2560, 
doi:10.1073/pnas.041620498 (2001). 
 
181. van Kessel, J. C., Ulrich, L. E., Zhulin, I. B. & Bassler, B. L. Analysis of activator and 
repressor functions reveals the requirements for transcriptional control by LuxR, the 
master regulator of quorum sensing in Vibrio harveyi. MBio 4, doi:10.1128/mBio.00378-
13 (2013). 
 
182. Vidal, O., Longin, R., Prigent-Combaret, C., Dorel, C., Hooreman, M. & Lejeune, P. 
Isolation of an Escherichia coli K-12 mutant strain able to form biofilms on inert 
surfaces: involvement of a new ompR allele that increases curli expression. Journal of 
Bacteriology 180, 2442-2449 (1998). 
 
183. Waldner, L. L., MacKenzie, K. D., Koster, W. & White, A. P. From Exit to Entry: 
Long-term Survival and Transmission of Salmonella. Pathogens 1, 128-155, 
doi:10.3390/pathogens1020128 (2012). 
 
184. Wen, Y., Ouyang, Z., Devreese, B., He, W., Shao, Y., Lu, W. & Zheng, F. Crystal 
structure of master biofilm regulator CsgD regulatory domain reveals an atypical receiver 
domain. Protein Science 26, 2073-2082, doi:10.1002/prot.3245 (2017). 
 
185. White, A. P., Gibson, D. L., Collinson, S. K., Banser, P. A. & Kay, W. W. 
Extracellular Polysaccharides Associated with Thin Aggregative Fimbriae of Salmonella 
enterica Serovar Enteritidis. Journal of Bacteriology 185, 5398-5407, 
doi:10.1128/jb.185.18.5398-5407.2003 (2003). 
 
186. White, A. P., Gibson, D. L., Grassl, G. A., Kay, W. W., Finlay, B. B., Vallance, B. A. 
& Surette, M. G. Aggregation via the red, dry, and rough morphotype is not a virulence 
adaptation in Salmonella enterica serovar Typhimurium. Infection and Immunity 76, 
1048-1058, doi:10.1128/IAI.01383-07 (2008). 
 
  
121
187. White, A. P., Gibson, D. L., Kim, W., Kay, W. W. & Surette, M. G. Thin aggregative 
fimbriae and cellulose enhance long-term survival and persistence of Salmonella. Journal 
of Bacteriology 188, 3219-3227, doi:10.1128/JB.188.9.3219-3227.2006 (2006). 
 
188. White, A. P. & Surette, M. G. Comparative genetics of the rdar morphotype in 
Salmonella. Journal of Bacteriology 188, 8395-8406, doi:10.1128/JB.00798-06 (2006). 
 
189. White, A. P., Weljie, A. M., Apel, D., Zhang, P., Shaykhutdinov, R., Vogel, H. J. & 
Surette, M. G. A global metabolic shift is linked to Salmonella multicellular 
development. PLoS One 5, e11814, doi:10.1371/journal.pone.0011814 (2010). 
 
190. Whitfield, C. & Roberts, I. S. Structure, assembly and regulation of expression of 
capsules in Escherichia coli. Molecular Microbiology 31, 1307-1319 (1999). 
 
191. Wong, K. H., Jin, Y. & Moqtaderi, Z. in Current Protocols in Molecular Biology. Ch. 
7, Unit 7.11, (2013). 
 
192. Wu, D. Y., Bittencourt, D., Stallcup, M. R. & Siegmund, K. D. Identifying differential 
transcription factor binding in ChIP-seq. Frontiers in Genetics 6, 169, 
doi:10.3389/fgene.2015.00169 (2015). 
 
193. Yrlid U., S. M., Hakansson A., Chambers B. J., Ljunggren H. G., Wick M. J. In vivo 
activation of dendritic cells and T cells during Salmonella enterica serovar Typhimurium 
infection. Infection and Immunity 69 (2001). 
 
194. Zakikhany, K., Harrington, C. R., Nimtz, M., Hinton, J. C. & Romling, U. 
Unphosphorylated CsgD controls biofilm formation in Salmonella enterica serovar 
Typhimurium. Molecular Microbiology 77, 771-786, doi:10.1111/j.1365-
2958.2010.07247.x (2010). 
 
195. Zhang, Y., Hu, Ji-Fan, Wang, Hong, Cui, Jiuwei, Gao, Sujun, Hoffman, Andrew R., 
Li, Wei. CRISPR Cas9-guided chromatin immunoprecipitation identi es miR483 as an 
epigenetic modulator of IGF2 imprinting in tumors. Oncotarget 8, 34177-34190 (2017). 
 
196. Zhang, Y., Lin, Y. H., Johnson, T. D., Rozek, L. S. & Sartor, M. A. PePr: a peak-
calling prioritization pipeline to identify consistent or differential peaks from replicated 
ChIP-Seq data. Bioinformatics 30, 2568-2575, doi:10.1093/bioinformatics/btu372 (2014). 
 
197. Zogaj, X., Nimtz, M., Rohde, M., Bokranz, W. & Römling, U. The multicellular 
morphotypes of Salmonella typhimurium and Escherichia coli produce cellulose as the 
second component of the extracellular matrix. Molecular Microbiology 39, 1452-1463, 
doi:10.1046/j.1365-2958.2001.02337.x (2001). 
  
122
APPENDIX A 
Anti-CsgD monoclonal antibody purification and characteristics. 
Table A1. Anti-CsgD mouse monoclonal antibody initial characteristics, purification 
methods, and final stocks for use in ChIP-seq in Salmonella Typhimurium. 
Ascites 
received 
Antibody product Raw mouse ascites 
Received from Immunoprecise 
Cell line  Mouse anti-CsgD His-RP 6D4 
Volume 36.5ml + 1ml stock 
Mouse strain 5x BALB/c 
Initial concentration 0.9-10mg/ml 
Purification Method Protein G  chromatography 
cartridge, syringe 
Solutions Pierce Protein G Binding buffer  
Elution buffer 0.1M Glycine pH 2.3 
Neutralization buffer  1M Tris-HCl 
pH 8.0 
Ascites flow-through volume and elutions ~5ml per flow-through 
10 elutions 
Processing Protein concentration cut-off >0.12mg/ml 
Combined and concentrated mAb 50K MWCO centrifugal filter 
Final 
antibody 
stocks 
Final volume and storage solution 10.3ml in 50mM Tris-HCl pH 8.0 + 
0.02% Sodium azide 
Aliquots 6x 1.5ml  
1x 1.3ml  
Concentration 3mg/ml 
Tested efficacy Yes, by Western blot and dot blot 
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APPENDIX B 
ChIP-seq protocol from a manuscript prepared for the Journal of Visualized Experiments 
(JoVE). 
1. Flask culture cell growth 
1.1.From frozen stocks, streak Salmonella serovar Typhimurium 14028 on LB agar and 
incubate at 37 °C for 16-20 h to obtain isolated colonies.  
1.2.Inoculate 5 mL LB broth with 1-3 colonies from streak plates and incubate at 37 °C with 
shaking for 7 h 
1.3.Find OD600 of broth culture using a spectrophotometer 
1.4.Add 1.0 OD600 volume equivalent of cell culture (i.e. 10
9 cells) to an Erlenmeyer flask 
containing 100 mL 1% tryptone. Incubate at 28 °C with shaking for 13 h 
 
2. Collect cell-free conditioned 1% tryptone 
2.1.Collect flask culture for cell-free conditioned 1% tryptone.  
2.2.Pipette flask culture several times to mix before adding to a centrifuge tube. Centrifuge at 
12 000 xg for 10 min at 10 °C. 
2.3.Decant supernatant into a 0.2 µm filter unit, vacuum filter, and dispense into a new tube. 
 
Note: Biofilm are highly resistant in conventional solutions (e.g. PBS) and will adhere to itself 
and the sides of tubes and pipette tips. Resuspension in conditioned tryptone allows for 
manipulation and homogenization. 
 
3. Separate biofilm and planktonic cells from flask cultures 111. 
3.1.Using a sterile 25 mL pipette, aliquot flask culture into 15 mL tubes. Centrifuge at 210 xg 
for 2 min, to separate the two cell types. 
Note: Biofilm cells should be a loose pellet at the bottom of the tube 
 
3.2.Pipette the supernatant containing the planktonic cells into a centrifuge tube. Do not 
disturb the pellet. The supernatant will be used later. Remove all remaining liquid from 
the pellet. 
 
4. Prepare biofilm aggregates 
 
Note: Biofilm is harvested by wet weight to yield 25 µg of DNA starting material. The CFU of S. 
Typhimurium biofilm can be found from biofilm weight by this conversion factor: 1.63x108 
CFU/mg. Researchers are advised to determine the weight of biofilm required using this 
equation: 
 
25 µ  	
1 g
1x10 g
	
6.022x10 bp
1 mole
	
1 mole
650 g
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genome size (bp)
		 
1 
1000 
	 
!#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4.1.Resuspend the biofilm pellet in 1 mL conditioned tryptone. Move the resuspended 
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biofilm into a pre-weighed 2 mL snap cap (i.e., Safe-Lock) or screw cap tube. 
4.2.Centrifuge for 5 s, rotate and centrifuge for 1 min at 11 000 xg at 20 °C 
4.3.Remove all supernatant from the tube and weigh the tube accurately. Subtract the tube 
weight from the weight of the tube with biofilm to find the weight of aggregates. It 
should be +/-10% of the target biofilm weight.  
4.4.Wash the biofilm pellet in PBS. Add 1ml PBS to the tube and vortex to resuspend the 
pellet. 
 
5. Prepare planktonic cells 
5.1.Dispense supernatant from slow speed centrifugation into 40 mL centrifuge tubes. 
5.2.Measure the OD600 of the planktonic cells using a spectrophotometer and calculate the 
required volume for a final OD600 of 6.0. 
& $. (0) = 5. # &J(. *%&(&( (0) 	 
K*%&(&( LMM 
6.0 LMM
 
5.3.Pellet planktonic cells using the floor centrifuge. Cool the floor centrifuge to 10 °C and 
spin at 10 000 xg for 10 min at 10 °C. 
5.4.Remove the supernatant and resuspend the pellet in the calculated final volume of PBS. 
Re-measure OD600 of the planktonic cells using a spectrophotometer. 
5.5.Dispense the volume of 6.0 OD600 planktonic cells into a 2 mL snap cap (i.e., Safe-Lock) 
or screw cap tube . Bring volume to 1 mL with conditioned tryptone. 
 
6. Homogenize cells 
6.1.Aseptically add one sterilized metal bead to each of the tubes. 
6.2.Homogenize using a mixer mill (i.e., Qiagen TissueLyser II) for 5 min at 30 Hz. Observe 
aggregate tubes to confirm that biofilm has been broken apart. 
6.3.Transfer the homogenized cells to a new 1.5 mL tube, avoiding the metal bead, Bring the 
volume to 1 mL with PBS.  
 
Note: perform drop dilutions to enumerate input cells and check that the final cell number is 
close to the desired or predicted number  
 
7. Cross-linking of proteins to DNA 
7.1.Dispense fresh formaldehyde into sample tubes to a final concentration of 1%. Incubate 
for 30 min at room temperature on a rotating wheel. 
 
Caution: Formaldehyde is corrosive, a skin, eye, and respiratory irritant, and flammable. 
Dispense in a fume hood. 
 
7.2.Add glycine to a final concentration of 125 mM to stop crosslinking. Incubate for 5 min 
at room temperature on a rotating wheel. 
 
8. Wash cells to remove excess crosslinker 
8.1.Centrifuge tube for 3 min at 8000 xg and remove the supernatant 
8.2.Resuspend the pellet in 20 µL 25x protease inhibitors (cOmplete™, EDTA-free Protease 
Inhibitor Cocktail, Sigma-Aldrich, COEDTAF-RO ROCHE) and 500 µL filter sterilized 
PBS. 
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8.3.Centrifuge tube for 3 min at 8000 xg and remove the supernatant. 
 
9. Lyse cells  
9.1.Resuspend the pellet in 600 µL Lysis buffer and incubate on ice for 10 min. 
9.2.Add 1.4 mL IP dilution buffer to a sterile 15 mL tube, and move lysed cells to the 15 mL 
tube. Keep the tube on ice for 1.5-2 h, and vortex occasionally.  
 
Note: Some resistant material may remain in tubes. A long incubation period on ice with 
occasional vortexing will break apart material. The remainder will be broken up through 
sonication. 
 
10. Sonicate to fragment DNA 
10.1. Tune the sonicator (Vibra-Cell Ultrasonic Processor, VC300, 3mm probe). Place 
the 15 mL tube in a beaker of ice, and place the probe inside the tube.  
10.2. Perform 5 sonication “bursts” of 30 s on at 20-40% of 400 W with 2 min cooling 
on ice between bursts.  
10.3. Remove precipitated material by centrifuging at 15800 xg for 10 min at 4 °C. 
Transfer the supernatant to a new tube.  
10.4. OPTIONAL: Rapidly decrosslink at 65°C and digest RNA and protein at 45°C 
before running on a 2% agarose gel gel to check for proper size fragments. 
 
Note: Immerse the probe into the cell lysate. Keep the solution on ice while sonicating and 
resting. Do not remove the tube while the sonicator probe is pulsing. The solution should appear 
cloudy pre-sonication and clear post-sonication.  
 
11. Immunoprecipitate DNA-protein-antibody complexes  
 
In this experimental format, DNA that binds non-specifically to normal mouse IgG is removed. 
The remaining DNA is immunoprecipitated with normal mouse IgG (control IP) or the 
transcription-factor specific monoclonal antibody (test IP). Pre-cleared input DNA without 
immunoprecipitation selection is also a suggested sequencing control. 
 
11.1. Pre-clear IP samples 
11.1.1. Add 50 µg normal mouse IgG to sonicated DNA and incubate for 1 h at 4 °C on a 
rotating wheel. 
11.1.2. Add 100 µl Protein G magnetic beads (ChIP-grade, Cell Signaling Technology, 
#9006S) to sonicated DNA containing normal mouse IgG. Incubate 3 h at 4 °C on a 
rotating wheel.  
11.1.3. Separate the bead complexes on a magnetic stand. Dispense the supernatant into a 
new 15 mL tube containing 1 mL IP Dilution buffer to bring it to a total volume of 3 
mL. 
11.1.4. Dispense two 1.35 mL aliquots for immunoprecipitation and one 200 µL aliquot as an 
input control. Keep the input control at -80 °C until decrosslinking and digesting 
steps. 
 
11.2. Immunoprecipitation with primary antibody. 
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11.2.1. Add 10 µg purified protein-specific primary antibody to one of the 1.35 µL aliquots 
as a test sample. Add 10 µg non-specific normal mouse IgG to one of the 1.35 µL 
aliquots as a control sample. Incubate overnight at 4 °C on a rotating wheel.  
 
Note: The primary antibody can be a monoclonal antibody, high-quality polyclonal serum or 
commercial epitope antibody (i.e., anti-FLAG) 
 
11.2.2. Add 50 µL Protein G magnetic beads to the precleared DNA with primary antibody 
and incubate at 4 °C for 3 h on a rotating wheel.  
11.2.3. Place IP wash buffer 1, IP wash buffer 2, and TE pH 8.0 in an ice bucket. Warm 
elution buffer to 65 °C. 
  
11.2.4. Bind beads to the side of tubes using a magnetic stand 
11.2.5. Perform washes: wash twice with 750 µL cold IP wash buffer 1, wash once with 750 
µL cold IP wash buffer 2, and twice with 750 µL cold TE at pH 8.0. Keep the tubes 
on the magnetic stand during washes.  
11.2.6. Add 450 µL IP Elution buffer to each tube and incubate at 65 °C for 30 min with 
gentle vortexing every 5 min. 
11.2.7. Bind beads to the side of tubes using a magnetic stand. Wait at least 2 min until the 
solution is clear.  
11.2.8. Dispense the cleared solution to a new 1.5 mL tube. 
Note: Do not put solution containing elution buffer on ice. 
12. Reverse crosslinks and digest RNA 
12.1. Add 2 µg RNase A and NaCl to a final concentration of 0.3 M to each tube. 
Incubate at 65 °C, for ≥6 h, or overnight 
 
13. Digest protein 
13.1. Add 180 µg Proteinase K to each tube 
13.2. Incubate at 45 °C for 3-5 h. 
 
14. Purify DNA. 
Note: Magnetic beads are preferred for isolating the small amounts of DNA usually recovered 
during ChIP with bacterial cells. 
15. Prepare libraries using a kit that is compatible with your selected sequencing platform 
(NEBNext Ultra DNA Library Prep Kit for Illumina, E7370S). 
Check library concentration with a Qubit (Thermo Fisher Scientific, Q33216) and BR dsDNA kit 
(Thermo Fisher Scientific, Invitrogen, Q32850) or a qRT-PCR library quantification kit.  
Note: Qubit measurements may overestimate DNA concentration slightly. 
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16. Pool libraries to 20 pM in 100 µL, accounting for adequate coverage for each library 
sample. For Salmonella, we pooled 10-12 libraries. Add Tris-HCl pH 8.0 to a final 
concentration of 1 mM, or TE pH 8.0 to a final concentration of 1 mM. 
16.1. Dilute the library pool and sequence according to the selected platform’s 
specifications (MiSeq, MiSeq Reagent Kit v3 (150 cycle) Illumina, MS-102-3001).  
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APPENDIX C 
Materials required for performing ChIP-seq with S. Typhimurium biofilm and planktonic cells 
from 13 hour flask culture. 
 
Table C1. Materials and equipment required for culturing and harvesting S. Typhimurium 
cell types 
Name of Material or 
Equipment 
Company Catalog 
Number 
Description/Procedural step 
Luria-Bertani broth  BD 
Biosciences 
 Overnight culture in 5 mL LB for 
inoculating flask culture 
BD Bacto™ 
Tryptone 
BD 
Biosciences 
 
211705 
 
Media for the growth of S. Typhimurium 
cell types in flask culture 
Serological pipettes, 
10 and 25 mL 
FroggaBio 2507646 
2507645 
Transfer of flask culture (biofilm 
adheres to glass pipettes) 
Spectrophotometer 
and 2.0 mL cuvettes 
  Measure OD600 of planktonic cells  
Nalgene® 115 mL 
Filter Units, Sterile, 
0.2 µm pore size 
Thermo 
Scientific 
73520-980 Filtration unit for preparing conditioned 
tryptone from a portion of flask culture. 
40 mL centrifuge 
tubes 
Sigma Aldrich T1418 Centrifugation of flask culture for 
conditioned tryptone and slow speed 
centrifugation supernatant for planktonic 
cells 
15 mL tubes FroggaBio 116930000 Collection and separation of cell types 
 
Table C2. Materials and equipment required for homogenizing, crosslinking, lysing, and 
sonicating cell samples  
Name of Material/ 
Equipment 
Company Catalog 
Number 
Description/Procedural step 
Safe-Lock Tubes, 
2.0 mL, colorless 
Eppendorf 22363344 Small tubes with a secure, snapping lid for 
use during homogenization. 
Mixer mill Retsch MM 400 Equipment for homogenizing cells in Safe-
Lock tubes 
5mm Stainless 
Steel Beads 
Qiagen 69989 Placed into Safe-Lock tubes with cell samples 
to aid homogenization with Retsch mixer mill 
Formaldehyde Sigma-Aldrich 252549 ACS reagent, 37 % in H2O, contains 10-15% 
methanol for crosslinking. 
Ultrasonic Liquid 
Processor 
Sonics & 
Materials, Inc. 
VC300 Probe sonicator for fragmenting DNA after 
lysis. 
Tapered microtip 
1/8” (3mm)  
Sonics & 
Materials, Inc. 
630-0418 Probe for sonication-based DNA 
fragmentation. 
Tube Revolver Crystal 
Industries 
HYQ-
1130A 
Portable rotating wheel for distributing and 
incubating ChIP reagents in Eppendorf tubes. 
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Can be substituted for tilting or “Belly 
Dancer” platform. 
Mouse Gamma 
Globulin 
Jackson 
ImmunoResear
ch 
Laboratories, 
Inc 
015-000-
002 
Normal species-matched IgG for control (i.e. 
“mock”) IP  
cOmplete™, 
EDTA-free 
Protease Inhibitor 
Cocktail 
Sigma-Aldrich COEDTA
F-
RO ROC
HE 
Prevents protein digestion prior to 
immunoprecipitation. 
Can be substituted for other protease inhibitor 
cocktails. 
RNase A, DNase 
and protease-free 
(10 mg/mL) 
ThermoFisher 
Scientific 
EN0531 Enzyme for digesting RNA prior to DNA 
purification. 
Proteinase K 
powder 
ThermoFisher 
Scientific 
AM2542 Enzyme for digesting protein prior to DNA 
purification 
Axygen Magnetic 
beads 
Macherey-
Nagel 
744970  DNA purification 
ChIP-Grade 
Protein G 
Magnetic Beads  
Cell Signaling 
Technology 
9006 Immunoprecipitation. 
DynaMag™-2 
Magnet 
 
Life 
Technologies 
12321D Separation of magnetic beads during DNA 
immunoprecipitation and purification 
 
Table C3. Buffer recipes for cell lysis. 
Lysis buffer IP dilution buffer 
50mM Tris-HCl pH 8.1 20mM Tris-HCl pH 8.1 
10mM EDTA 2mM EDTA 
1% SDS 0.01% SDS  
protease inhibitors protease inhibitors  
 150mM NaCl 
 1% Triton X-100 
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Table C4. Materials and equipment required for immunoprecipitation and DNA 
purification 
Name of Material/ 
Equipment 
Company Catalog 
Number 
Description/Procedural step 
ChIP-Grade Protein 
G Magnetic Beads  
Cell Signaling 
Technology 
9006 Immunoprecipitation. 
NGS Cleanup and 
Size Select 
Machery-
Nagel 
744970.5 Purify DNA after immunoprecipitation 
Anti-CsgD Antibody See above (Immunoprecise antibody) 
DynaMag™-2 
Magnet 
 
Life 
Technologies 
12321D Separation of magnetic beads during DNA 
immunoprecipitation and purification 
Tube Revolver Crystal 
Industries 
HYQ-
1130A 
Portable rotating wheel for distributing and 
incubating ChIP reagents in Eppendorf 
tubes. 
Can be substituted for tilting or “Belly 
Dancer” platform. 
 
Table C5. Buffer recipes for immunoprecipitation washes and elution 
IP wash buffer 1 IP wash buffer 2 TE (T10E1) pH 8.0 Elution buffer 
20mM Tris-HCl pH 8.1 10mM Tris-HCl pH 8.1 10mM Tris-HCl 1% SDS 
2mM EDTA 1mM EDTA 1mM EDTA 100mM NaHCO3 
50mM NaCl 250mM LiCl   
1% Triton X-100 1% NP-40   
0.1% SDS 1% deoxycholic acid   
 
Table C6. Materials and equipment required for confirmatory tests, library preparation, 
and sequencing 
Name of Material/ 
Equipment 
Company Catalog 
Number 
Description/Procedural step 
Qubit 3.0 Thermo Fisher 
Scientific 
Q33216 Measure DNA concentration of ChIP DNA 
accurately  
BR dsDNA kit  ThermoFisher 
Scientific 
Q32850 
2100 Bioanalyzer Agilent G2939BA Observe fragment size range of DNA 
before and after library preparation High Sensitivity DNA 
kit 
Agilent 5067-
4626 
NEBNext Ultra DNA 
Library Prep Kit for 
Illumina 
New England 
BioLabs 
E7370S Prepare libraries from ChIP DNA 
MiSeq Reagent Kit 
v3 (150 cycle)   
Illumina MS-102-
3001 
Sequence DNA libraries 
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APPENDIX D 
Materials required for performing luciferase assays with S. Typhimurium with luxCDABE 
promoter-reporters for virulence- and persistence-associated genes. 
 
Table D1. Materials and equipment required for luciferase assays measuring gene 
expression in the presence of waste effluent.  
Name of Material or 
Equipment 
Company Catalog 
Number 
Description 
96-Well Clear Bottom 
Black or White Polystyrene 
Microplates 
Corning 07-200-567 Plates for detection of bacterial 
growth and fluorescence  
Multi-Detector Microplate 
Reader VICTOR™ X3, 
VICTOR3V 1420 
Perkin 
Elmer 
2030-0050 
1420-040  
Equipment for detecting bacterial 
growth and fluorescence intensity 
Mineral oil Sigma-
Aldrich 
M5904  Applied to plate wells to prevent 
evaporation 
Waste effluent or 
chemostat media 
Given by Dr. Emma Allen-Vercoe 
Luria-Bertani broth  BD 
Biosciences 
244620 Overnight culture in 5 mL LB for 
inoculating plates, growth media for 
luciferase assays 
BD Bacto™ Tryptone BD 
Biosciences 
211705 Growth media for luciferase assays 
2,2-dipyridyl (2,2′-
Bipyridyl) 
Sigma-
Aldrich 
D7505 Iron chelator 
Kanamycin Sigma-
Aldrich 
60615 Maintenance of the pCS26-
luxCDABE plasmid during growth  
 
 
 
 
